<SEC-DOCUMENT>0001193125-22-062200.txt : 20220302
<SEC-HEADER>0001193125-22-062200.hdr.sgml : 20220302
<ACCEPTANCE-DATETIME>20220302061602
ACCESSION NUMBER:		0001193125-22-062200
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220301
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220302
DATE AS OF CHANGE:		20220302

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMPUTER PROGRAMS & SYSTEMS INC
		CENTRAL INDEX KEY:			0001169445
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		IRS NUMBER:				743032373
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-49796
		FILM NUMBER:		22701318

	BUSINESS ADDRESS:	
		STREET 1:		6600 WALL STREET
		CITY:			MOBILE
		STATE:			AL
		ZIP:			36695
		BUSINESS PHONE:		2516398100

	MAIL ADDRESS:	
		STREET 1:		6600 WALL STREET
		CITY:			MOBILE
		STATE:			AL
		ZIP:			36695
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d301274d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cpsi="http://cpsi.com/20220301" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-03-01_to_2022-03-01">COMPUTER PROGRAMS &amp; SYSTEMS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-03-01_to_2022-03-01">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-03-01_to_2022-03-01">0001169445</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cpsi-20220301.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-03-01_to_2022-03-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001169445</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-01</xbrli:startDate> <xbrli:endDate>2022-03-01</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-03-01_to_2022-03-01">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt:datemonthdayyearen">March&#160;1, 2022</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">COMPUTER PROGRAMS AND SYSTEMS, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-03-01_to_2022-03-01">000-49796</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-03-01_to_2022-03-01">74-3032373</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-03-01_to_2022-03-01">54 St. Emanuel Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-03-01_to_2022-03-01">Mobile</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:stateprovnameen">Alabama</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-03-01_to_2022-03-01">36602</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, including Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-03-01_to_2022-03-01">(251)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-03-01_to_2022-03-01">639-8100</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-03-01_to_2022-03-01">Common Stock, par value $.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-03-01_to_2022-03-01">CPSI</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-03-01_to_2022-03-01" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;1, 2022, Computer Programs and Systems, Inc., a Delaware corporation (&#8220;<span style="text-decoration:underline">CPSI</span>&#8221;), entered into a Stock Purchase Agreement (the &#8220;<span style="text-decoration:underline">Purchase Agreement</span>&#8221;) with Healthcare Resource Group, Inc., a Washington corporation (&#8220;<span style="text-decoration:underline">HRG</span>&#8221;), the stockholders of HRG set forth on the signature pages to the Purchase Agreement (each a &#8220;<span style="text-decoration:underline">Seller</span>&#8221; and, collectively, the &#8220;<span style="text-decoration:underline">Sellers</span>&#8221;), and Steven McCoy, in his capacity as the representative (the &#8220;<span style="text-decoration:underline">Securityholder Representative</span>&#8221;) of the Sellers and the optionholders of HRG (collectively, the &#8220;<span style="text-decoration:underline">Securityholders</span>&#8221;). The Purchase Agreement provides, among other things, that, upon the terms and subject to the conditions set forth therein, (i)&#160;CPSI will purchase from the Sellers all of the issued and outstanding shares of capital stock of HRG (the &#8220;<span style="text-decoration:underline">HRG Shares</span>&#8221;), (ii) the outstanding stock options of HRG (the &#8220;<span style="text-decoration:underline">HRG Options</span>&#8221;) will be cancelled, and (iii)&#160;CPSI will pay the purchase price to the Securityholders, for the purchase of the HRG Shares and the cancellation of the HRG Options, as provided in the Purchase Agreement (collectively, the &#8220;<span style="text-decoration:underline">Transaction</span>&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties to the Purchase Agreement closed the Transaction on March&#160;1, 2022. Effective upon the consummation of the Transaction (the &#8220;<span style="text-decoration:underline">Closing</span>&#8221;), HRG became a wholly-owned subsidiary of CPSI. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement provides for a total purchase price (the &#8220;<span style="text-decoration:underline">Purchase Price</span>&#8221;) of $44.0&#160;million (the &#8220;<span style="text-decoration:underline">Base Cash Price</span>&#8221;), subject to various upward or downward adjustments, including for working capital, cash, indebtedness and transaction expenses of HRG. Additionally, pursuant to the Purchase Agreement, a total of approximately $11.9&#160;million was withheld from the Base Cash Price at the Closing and deposited by CPSI into various escrow accounts with an escrow agent, including $11.0&#160;million as an indemnity escrow. Based upon the adjustments and the various escrow holdbacks, at the Closing CPSI paid a net amount of approximately $32.9&#160;million to the Securityholders. As an inducement to CPSI entering into the Purchase Agreement, HRG entered into employment agreements, effective as of the Closing, with certain of its key employees. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Purchase Agreement contains customary representations, warranties and covenants. The representations and warranties made by the Sellers to CPSI cover a broad range of items related to, among other things, the business and financial condition of HRG. Subject to certain exceptions and limitations, including but not limited to time limitations and limitations on sources of recovery, the Securityholders have agreed to indemnify CPSI for certain breaches of representations, warranties and covenants and certain other enumerated items. Subject to certain exceptions and limitations, CPSI has likewise agreed to indemnify the Securityholders for certain breaches of representations, warranties and covenants. The foregoing limitations on indemnification obligations are subject to an exception for fraud by the indemnifying party. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Closing of the Transaction, CPSI made a draw of $48&#160;million on its existing senior secured revolving credit facility. A portion of the proceeds from such draw, together with available cash on hand, was used by CPSI to make the various required payments at the Closing. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is filed herewith as Exhibit&#160;2.1 and is incorporated herein by reference. The Purchase Agreement has been included as an exhibit to provide investors with information regarding its terms. It is not intended to provide any other factual information about CPSI, HRG or any of their respective affiliates. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of that agreement and as of specific dates; were made solely for the benefit of the parties to that agreement; are subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures; may not have been intended to be statements of fact, but rather, as a method of allocating contractual risk and governing the contractual rights and relationships between the parties to that agreement; and may be subject to standards of materiality applicable to contracting parties that differ from those applicable to investors. Investors should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of CPSI, HRG or any of their respective affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in CPSI&#8217;s public disclosures. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;1, 2022, CPSI issued a press release announcing the execution of the Purchase Agreement and the Closing of the Transaction. A copy of the press release is furnished herewith as Exhibit&#160;99.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;<span style="text-decoration:underline">Exchange Act</span>&#8221;), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following exhibits are filed herewith: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;2.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d301274dex21.htm">Stock Purchase Agreement, dated March&#160;1, 2022, by and among Computer Programs and Systems, Inc., Healthcare Resource Group, Inc., the Sellers named therein, and the Securityholder Representative.* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d301274dex991.htm">Press Release dated March&#160;1, 2022. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain annexes and schedules have been omitted pursuant to Item 601(a)(5) of Regulation <span style="white-space:nowrap">S-K.</span> CPSI hereby agrees to furnish supplementally copies of any of the omitted documents to the SEC upon its request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" colspan="5"><span style="font-weight:bold">COMPUTER PROGRAMS AND SYSTEMS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: March&#160;2, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ J. Boyd Douglas</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">J. Boyd Douglas</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d301274dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>by and among </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Computer
Programs and Systems, Inc., as Buyer, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Each of the Persons Listed on <FONT STYLE="white-space:nowrap">Annex&nbsp;A-1,</FONT> as
Sellers, </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Steven McCoy, as the Securityholder Representative, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>and </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Healthcare Resource
Group, Inc., as the Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>March 1, 2022 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE I </B>DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE II </B>SALE AND PURCHASE OF THE COMPANY SHARES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Sale and Purchase</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Closing Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Purchase Price Adjustment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>2.6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Treatment of Company Options</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE III </B>REPRESENTATIONS AND WARRANTIES REGARDING SELLERS AND THE
COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization and Good Standing; Capitalization; Subsidiaries.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority; No Conflict</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Financial Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Intellectual Property Rights; Company Products; Information Systems</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Data Security and Privacy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Material Customers; Material Suppliers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Contracts; No Defaults</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governmental Authorizations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Compliance with Laws; Anti-Bribery and Anti-Money Laundering Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.14</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Business Associates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.16</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.17</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>ESOP Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.18</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.19</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Related Persons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.20</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Powers of Attorney; Bank Accounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.21</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Absence of Certain Changes, Events and Conditions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.22</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers or Finders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.23</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>3.24</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>ESOP Representations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE IV </B>REPRESENTATIONS AND WARRANTIES REGARDING BUYER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Organization and Good Standing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Authority, No Conflict</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Proceedings; Orders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Brokers or Finders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>No Other Representations or Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE V </B>COVENANTS AND AGREEMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Returns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Amended Tax Returns and Carrybacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Refunds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tail Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Public Announcements and Other Communications</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Restrictive Covenants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification of Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>ESOP Covenants</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>5.10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE VI </B>INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification Obligations of Securityholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Indemnification Obligations of Buyer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Time Limitations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Other Limitations and Guidelines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Procedure for Indemnification &#150; Third-Party Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Procedure for Indemnification &#150; Direct Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Payment of Indemnification Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Exclusive Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>6.10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Tax Treatment of Indemnification Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman; "><B>ARTICLE VII </B>GENERAL PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.1</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.2</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Successors and Assigns; No Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.4</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Entire Agreement; Modification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.5</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.6</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Governing Law; Venue; Waiver of Jury Trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.8</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Enforcement of Agreement; Remedies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.9</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Counterparts; Execution of Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Rules of Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.11</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Securityholder Representative</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.12</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Certain Waivers and Releases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>7.13</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Set Off</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Annexes</U>: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Annex&nbsp;A-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sellers</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex <FONT STYLE="white-space:nowrap">A-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Optionholders</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex <FONT STYLE="white-space:nowrap">A-3</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Securityholders</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Defined Terms</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Required Notices, Filings, and Consents</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit Plans, Insurance Policies, and Company Contracts to be Terminated</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex&nbsp;E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Example Calculation of Net Working Capital</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification Matters</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annex G</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Restricted Securityholders</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock Purchase Agreement (this &#147;<U>Agreement</U>&#148;), dated as of March&nbsp;1, 2022 (the &#147;<U>Closing Date</U>&#148;), is by
and among Computer Programs and Systems, Inc., a Delaware corporation (&#147;<U>Buyer</U>&#148;), on the one hand, and each of the Persons listed on <U>Annex</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;A-1</FONT></U> (each, a
&#147;<U>Seller</U>&#148; and, collectively, &#147;<U>Sellers</U>&#148;), Steven McCoy, as the representative of Securityholders (the &#147;<U>Securityholder Representative</U>&#148;), and Healthcare Resource Group, Inc., a Washington corporation
(the &#147;<U>Company</U>&#148;), on the other hand. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Sellers collectively own all of the issued and outstanding shares of capital stock of the Company (the &#147;<U>Company Shares</U>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Sellers desire to sell to Buyer, and Buyer desires to purchase from Sellers, all of the Company Shares for the consideration and on
the terms set forth in this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Parties, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth on <U>Annex</U><U></U><U>&nbsp;B</U> are the definitions of certain capitalized terms used in this Agreement, as well as
cross-references to the applicable portions of this Agreement where certain other capitalized terms are defined. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SALE AND PURCHASE OF THE COMPANY SHARES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_3"></A><B>2.1</B> <B><U>Sale and Purchase</U></B>. In accordance with the terms of this Agreement, Sellers hereby sell
to Buyer, and Buyer hereby purchases from Sellers, the Company Shares, free and clear of all Encumbrances (other than Statutory Transfer Restrictions). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> <B><U>Purchase Price</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The aggregate price for the purchase of the Company Shares and cancellation of the Company Options (the &#147;<U>Purchase Price</U>&#148;)
is a dollar amount equal to Base Cash Price, as adjusted pursuant to this Agreement, including <U>Section</U><U></U><U>&nbsp;2.5</U> and <U>Article</U><U></U><U>&nbsp;VI</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Closing, Buyer shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) pay to each Seller the amount set forth opposite such Seller&#146;s name on <U>Annex <FONT STYLE="white-space:nowrap">A-3</FONT></U> (each
such payment amount, a &#147;<U>Seller Closing Payment</U>,&#148; and collectively, the &#147;<U>Seller Closing Payments</U>&#148;) by wire transfer of immediately available funds to the Seller&#146;s Purchase Price Bank Account; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) pay to the Lenders, on behalf of the Company, the amounts necessary to pay off the Estimated Closing Indebtedness owed to the Lenders by
wire transfer of immediately available funds to the accounts designated by the Lenders in the Debt Payoff Letters; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) pay to the Persons identified in the Invoices, on behalf of the Company, the amounts
necessary to pay off the Estimated Closing Transaction Expenses owed to such Persons by wire transfer of immediately available funds to the accounts designated in the Invoices; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) deposit with the Escrow Agent the Escrow Amount into a holdback escrow account to be governed by the terms of this Agreement and the
Escrow Agreement, which shall provide that the Buyer is considered the owner of the escrow account such that the Escrow Amount shall not be considered plan assets of the ESOP until such time as, and to the extent that, any portion of the Escrow
Amount is distributed to the ESOP in accordance with this Agreement and the Escrow Agreement, and, to the extent not paid pursuant to <U>Section</U><U></U><U>&nbsp;2.2(b)(iii)</U>, pay to the Escrow Agent the Escrow Fee, in each case, by wire
transfer of immediately available funds to the account designated by the Escrow Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_4"></A><B>2.3</B>
<B><U>Closing</U></B>. Subject to the terms of this Agreement, the Parties shall consummate the Transactions (the &#147;<U>Closing</U>&#148;) on the Closing Date and the Parties shall, and shall cause their respective Representatives to, conduct the
Closing remotely through the exchange of Transaction Documents and signatures thereto by facsimile, electronic mail, or other means of electronic transmission (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of
2000, e.g., www.docusign.com), or by such other method as Buyer, on the one hand, and the Securityholder Representative, on the other hand, mutually agree upon in writing, effective as of 12:00:01 a.m. (Central Time) on the Closing Date (the
&#147;<U>Effective Time</U>&#148;). All Transactions that are to occur on and as of the Closing Date will be deemed to have occurred simultaneously as of the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4</B> <B><U>Closing Obligations</U></B>. In addition to any other documents to be delivered under, or actions to be taken pursuant to,
other provisions of this Agreement, at the Closing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Sellers and the Company shall, and Sellers shall cause the Company to, deliver, or
cause to be delivered, to Buyer the following (collectively, the &#147;<U>Seller Closing Documents</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) stock powers,
accompanied by certificates representing the Company Shares or appropriate indemnities for any lost certificates representing the Company Shares, in each case, in form and substance reasonably acceptable to Buyer, duly executed by Sellers; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Escrow Agreement, duly executed by the Securityholder Representative; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) instruments evidencing the resignation of each director and officer of the Company (solely with respect to their director and officer
designations, but not from employment with the Company) that Buyer has requested to resign as of the Closing, in form and substance reasonably acceptable to Buyer, duly executed by each such director and officer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) an employment agreement with Buyer (an &#147;<U>Employment Agreement</U>&#148;), in form and substance reasonably acceptable to Buyer,
duly executed by each Key Employee and the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) payoff letters (the &#147;<U>Debt Payoff Letters</U>&#148;), in form and
substance reasonably acceptable to Buyer, duly executed by the Lenders, providing for, upon the payment of all Closing Indebtedness owed by the Company to such Lender at the Closing, the termination of all Encumbrances held by such Lender with
respect to the Assets of the Company (including authorization of the Company to file all necessary <FONT STYLE="white-space:nowrap">UCC-3</FONT> termination statements and other necessary documentation in connection with the termination of such
Encumbrances); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) evidence, in form and substance reasonably acceptable to Buyer, that all Encumbrances
on the Company Shares (other than Statutory Transfer Restrictions) and all Encumbrances on the Assets of the Company (other than Permitted Encumbrances and Encumbrances terminated pursuant to any Debt Payoff Letter) have been released, in each case,
at or prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) invoices (the &#147;<U>Invoices</U>&#148;) from the applicable Persons, dated no more than four
(4)&nbsp;Business Days prior to the Closing Date, with respect to all Closing Transaction Expenses due and payable to such applicable Persons as of the Closing Date; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) evidence, in form and substance reasonably acceptable to Buyer, that those notices required to be given and Filings required to be
made by any Seller or the Company in connection with the execution, delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions that are set forth on <U>Annex</U><U></U><U>&nbsp;C</U> have been
duly given to or made with the appropriate Persons, and copies, in form and substance reasonably acceptable to Buyer, of those Consents required to be obtained by any Seller or the Company in connection with the execution, delivery, and performance
of the Transaction Documents and the consummation and performance of the Transactions that are set forth on <U>Annex</U><U></U><U>&nbsp;C</U>, duly executed by the appropriate Persons; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) with respect each of the Real Property Leases,&nbsp;(A) a landlord waiver and estoppel certificate, in form and substance reasonably
acceptable to Buyer, duly executed by the landlord under each Real Property Lease, and (B)&nbsp;the original or an accurate and complete copy of each Real Property Lease; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) an affidavit stating, under penalty of perjury, that the Company is not, and has not been, a &#147;United States real property holding
corporation&#148; as defined in Section&nbsp;897(c)(2) of the Code during the applicable period described in Section&nbsp;897(c)(1)(A)(ii) of the Code, in form and substance reasonably acceptable to Buyer, duly executed by the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) certificates of status or good standing (or the equivalent) for the Company from the State of Washington and each other jurisdiction in
which the Company is qualified to do business, all issued by the Secretary of State or Commonwealth (or other applicable Governmental Authority) of such jurisdiction, and all dated no more than ten (10)&nbsp;Business Days prior to the Closing Date;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) a certificate, in form and substance reasonably acceptable to Buyer, duly executed by the
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, (A)&nbsp;certifying as accurate and complete as of the Closing, attached copies of the Constitutive Documents of the Company (certified by the Department of State (or other applicable
Governmental Authority) of the State of Washington, dated no more than ten (10)&nbsp;Business Days prior to the Closing Date) and the Governance Documents of the Company, (B)&nbsp;attaching all requisite resolutions or actions of the board of
directors and shareholders of the Company approving the (1)&nbsp;execution, delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions, and (2)&nbsp;the termination of those Benefit Plans,
Insurance Policies (or replacement insurance policies), and Company Contracts set forth on <U>Annex</U><U></U><U>&nbsp;D</U>, and certifying that all such resolutions or actions were duly adopted, have not been amended, modified, or rescinded in any
respect, and remain in full force and effect as of the Closing, and (C)&nbsp;certifying as to the names, titles, and signatures of the officers of the Company authorized to sign and deliver the Transaction Documents on behalf of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) evidence, in form and substance reasonably acceptable to Buyer, that the Company has terminated those Benefit Plans, Insurance
Policies (or replacement insurance policies), and Company Contracts set forth on <U>Annex</U><U></U><U>&nbsp;D</U>, in each case, in compliance with the terms of each such Benefit Plan, Insurance Policy (or replacement insurance policy), and Company
Contract; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) evidence, in form and substance reasonably acceptable to Buyer, that the Company has
paid in cash in accordance and consistent with past practices of the Company&nbsp;the portion of all semi-annual director bonuses (but not monthly or quarterly commissions to the extent such commissions constitute a Current Liability in the
calculation of Estimated Net Working Capital), including any employer paid payroll Taxes payable with respect thereto, payable to the Business Associates for services performed by such Business Associates through the Closing Date (collectively, the
&#147;<U>Pro Rated Bonus Payments</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) the ESOP Amendment and written resolutions approving the ESOP Amendment and the
termination of the ESOP and, both in form and substance reasonably acceptable to Buyer, duly adopted by the Company and Trustee; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) a
certificate, in form and substance reasonably acceptable to Buyer, duly executed by the Trustee, setting forth the Trustee&#146;s determination that (A)&nbsp;the Transactions contemplated hereby will not violate any provision of the ESOP or ERISA,
including any of the Trustee&#146;s fiduciary obligations under ERISA, (B)&nbsp;the consideration to be received by the Trust in connection with the Transactions contemplated hereby is not less than &#147;adequate consideration&#148; within the
meaning of Section&nbsp;3(18) of ERISA, and (C)&nbsp;the terms and conditions of the Transactions contemplated hereby, taken as a whole, are fair to the ESOP and its participants from a financial point of view and are in the best interests of the
participants in the ESOP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) the Final Fairness Opinion, in form and substance reasonably acceptable to Buyer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) a legal opinion from independent counsel for the ESOP, in form and substance reasonably acceptable to Buyer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) an Option Cancellation Agreement for each Optionholder, duly executed by each Optionholder and the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) an electronic copy (e.g., <FONT STYLE="white-space:nowrap">CD-ROM</FONT> or USB drive) of the Virtual Data Room as it exists immediately
prior to the Closing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi) a Consulting Agreement, in form and substance acceptable to Buyer, duly executed by Steven McCoy and the
Company; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii) such other documents as Buyer reasonably requests, each in form and substance reasonably acceptable to Buyer, and
each duly executed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Buyer shall deliver, or cause to be delivered, to the Securityholder Representative the following
(collectively, the &#147;<U>Buyer Closing Documents</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the Escrow Agreement, duly executed by Buyer; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) a certificate of good standing for Buyer issued by the Secretary of State of the State of Delaware, and dated no more than ten
(10)&nbsp;Business Days prior to the Closing Date; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a certificate, in form and substance reasonably acceptable to the Securityholder
Representative, duly executed by an authorized officer of Buyer, (A)&nbsp;attaching all requisite resolutions or actions of the board of directors of Buyer approving the execution, delivery, and performance of the Transaction Documents and the
consummation and performance of the Transactions, and certifying that all such resolutions or actions were duly adopted, have not been amended, modified, or rescinded in any respect, and remain in full force and effect as of the Closing, and
(B)&nbsp;certifying as to the names, titles, and signatures of the officers of Buyer authorized to sign and deliver the Transaction Documents on behalf of Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_5"></A><B>2.5</B> <B><U>Purchase Price Adjustment</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Prior to the Closing Date, the Securityholder Representative prepared and delivered to Buyer a statement (in form and substance reasonably
acceptable to Buyer) (the &#147;<U>Estimated Closing Statement</U>&#148;) setting forth the Securityholder Representative&#146;s good faith estimates of (i)&nbsp;Net Working Capital (the &#147;<U>Estimated Net Working Capital</U>&#148;),
(ii)&nbsp;Closing Cash (the &#147;<U>Estimated Closing Cash</U>&#148;), (iii)&nbsp;Closing Indebtedness (the &#147;<U>Estimated Closing Indebtedness</U>&#148;), (iv)&nbsp;Closing Transaction Expenses (the &#147;<U>Estimated Closing Transaction
Expenses</U>&#148;), and (v)&nbsp;Estimated Cash Consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As promptly as practicable, but in no event later than sixty
(60)&nbsp;days after the Closing Date, Buyer shall prepare and deliver to the Securityholder Representative a statement (the &#147;<U>Revised Closing Statement</U>&#148;) setting forth Buyer&#146;s good faith calculation of (i)&nbsp;Net Working
Capital (the &#147;<U>Revised Net Working Capital</U>&#148;), (ii)&nbsp;Closing Cash (the &#147;<U>Revised Closing Cash</U>&#148;), (iii)&nbsp;Closing Indebtedness (the &#147;<U>Revised Closing Indebtedness</U>&#148;), (iv)&nbsp;Closing Transaction
Expenses (the &#147;<U>Revised Closing Transaction Expenses</U>&#148;), and (v)&nbsp;Revised Cash Consideration. During the Objection Period, Buyer shall provide the Securityholder Representative with a reasonable opportunity to review any books and
records and work papers used in preparing the Revised Closing Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If, upon the Objection Deadline, the Securityholder
Representative has not given Buyer an Objection Notice with respect to the Revised Closing Statement, then (i)&nbsp;the Revised Closing Statement and all components thereof will be deemed final and will be binding and conclusive on the Parties for
all purposes under this Agreement and not subject to further dispute or challenge and (ii)&nbsp;the Revised Cash Consideration will be deemed the Final Cash Consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If, prior to the Objection Deadline, the Securityholder Representative has given Buyer an Objection Notice with respect to the Revised
Closing Statement, then Buyer and the Securityholder Representative shall in good faith attempt to resolve the Disputed Matters (and, for avoidance of doubt, all other matters not disputed in the Objection Notice with respect to the Revised Closing
Statement will be binding and conclusive on the Parties for all purposes under this Agreement and not subject to further dispute or challenge). If Buyer and the Securityholder Representative fail to resolve all of the Disputed Matters within thirty
(30)&nbsp;days following Buyer&#146;s receipt of such Objection Notice, then either Buyer or the Securityholder Representative will be entitled to submit the Disputed Matters remaining in dispute (and only such Disputed Matters, as all other matters
with respect to, and all other components of, the Closing Statement (including those Disputed Matters resolved by Buyer and the Securityholder Representative in accordance with the immediately preceding sentence) will be binding and conclusive on
the Parties for all purposes under this Agreement and not subject to further dispute or challenge) to the Independent Accounting Firm for resolution in accordance with the guidelines and procedures set forth in this Agreement. If Disputed Matters
are submitted to the Independent Accounting Firm for resolution in accordance with the immediately preceding sentence, (i)&nbsp;Buyer and the Securityholder Representative shall furnish, or cause to be furnished, to the Independent Accounting Firm
such work papers and other documents and information relating to such Disputed Matters as the Independent Accounting Firm requests and as are available to such Party or such Party&#146;s Representatives and Buyer and the Securityholder
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representative will be afforded the opportunity to present to the Independent Accounting Firm any material relating to such Disputed Matters, (ii)&nbsp;Buyer and the Securityholder Representative
shall instruct the Independent Accounting Firm not to revise any element of the Revised Closing Statement that is not such a Disputed Matter or assign a value to any element of such a Disputed Matter greater than the largest value for such item
claimed by either such Party or less than the smallest value for such item claimed by either such Party, (iii)&nbsp;Buyer and the Securityholder Representative shall instruct the Independent Accounting Firm to deliver the Independent Accounting
Firm&#146;s determination in a written notice to Buyer and Sellers within sixty (60)&nbsp;days of the submission to the Independent Accounting Firm of such Disputed Matters, and such determination (to the extent compliant with the instructions
required by <U>Section</U><U></U><U>&nbsp;2.5(d)(ii)</U> and absent manifest error) will be final, binding, and conclusive on the Parties for all purposes under this Agreement and not subject to further dispute or challenge and will be used in the
determination of the Final Cash Consideration, and (iv)&nbsp;the fees and expenses of the Independent Accounting Firm will be allocated and payable by Buyer, on the one hand, and Securityholders, on the other hand, in proportion to the amounts by
which the proposals of Buyer and the Securityholder Representative, respectively, differed from the Independent Accounting Firm&#146;s final determination of such Disputed Matters, and Buyer and the Securityholder Representative shall instruct the
Independent Accounting Firm to determine such proportions in the Independent Accounting Firm&#146;s final determination pursuant to this <U>Section</U><U></U><U>&nbsp;2.5(d)</U>. The Parties are entitled to enter and reduce to judgment any award
given by the Independent Accounting Firm in accordance with this <U>Section</U><U></U><U>&nbsp;2.5(d)</U> in a court of competent jurisdiction if payment is not timely made in accordance with <U>Section</U><U></U><U>&nbsp;2.5(e)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If the Final Cash Consideration exceeds the Estimated Cash Consideration, then, within two (2)&nbsp;Business Days of the final
determination of the Final Cash Consideration in accordance with this <U>Section</U><U></U><U>&nbsp;2.5</U>, (i)&nbsp;Buyer shall pay to each Securityholder such Securityholder&#146;s Pro Rata Percentage of the amount of such excess by wire transfer
of immediately available funds to such Seller&#146;s Purchase Price Bank Account, and (ii)&nbsp;Buyer and the Securityholder Representative shall instruct the Escrow Agent to pay to the Securityholder Representative (for further distribution to each
Securityholder in accordance with such Securityholder&#146;s Pro Rata Percentage) the then current balance of the Adjustment Escrow Amount in accordance with Escrow Agreement. If the Estimated Cash Consideration exceeds the Final Cash Consideration,
then, within two (2)&nbsp;Business Days of the final determination of the Final Cash Consideration in accordance with this <U>Section</U><U></U><U>&nbsp;2.5</U>, Buyer and the Securityholder Representative shall instruct the Escrow Agent to pay to
(A)&nbsp;Buyer the amount of such excess out of the then current balance of the Adjustment Escrow Amount in accordance with the Escrow Agreement, and (B)&nbsp;the Securityholder Representative (for further distribution to each Securityholder in
accordance with such Securityholder&#146;s Pro Rata Percentage) the then remaining balance of the Adjustment Escrow Amount, if any after making such payment to Buyer, in accordance with the Escrow Agreement; provided, however, if the then current
balance of the Adjustment Escrow Amount is insufficient to cover the entire amount payable to Buyer pursuant to clause&nbsp;(A) of this <U>Section</U><U></U><U>&nbsp;2.5(e)</U>, then the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders, Jointly/Severally, shall promptly pay to Buyer the unpaid portion of such amount of such excess by wire transfer of immediately available funds to the account designated by Buyer to the Securityholder Representative in writing. If
the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders do not timely pay Buyer in accordance with the foregoing sentence, then Buyer may elect, in Buyer&#146;s sole discretion, to recover any portion or all of such amounts so payable
to Buyer by retaining such amount out of the then current balance of the Indemnification Escrow Amount, in addition to all other rights and remedies available to Buyer at law, in equity, or by Legal Requirement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Estimated Closing Statement and the Revised Closing Statement, as well as all estimates, calculations, and determinations therein,
will be prepared and calculated by the applicable Parties in accordance with GAAP. An example calculation of Net Working Capital calculated in accordance with GAAP is set forth on <U>Annex</U><U></U><U>&nbsp;E</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Parties shall treat each payment made under this
<U>Section</U><U></U><U>&nbsp;2.5</U> as an adjustment to the Purchase Price for Tax purposes, unless (i)&nbsp;a final &#147;determination&#148; (as that term is defined for purposes of Section&nbsp;1313 of the Code or corresponding applicable state
Legal Requirements) with respect to any such payment causes such payment not to be treated as an adjustment to the Purchase Price for Tax purposes or (ii)&nbsp;as otherwise required by applicable Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_6"></A><B>2.6</B> <B><U>Treatment of Company Options</U></B>. At the Closing, without any action on the part of the
Company, any holder of Company Options, or any other Person, each outstanding option to purchase Company Capital Stock (whether vested or unvested) that has not been exercised prior to the Effective Time (the &#147;<U>Company Options</U>&#148;)
shall be cancelled and terminated. Upon the cancellation and termination thereof, each holder of Company Options, all of whom are listed on <U>Annex <FONT STYLE="white-space:nowrap">A-2</FONT></U> (each, an &#147;<U>Optionholder</U>&#148; and,
collectively, the &#147;<U>Optionholders</U>&#148;), shall be entitled to receive payment in the amount set forth opposite such Optionholder&#146;s name on <U>Annex <FONT STYLE="white-space:nowrap">A-3</FONT></U> (each such payment amount, an
&#147;<U>Option Payment</U>&#148;). The Option Payments shall be paid pursuant to the Optionholders&#146; respective Option Cancellation Agreements. In addition to the Option Payment, each Optionholder shall be entitled to receive (x)&nbsp;such
Optionholder&#146;s Pro Rata Percentage of (i)&nbsp;any adjustment amount due to be paid to Securityholders pursuant to <U>Section</U><U></U><U>&nbsp;2.5(e)</U>, (ii) any portion of the Securityholder Expense Escrow Amount due to be released to the
Securityholders pursuant to this Agreement and the Escrow Agreement, and (iii)&nbsp;any portion of the Primary Indemnification Escrow Amount due to be released to the Securityholders pursuant to this Agreement and the Escrow Agreement, and
(y)&nbsp;such Optionholder&#146;s Allocable Share of any portion of the Special Indemnification Escrow Amount due to be released to the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders pursuant to this Agreement and the Escrow
Agreement. For the avoidance of doubt, all Company Options that are &#147;out of the money&#148; shall be automatically terminated effective as of the Closing without any consideration being paid therefor. Notwithstanding the foregoing, neither
Buyer nor the Company shall be obligated to pay any Option Payment to any Optionholder unless and until such holder has duly executed and delivered to the Company an Option Cancellation Agreement. All amounts to be paid to an Optionholder pursuant
to this <U>Section</U><U></U><U>&nbsp;2.6</U> shall be paid net of any Taxes or other amounts required to be deducted or withheld under applicable Legal Requirements and any such deducted or withheld amounts shall also be deemed to be part of the
applicable Option Payment and shall be treated for all purposes of this Agreement as having been paid to such Optionholder. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGARDING SELLERS AND THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as set forth in the Disclosure Letter (with each Schedule to the Disclosure Letter qualifying the correspondingly numbered and lettered
Section of this <U>Article</U><U></U><U>&nbsp;III</U> and any other Section of this <U>Article</U><U></U><U>&nbsp;III</U> to the extent it is reasonably apparent that the disclosure on such Schedule is responsive to such other Section of this
<U>Article</U><U></U><U>&nbsp;III</U>), the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers hereby represent and warrant to Buyer as of the Closing as set forth in this <U>Article III</U>, except <U>Section</U><U></U><U>&nbsp;3.24</U>. The
ESOP hereby represents and warrants to Buyer as of the Closing solely as set forth in <U>Section</U><U></U><U>&nbsp;3.24</U> (and solely with respect to the ESOP and not any other Seller). For purposes of this <U>Article</U><U></U><U>&nbsp;III</U>,
all references to &#147;Company&#148; are deemed to also be references to all predecessor and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">predecessor-in-interest</FONT></FONT> companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_7"></A><B>3.1</B> <B><U>Organization and Good Standing; Capitalization; Subsidiaries</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is duly incorporated, validly existing, and in good standing under the Legal Requirements of the State of Washington and has
full power and authority to own and lease the Assets of the Company as they are now owned and leased, and to carry on the businesses and operations of the Company as they are conducted immediately prior to Closing. The Company is duly qualified and
licensed to do business and is in good standing in all jurisdictions where the character of the Assets owned </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or leased by the Company or the nature of the Company&#146;s activities, businesses, and operations makes such qualification necessary, and each jurisdiction where the Company is qualified and
licensed to do business is set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(a)</U> to the Disclosure Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Schedule</U><U></U><U>&nbsp;3.1(b)</U> to the Disclosure Letter sets forth all of the authorized, issued, and outstanding securities of the Company, including the Company Shares and Company Options (collectively, the
&#147;<U>Securities</U>&#148;), along with the name of each record holder of the Securities, the number of Securities held by each such record holder, and, with respect to the Company Options, the grant date, exercise price and vesting schedule for
such Company Options and the extent to which each such Company Options are vested and exercisable. The Company Capital Stock constitutes all of the authorized shares of capital stock of the Company. Each record holder of Securities identified on
<U>Schedule</U><U></U><U>&nbsp;3.1(b)</U> to the Disclosure Letter owns such Securities free and clear of all Encumbrances (other than Statutory Transfer Restrictions) and has good, valid, and marketable title to such Securities. No Person, except
as set forth on <U>Schedule</U><U></U><U>&nbsp;3.1(b)</U> to the Disclosure Letter, has any ownership, investment, financial, or governance rights or interest, or option or warrant to acquire any such right or interest in the Company. All of the
Securities were duly authorized and validly issued, and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> None of the Securities were offered, sold, or issued in violation of the Securities Act, any other applicable Legal
Requirements relating to the offer, sale, or issuance of securities, or any Preferential Right. The Company is not under any obligation, contingent or otherwise, to register any of the Securities under the Securities Act or any other applicable
Legal Requirements. There are no outstanding options, warrants, calls, rights, convertible or exchangeable securities, stock appreciation rights, phantom stock, profit participation rights, or other rights, obligations, or Contracts of any character
(i)&nbsp;relating to any of the Securities or any other interest in the Company, or (ii)&nbsp;requiring any payments, directly or indirectly (in whole or in part), based on the price or value of the Securities by the Company. There are no rights,
obligations, or Contracts, contingent or otherwise, of the Company to purchase, redeem, or otherwise acquire any of the Securities. There are no voting trusts, shareholder agreements, proxies, or other Contracts or understandings in effect with
respect to the voting or transfer of any of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Company Option was granted by the Company in compliance in all
material respects with (i)&nbsp;all applicable Legal Requirements, (ii)&nbsp;for each Company Option granted prior to the expiration of the Stock Option Plan, all of the terms and conditions of the Company&#146;s 2004 Stock Option Plan (&#147;<U>the
Stock Option Plan</U>&#148;), and (iii)&nbsp;the terms and conditions of all Contracts pursuant to which such Company Option was issued (such Contracts described in clause (iii), collectively, the &#147;<U>Stock Option Agreements</U>&#148;), and
each Stock Option Agreement is either: (i)&nbsp;exempt from the requirements of Section&nbsp;409A of the Code; or (ii)&nbsp;in compliance with the operational and documentary requirements of Section&nbsp;409A of the Code and all applicable
regulatory guidance (including notices, rulings and proposed and final regulations) thereunder. Each Company Option was granted with an exercise price equal to or greater than the fair market value of the underlying Company Capital Stock on the date
of grant. Each Company Option has a grant date that is within 45 days of the date on which the board of directors of the Company actually awarded such Company Option. The Company has heretofore provided or made available to Buyer true and complete
copies of all Stock Option Agreements pursuant to which the Company Options were granted, all resolutions adopted by the board of directors of the Company approving the award of any options to purchase Company Capital Stock (including the Company
Options), and documents evidencing or relied on by the board of directors of the Company to determine the fair market value of the underlying Company Capital Stock on the date of grant of such options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company (i)&nbsp;does not have, and has never had, any Subsidiaries, (ii)&nbsp;does not own, and has never owned, any securities of,
or any other ownership interest in, any Person, or (iii)&nbsp;does not otherwise control, and has never otherwise controlled, directly or indirectly, any other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_8"></A><B>3.2</B> <B><U>Authority; No Conflict</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement has been duly and validly executed by the Company, Sellers, and the Securityholder Representative, and this Agreement
(assuming due authorization, execution, and delivery by Buyer) constitutes the legal, valid, and binding obligation of the Company, Sellers, and the Securityholder Representative enforceable against Sellers, the Company and the Securityholder
Representative in accordance with its terms, except as enforceability is limited by bankruptcy laws, other similar laws affecting creditors&#146; rights, and general principles of equity affecting the availability of specific performance and other
equitable remedies (the &#147;<U>Enforceability Exceptions</U>&#148;). Upon the delivery (and execution, if applicable) by Sellers and the Company of each of the Seller Closing Documents, each of the Seller Closing Documents (assuming due
authorization, execution, and delivery by the other party or parties thereto, if applicable) will constitute the legal, valid, and binding obligation of each Seller, the Company, and the Securityholder Representative that is a party thereto,
enforceable against each Seller, the Company, and the Securityholder Representative that is a party thereto in accordance with the terms thereof, except as enforceability is limited by the Enforceability Exceptions. Sellers, the Company, and the
Securityholder Representative have the right, power, authority, and capacity to execute and deliver this Agreement and the Seller Closing Documents to which they are a party and to perform their respective obligations under this Agreement and the
Seller Closing Documents to which they are a party, and such actions have been duly authorized by all necessary company or other governing action by Sellers, the Company, and the Securityholder Representative, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the execution, delivery, or performance of this Agreement or any of the other Transaction Documents by any Sellers, the Company,
or the Securityholder Representative nor the consummation or performance of any of the Transactions by any Sellers, the Company, or the Securityholder Representative will, directly or indirectly (with or without notice or lapse of time or both),
(i)&nbsp;contravene, conflict with, or result in a violation or breach of any provision of any of the Constitutive Documents or Governance Documents of any Seller (if not an individual) or the Company, (ii)&nbsp;contravene, conflict with, or result
in a violation or breach of any Legal Requirement to which any Seller, the Company, or the Securityholder Representative is subject, (iii)&nbsp;contravene, conflict with, or result in a material violation or material breach of, constitute a material
default under, or give any Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate, or modify any Governmental Authorization held by any Seller or the Securityholder Representative or any Company Governmental Authorization,
(iv)&nbsp;contravene, conflict with, or result in a violation or breach of, in each case, in any material respect, or constitute a material default under, or give any Person the right to declare a material default or exercise any remedy under,
accelerate the maturity or performance of or payment under, or cancel, terminate, or modify any material Contract to which any Seller or the Securityholder Representative is a party or by which any Seller or the Securityholder Representative or any
of such Seller&#146;s or the Securityholder Representative&#146;s Assets is otherwise bound or any Material Company Contract, or (v)&nbsp;result in the creation or imposition of any Encumbrance upon any of the Assets of the Company (other than
Permitted Encumbrances) or any of the Company Shares (other than Statutory Transfer Restrictions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of Sellers, the
Securityholder Representative, or the Company is or will be required to give any notice to, make any Filing with, or obtain any Consent from any Person in connection with the execution, delivery, and performance of this Agreement or any of the other
Transaction Documents, or the consummation and performance of the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_9"></A><B>3.3</B> <B><U>Financial Information</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(a) The <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers have made available to Buyer in the Virtual Data Room copies of (i)&nbsp;the
audited financial statements of the Company as of and for each of the years ended December&nbsp;31, 2018, 2019, and 2020 (collectively, the &#147;<U>Fiscal Year Financial Statements</U>&#148;) and (ii)&nbsp;the unaudited financial statements of the
Company as of and for the eleven (11)&nbsp;month period ended November&nbsp;30, 2021 (collectively, the &#147;<U>Interim Financial Statements</U>&#148; and, together with the Fiscal Year Financial Statements, the &#147;<U>Financial
Statements</U>&#148;). The Financial Statements (i)&nbsp;are accurate and complete in all material respects and reflect only actual transactions, (ii)&nbsp;fairly present in all material respects the financial position, results of operations, and
changes in financial position and cash flows of the Company as of the dates and for the periods specified, and (iii)&nbsp;have been prepared in accordance GAAP on a consistent basis throughout the periods covered by the Financial Statements (except,
in the case of the Interim Financial Statements, for normal recurring <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments (the effect of which will not, individually or in the aggregate, be material) and the absence of footnotes (that, if
presented, would not differ materially from those included in the Fiscal Year Financial Statements). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has established and
maintained a system of internal controls, including policies and procedures, that (i)&nbsp;require the maintenance of records that in reasonable detail accurately and fairly reflect the material transactions and dispositions of the Assets of the
Company, (ii)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with the historic accounting practices of the Company, and that receipts and expenditures of the
Company are being made only in accordance with appropriate authorizations of the board of directors and management of the Company, and (iii)&nbsp;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use,
or disposition of the Assets of the Company that could have a material effect on their financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) All the accounts and
notes receivable owing to the Company (the &#147;<U>Accounts Receivable</U>&#148;) arose from bona fide transactions in the Ordinary Course and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, there are no claims, valid
legal defenses, refusals to pay, or other rights of offset against any of the Accounts Receivable, except as have arisen or will arise in the Ordinary Course and for which adequate reserves have been established in the Interim Balance Sheet. There
has not been a materially adverse change in the composition of the Accounts Receivable arising after the Interim Balance Sheet Date, in terms of aging, as reflected in the accounting records of the Company as of the Closing as compared to the
Accounts Receivable as reflected on the Interim Balance Sheet. The reserve for bad debts established on the Interim Balance Sheet or, with respect to those Accounts Receivable arising after the Interim Balance Sheet Date, in the accounting records
of the Company has been determined in accordance with the historic accounting practices of the Company. All accounts and notes payable owing by the Company (the &#147;<U>Accounts Payable</U>&#148;) arose in the Ordinary Course and none of the
Accounts Payable is delinquent in its payment, except those contested in good faith and for which adequate reserves have been established in the Interim Balance Sheet. The Company has no outstanding Accounts Receivable or Accounts Payable due from
or payable to, respectively, any Related Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company does not have any Liabilities, except for (i)&nbsp;Liabilities reflected
or reserved against on the Interim Balance Sheet, (ii)&nbsp;the Transaction Expenses, which will be paid in full as of the Closing pursuant to <U>Section</U><U></U><U>&nbsp;2.2(b)(iii)</U>, and (iii)&nbsp;current Liabilities incurred in the Ordinary
Course since the Interim Balance Sheet Date, which are not material in amount (either individually or in the aggregate) and none of which results from, arises out of, relates to, is in the nature of, or was caused by any breach of Contract or
warranty, infringement, professional error or omission, act or event creating a severance obligation, wrongful discharge claim, or similar Liability, tort, violation of any Legal Requirement, or Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Prior to the Closing Date, the Company was eligible for, applied for, and obtained a &#147;Paycheck Protection Program&#148; loan under
15&nbsp;U.S.C.&nbsp;636(a)(36) (as added to the Small Business Act by Section&nbsp;1102 of the CARES Act), in the original principal amounts of $4,947,168.00 on or about May&nbsp;9, 2020 (the<B> </B>&#147;<U>PPP Loan</U>&#148;). At the time of
submitting such application, the Company had a good faith belief that current economic uncertainty made the application for the PPP Loan necessary to support the ongoing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operations of the Company taking into account the Company&#146;s current business activity and ability to access other sources of liquidity sufficient to support its ongoing operations in a
manner not significantly detrimental to the Company. The Company has at all times prior to the Closing Date (i)&nbsp;expended the proceeds from the PPP Loan solely for the purpose of satisfying or paying any (1) &#147;payroll costs,&#148; (2)
&#147;covered mortgage obligation,&#148; (3) &#147;covered rent obligation&#148; or (4) &#147;covered utility payment,&#148; in each case, with respect to subclauses (1), (2), (3), and (4), as such term is defined in the CARES Act;
(ii)&nbsp;expended the proceeds from the PPP Loan solely on &#147;costs incurred and payments made during the covered period,&#148; as such phrase is contemplated by Section&nbsp;1106 of the CARES Act; and (iii)&nbsp;otherwise complied in all
material respects with all requirements under applicable Legal Requirements (including the CARES Act). The certifications made by the Company in connection with applying for the PPP Loan and for forgiveness of the PPP Loan were true, correct and
complete in all material respects. The PPP Loan was forgiven on June&nbsp;15, 2021, and has been satisfied in full. Except for the PPP Loan, the Company has not applied for or obtained a &#147;Paycheck Protection Program&#148; loan under
15&nbsp;U.S.C.&nbsp;636(a)(36) (as added to the Small Business Act by Section&nbsp;1102 of the CARES Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_10"></A><B>3.4</B> <B><U>Assets</U></B>. The Company has good, valid, and marketable title to, or a valid and
enforceable leasehold interest in, all of the Assets used or held for use by the Company, including all such Assets reflected in the Interim Balance Sheet or acquired since the Interim Balance Sheet Date, free and clear of all Encumbrances (other
than Permitted Encumbrances). The tangible Assets of the Company are in good operating condition and repair, ordinary wear and tear excepted, and none of which are in need of maintenance or repair, except for ordinary, routine maintenance and repair
that are not material in nature or cost. The Assets of the Company include all of those Assets necessary to conduct the businesses and operations of the Company as presently conducted, and none of Sellers have or will have possession or title to any
such Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.5</B> <B><U>Real Property</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has not owned and does not currently own any real property and the Company does not hold any options or rights to acquire any
real property and is not obligated or bound by any options, obligations, or rights of first refusal or contractual rights to sell, lease (other than the Real Property Leases), or purchase any real property. The Company leases or subleases all real
property used in the Company&#146;s businesses and operations. <U>Schedule</U><U></U><U>&nbsp;3.5(a)</U> to the Disclosure Letter sets forth the street address and legal description of each parcel of leased real property (collectively, the
&#147;<U>Leased Real Property</U>&#148;), and a list of all real property leases to which the Company is a party (collectively, the &#147;<U>Real Property Leases</U>&#148;), along with the monthly rent and expiration date with respect to the Real
Property Leases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to the Leased Real Property and the Real Property Leases, (i)&nbsp;the Company enjoys peaceful and
undisturbed possession of the Leased Real Property, (ii)&nbsp;there are no debts or other Liabilities of the Company relating to the Real Property Leases or the Leased Real Property, including tenant improvement costs and leasing commissions,
vesting, accruing, and/or arising prior to or in connection with the Closing, (iii)&nbsp;the Company has not subleased, assigned, or otherwise granted to any Person the right to use or occupy any of the Leased Real Property or any portion thereof,
(iv)&nbsp;the Company has not pledged, mortgaged, or otherwise granted an Encumbrance on the Company&#146;s leasehold interest in any Leased Real Property, (v)&nbsp;all space and improvements covered by the Real Property Leases have been completed
and furnished to the satisfaction of the Company, all material conditions under the Real Property Leases have been satisfied, and the Company has accepted and taken possession of and presently occupies the Leased Real Property, (vi)&nbsp;the
buildings, structures, improvements, fixtures, building systems, and equipment, and all components thereof, included in the Leased Real Property under the Real Property Leases are, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Sellers, structurally sound and in good condition and repair, ordinary wear and tear excepted, none of which are in need of maintenance or repair, except for ordinary, routine maintenance and repair that are not material in nature or cost, and all
of which are sufficient for the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conduct of the businesses and operations conducted thereon, (vii)&nbsp;the Leased Real Property has adequate rights of access to dedicated public ways and is served by water, electric, sewer,
telephone, gas, and other services necessary for the conduct of the businesses and operations of the Company, (viii)&nbsp;no rent has been paid by the Company in advance under the Real Property Leases, the Company has no charge or claim of offset
under the Real Property Leases or otherwise against rents or other amounts due or to become due thereunder, and no &#147;discounts&#148;, &#147;free rent&#148;, or &#147;discounted rent&#148; have been agreed to or are in effect, (ix)&nbsp;the
Company has no claim against any lessor under the Real Property Leases for any deposit or prepaid rent, (x)&nbsp;the lessors under the Real Property Leases have satisfied all material commitments, arrangements, and understandings made to induce the
Company to enter into the applicable Real Property Lease, and no lessor is in any respect in default in the performance of the terms and provisions of the applicable Real Property Lease nor, to the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, is there any fact or condition that, with or without notice or lapse of time or both, would become such a default, and (xi)&nbsp;except as expressly provided in the applicable Real Property
Lease, the Company (A)&nbsp;does not have any right to renew or extend the term of such Real Property Lease, (B)&nbsp;does not have any Preferential Right to purchase all or any portion of the Leased Real Property or all or any portion of the
buildings, structures, improvements, fixtures, building systems, and equipment, or all or any components thereof, or premises of which the Leased Real Property is a part, and (C)&nbsp;does not have any right, title, or interest with respect to the
Leased Real Property other than as lessee under the Real Property Leases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_11"></A><B>3.6</B> <B><U>Intellectual
Property Rights; Company Products; Information Systems</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule</U><U></U><U>&nbsp;3.6(a)</U> to the Disclosure Letter
sets forth an accurate and complete list of all registered Marks, Net Names, Patents, and Copyrights and the material unregistered Marks and Copyrights, that comprise the Company IP Rights, and indicates for any such registered Company IP Right,
where applicable, the jurisdictions, dates issued, dates filed, registration numbers, and the owners of record. The Company owns all right, title, and interest in and to all Company IP Rights, free and clear of all Encumbrances (other than Permitted
Encumbrances). In each case in which the Company has acquired, other than through a license, any Intellectual Property Rights from any Person, the Company obtained a valid and enforceable assignment sufficient to irrevocably transfer all rights in
and to such Intellectual Property Rights to the Company. All Company IP Rights were (i)&nbsp;created by an employee or independent contractor of the Company within the scope of such employee&#146;s or independent contractor&#146;s employment or
engagement, and (ii)&nbsp;unconditionally, irrevocably, and validly assigned to the Company by an employee or independent contractor of the Company, and no current or former employee or independent contractor of the Company owns (or, to the
Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, claims to own) any rights in any Company IP Rights. With respect to trade secrets owned by the Company that are material to any of its businesses and operations as presently
conducted, the Company has taken all reasonable precautions to protect the secrecy, confidentiality, and value of such trade secrets. To the Knowledge of the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, such trade secrets are not part
of the public knowledge or literature and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, have not been used, divulged, or appropriated either for the benefit of any Person (other than the Company) or to the detriment
of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Schedule</U><U></U><U>&nbsp;3.6(b)</U> to the Disclosure Letter is an accurate and complete list of all
Intellectual Property Rights licensed to the Company, except for any commercially available <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> Software products licensed under
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> <FONT STYLE="white-space:nowrap">end-user</FONT> object code license agreements for an annual license fee of $25,000 or less, and sets forth a reference to an accurate and complete written
Company Contract evidencing such license (each such Company Contract, an &#147;<U>Inbound License Agreement</U>&#148;). <U>Schedule 3.6(b)</U> to the Disclosure Letter sets forth an accurate and complete list of all Company Contracts by which
Company licenses any Company IP Rights to another Person (each such Company Contract, an &#147;<U>Outbound License Agreement</U>&#148;). The Company has not received or provided any written notice of (i)&nbsp;termination or cancellation under any
current License Agreement, or (ii)&nbsp;a breach or default under any License Agreement within the six (6)&nbsp;years prior to the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company IP Rights and, to the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, all Intellectual Property Rights licensed, used, or exploited by the Company, are valid and subsisting, in full force and effect, and have not been cancelled, expired, or abandoned. No
actions must be taken within ninety (90)&nbsp;days of the Closing Date, including the payment of any registration, maintenance, or renewal fees or the filing of any response to an official action of a Governmental Authority or the filing of any
application for the purpose of obtaining, maintaining, perfecting, preserving, or renewing any of the Company IP Rights. Neither the execution and delivery of this Agreement or any of the other Transaction Documents nor the consummation and
performance of the Transactions will (i)&nbsp;result in the loss or impairment of the Company&#146;s rights to own, license, use, or exploit any of the Company IP Rights or any of the Intellectual Property Rights covered by the Inbound License
Agreements, as compared to such rights of the Company as of the date immediately prior to the Closing Date, (ii)&nbsp;obligate the Company to pay any royalties or other amounts to any Person in excess of the amounts payable by the Company as of the
date immediately prior to the Closing Date, or (iii)&nbsp;require notice to, a Filing with, or the Consent of any Person in respect of any of the Company IP Rights or License Agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, the Company is not infringing, misappropriating, diluting,
or violating any of the Intellectual Property Rights of another Person and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no Person is infringing, misappropriating, diluting, or violating any of the Company IP Rights.
None of Sellers or the Company has received any written communications in the past six (6)&nbsp;years&nbsp;alleging that the Company has infringed, misappropriated, diluted, or violated any Intellectual Property Rights of any Person. No Proceeding
is pending or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened against the Company related to any of the Company IP Rights or any of the Intellectual Property Rights of another Person, including based upon,
challenging, or seeking to deny or restrict the ownership, license, use, or exploitation by the Company of any of the Company IP Rights or Intellectual Property Rights licensed to the Company under an Inbound License Agreement. No government funding
or facilities of any university, college, or other educational institution or research center was used in the development of any Company IP Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Schedule 3.6(e)</U> to the Disclosure Letter is an accurate and complete list (by name and version number) of all product and service
offerings (including Software) of the Company that have been offered for sale, sold, leased, licensed, distributed, or otherwise made available in return for consideration (collectively, the &#147;<U>Company Products</U>&#148;). <U>Schedule
3.6(e)</U> to the Disclosure Letter also lists all third party Intellectual Property Rights that are incorporated into, integrated into, or bundled with the Company Products and identifies (i)&nbsp;the applicable License Agreement under which such
third party Intellectual Property Rights are licensed to the Company, and (ii)&nbsp;the Company Product into or with which the third party Intellectual Property Rights are incorporated, integrated, or bundled. Each such License Agreement listed
includes a valid, written, perpetual, and <FONT STYLE="white-space:nowrap">non-terminable</FONT> (except for cause) license to the third party Intellectual Property Rights incorporated, integrated, or bundled into the Company Products. The Company
IP Rights include all source code, object code, and other documentation and materials necessary to compile and operate the Company Products. The Company Products operate and perform in accordance with their documentation and functional
specifications, and otherwise as required in connection with the conduct of the businesses and operations of the Company. To the Knowledge of the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, the Company Products are free from
all computer programs, instructions, routines, features, and code that could adversely affect the operation, integrity, or function of, or provide unauthorized access to, or use of, any computer system, computer program (including the Software
products and computer-based services themselves), or data operated upon, processed by, or stored by, any computer system, including back doors, viruses, worms, Trojan horses, time bombs, spyware, trap doors, and other types of malware.
<U>Schedule</U><U></U><U>&nbsp;3.6(e)</U> to the Disclosure Letter includes accurate and complete copies of the standard terms and conditions of sale, lease, license, distribution, or delivery for the Company (containing applicable warranty,
guaranty and indemnity provisions). No Company Products, or service performed by the Company, is subject to any warranty, guaranty, or other indemnity beyond the applicable standard terms and conditions of sale, lease, license, distribution, or
delivery set forth on <U>Schedule</U><U></U><U>&nbsp;3.6(e)</U> to the Disclosure Letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the Knowledge of the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders, there are no problems, defects, or deficiencies in the Software owned by the Company that&nbsp;prevent the Company from conducting its businesses and operations as presently conducted in all material respects. The Company has
possession of, or access to, the source code for each material version of Software owned by the Company, as well as all documentation related thereto. The Company has maintained and protected the source code for the Software that the Company owns
with appropriate proprietary notices and confidentiality agreements as are necessary to protect the information therein. None of the source code for any Software owned, licensed, used, distributed, or exploited by the Company (including by using in,
incorporating, integrating or bundling into, or linking with, in whole or in part, in any manner, any Company Products) has been published, put into escrow, or otherwise disclosed by the Company to any Person, and no licenses or rights have been
granted to any Person to distribute, or to otherwise use, the source code for such Software. The Company has never owned, licensed, used, distributed, or exploited (including by using in, incorporating, integrating or bundling into, or linking with,
in whole or in part, in any manner, any Company Products) any Software subject to open source, copyleft, or community source code licenses (e.g., the GNU General Public License or a similar &#147;viral&#148; open source licensing regime) in a manner
that could (i)&nbsp;grant, purport to grant, or require the granting to any other Person any rights or immunities under any Company IP Rights (including any licenses for the purpose of making derivative works), (ii)&nbsp;require any Company Products
to be distributed without charge, (iii)&nbsp;require the source code for any portion of any Company Products or any other Software owned by the Company to be made available, disclosed, or distributed to any other Person, or (iv)&nbsp;impose any
material limitation, restriction, or condition on the right or ability of the Company to use any portion of any Company Products or any Software owned by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) All Information Systems used in the businesses and operations of the Company are (i)&nbsp;in good working condition, reasonable wear and
tear excepted, and operate and perform in all material respects as necessary for the conduct of the businesses and operations of the Company as currently conducted and in accordance with their documentation and functional specifications, and
(ii)&nbsp;to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, are free from all computer programs, instructions, routines, features, and code that could adversely affect the operation, integrity, or function of, or provide
unauthorized access to, or use of, any computer system, computer program (including the software products and computer based services themselves), or data operated upon, processed by, or stored by, any of the Information Systems. The Company has
commercially reasonable information security safeguards in place to maintain the confidentiality, integrity, and availability of the information stored, processed, and/or transmitted by the Information Systems that are used to conduct the businesses
and operations of the Company. To the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, the Company has not allowed unauthorized access, acquisition, disclosure, or use of any of the foregoing. The Company has in place adequate
disaster recovery plans, procedures, and facilities to ensure the ongoing operation and performance of the Company&#146;s businesses and operations in the event of a disruption to its Information Systems. The Company has obtained and possesses, is
in compliance in all material respect with, and has paid in full, a sufficient number of valid licenses to use all of the Software programs present on the computers and other Software-enabled electronic devices that the Company uses in connection
with its businesses and operations and for the operation of the Information Systems. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_12"></A><B>3.7</B>
<B><U>Data Security and Privacy</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company&#146;s information security and privacy program is designed to comply with and,
at all times within the six (6)&nbsp;years prior to Closing, has been in compliance in all material respects with, (i)&nbsp;applicable Legal Requirements relating to the rights of any natural Person with respect to Personal Information, including
the Processing of Personal Information, data security, breach notification, and all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable industry standards related to the same (including industry standards with which payment card companies require merchants to comply, including the Payment Card Industry Data Security
Standards) (collectively, &#147;<U>Privacy Laws</U>&#148;), (ii)&nbsp;any privacy choices, including <FONT STYLE="white-space:nowrap">opt-in</FONT> or <FONT STYLE="white-space:nowrap">opt-out</FONT> preferences and rights&#146; requests, of natural
Persons relating to the Processing of Personal Information, (iii)&nbsp;any obligations contained in or resulting from the Company&#146;s internal and external data privacy, data security, incident response, or similar policies, notices, protocols,
or standards with respect to the Processing or security of Personal Information (clauses&nbsp;(ii) and (iii)&nbsp;together, the &#147;<U>Company Privacy Commitments</U>&#148;), and (iv)&nbsp;any Company Contract that is applicable to such Personal
Information (each, a &#147;<U>Company Data Agreement</U>&#148;). None of the Company Privacy Commitments conflict in any material respect with any Company Data Agreement. To the extent required under any Privacy Law, the Company has provided
adequate notice, obtained valid consents, offered <FONT STYLE="white-space:nowrap">opt-outs,</FONT> maintained accurate records of the communications preferences of users of Company products, processes, and services (including any of the Company
Products) and other natural Persons whose Personal Information is Processed by or on behalf of the Company, and taken all other reasonable actions in connection with the Processing of Personal Information. Neither the execution, delivery, and
performance of this Agreement nor the consummation of the Transactions will cause, constitute, or result in a breach or violation of any Privacy Law, Company Privacy Commitments, Company Data Agreements, or standard terms of service entered into by
users of any Company products, processes, and services (including any of the Company Products). The Company has made available to Buyer in the Virtual Data Room accurate and complete copies of all current and prior privacy policies used by the
Company within the six (6)&nbsp;years prior to the Closing.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Company Contract between the Company and any Person that
Processes Personal Information for or on behalf of the Company (a &#147;<U>Third-Party Processor</U>&#148;) complies in all material respects with all Privacy Laws, Company Privacy Commitments, and Company Data Agreements. Without limiting the
generality of the foregoing, the Company has contractually obligated each Third-Party Processor to (i)&nbsp;take appropriate steps to protect and secure from unauthorized disclosure such Personal Information, (ii)&nbsp;restrict use of such Personal
Information to those authorized to use such Personal Information or who require the use of such Personal Information in order to perform the applicable services for the Company, (iii)&nbsp;prohibit such Third-Party Processor from further
transferring the Company&#146;s data without the prior written consent of the Company, and (iv)&nbsp;afford to the Company or any of the Company&#146;s Representatives reasonable access to the places of business and systems of such Third-Party
Processor to audit compliance with such contractual obligations, and in each case, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no such Third-Party Processor is in breach of any of such Third-Party Processor&#146;s
contractual obligations to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has implemented and maintains reasonable written security procedures and
practices appropriate to protect Personal Information and employs a system of written internal controls sufficient to provide reasonable assurance that the Company complies in all material respects with all Privacy Laws, Company Privacy Commitments,
and Company Data Agreements. No Proceedings are pending or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened with respect to the Company&#146;s Processing of Personal Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The conduct and operation of the businesses of the Company, including the operations of Company products, processes, and services
(including any of the Company Products) and their distribution to and use by any natural Persons, complies in all material respects with the applicable provisions of Regulation (EU) 2016/679 of the European Parliament and of the Council of
27&nbsp;April 2016 on the protection of natural Persons with regard to the Processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation). The conduct and operation of the
businesses of the Company complies in all material respects with the applicable provisions of the California Consumer Privacy Act of 2018, as amended. The Company has not sold, rented, released, disclosed, disseminated, made available, transferred,
or otherwise communicated orally, in writing, or by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
electronic or other means, any Personal Information to another Person for monetary or other valuable consideration. The Company has at all times within the six (6)&nbsp;years prior to Closing,
complied in all material respects with the applicable requirements of the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (&#147;<U>HIPAA</U>&#148;). The Company has entered into business associate
agreements with (i)&nbsp;all &#147;Covered Entities&#148; and &#147;Business Associates&#148; (as such terms are defined in 45 C.F.R. &#167; 160.103) who provide the Company with, or for whom the Company receives, creates, maintains, transmits, or
processes Protected Health Information (as defined under HIPAA), and (ii)&nbsp;with all Persons acting as &#147;Business Associates&#148; or &#147;Subcontractors&#148; of the Company (as such terms are defined in 45 C.F.R. &#167; 160.103). The
Company is, and has at all times been, in compliance in all material respects with all business associate agreements to which it is a party or is otherwise bound. The Company has performed a security risk assessment that meets the HIPAA security
rule standards set forth in 45 C.F.R. &#167; 164.306 and &#167; 164.308(a)(1)(ii)(A) and timely addressed and remediated all threats and deficiencies identified in such security risk assessment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company has implemented and maintained at all times within the six (6)&nbsp;years prior to Closing, appropriate technical, physical,
and organizational measures, security systems, and technologies in compliance in all material respects with all data security requirements under all Privacy Laws and Company Privacy Commitments and that are designed to protect computers, networks,
software, and systems used by the Company and Personal Information Processed by the Company from loss, theft, unauthorized access, use, disclosure, or modification. No breach, security incident, or violation of any data security policy in relation
to any information or data Processed by or on behalf of the Company, including a &#147;Breach&#148; of &#147;Unsecured Protected Health Information&#148; (as such terms are defined in 45 C.F.R. &#167; 164.402), has occurred, and there has been no
unauthorized or illegal Processing of any such information or data. The Company has made available to Buyer in the Virtual Data Room accurate and complete copies of all prior reports, studies, and other analyses, in the Company&#146;s possession or
control, whether conducted by third Persons or by the Company, of the measures the Company takes or has taken to protect computers, networks, Software, and systems used by the Company. None of such reports, studies, or other analyses has revealed
any material failure of such security and other measures to be consistent with customary industry practices, the Company&#146;s obligations to other Persons, or applicable Legal Requirements. To the Knowledge of the
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no circumstance has arisen in which: (i)&nbsp;any Privacy Law would require the Company to notify a Governmental Authority or Person of a data security breach or security incident or
(ii)&nbsp;applicable guidance or codes of practice promulgated under any Privacy Law would recommend the Company to notify a Governmental Authority or other Person of a data security breach or security incident. The Company has ensured that all
Third-Party Processors are under written obligations of confidentiality with respect to such data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) There is no Proceeding pending or,
to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened against the Company: (i)&nbsp;alleging or confirming <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Privacy Laws, Company Privacy Commitments,
or Company Data Agreements, (ii)&nbsp;requiring or requesting the Company to amend, rectify, cease Processing, <FONT STYLE="white-space:nowrap">de-combine,</FONT> permanently anonymize, block, or delete any Personal Information,
(iii)&nbsp;initiating, announcing, permitting or mandating investigations, audits, the requisition of information from, or the entering of the premises of, the Company by any Governmental Authorities, or (iv)&nbsp;claiming compensation from the
Company with respect to the Processing of Personal Information. Within the six (6)&nbsp;years prior to the Closing, the Company has not been involved in any Proceedings involving a breach or alleged breach of any Privacy Law or Company Privacy
Commitments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_13"></A><B>3.8</B> <B><U>Material Customers; Material
Suppliers</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule</U><U></U><U>&nbsp;3.8(a)</U> to the Disclosure Letter sets forth (i)&nbsp;an accurate and complete
list of each customer of the Company that paid aggregate consideration to the Company for goods or services rendered by the Company in an amount equal to or greater than $250,000 for any of the 2019, 2020, or 2021 fiscal years (collectively, the
&#147;<U>Material Customers</U>&#148;), and (ii)&nbsp;the dollar amount of consideration paid by each Material Customer to the Company during each such period. None of Sellers or the Company has received any written notice, nor has any reason to
believe, that any of the Material Customers has ceased or intends to cease after the Closing to use the Company&#146;s goods or services or to otherwise terminate or materially reduce such Material Customer&#146;s relationship with the Company. None
of Sellers or the Company has received from any Material Customer or given to any Material Customer any written notice of force majeure, impossibility of performance, frustration of purpose, or similar notices of
<FONT STYLE="white-space:nowrap">non-performance.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Schedule</U><U></U><U>&nbsp;3.8(b)</U> to the Disclosure Letter sets
forth (i)&nbsp;an accurate and complete list of each supplier or vendor of the Company to whom the Company paid aggregate consideration for goods or services rendered to the Company in an amount equal to or greater than $150,000 for any of the three
(3)&nbsp;most recent fiscal years (collectively, the &#147;<U>Material Suppliers</U>&#148;), and (ii)&nbsp;the dollar amount of consideration paid by the Company to each Material Supplier during each such period. None of Sellers or the Company has
received any written notice, nor has any reason to believe, that any of the Material Suppliers has ceased or intends to cease after the Closing to supply goods or services to the Company or to otherwise terminate or materially reduce such Material
Supplier&#146;s relationship with the Company. None of Sellers or the Company has received from any Material Supplier or given to any Material Supplier any written notice of force majeure, impossibility of performance, frustration of purpose, or
similar notices of <FONT STYLE="white-space:nowrap">non-performance.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_14"></A><B>3.9</B> <B><U>Contracts;
No Defaults</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule</U><U></U><U>&nbsp;3.9(a)</U> to the Disclosure Letter sets forth an accurate and complete list of
each of the following Contracts (collectively, the &#147;<U>Material Company Contracts</U>&#148;) (with the Material Company Contracts being categorized on <U>Schedule</U><U></U><U>&nbsp;3.9(a)</U> to the Disclosure Letter in a manner that
corresponds with the following numbered clauses of this <U>Section</U><U></U><U>&nbsp;3.9(a)</U>): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each Company Contract other than a
Company Contract with a Material Customer or Material Supplier (A)&nbsp;having a value per Contract, or involving payments by or to the Company, of at least (1)&nbsp;$250,000 during either of the two (2)&nbsp;most recent fiscal years or $229,267 for
the eleven (11)&nbsp;month period ended November&nbsp;30, 2021, or (2)&nbsp;$200,000 in the aggregate, or (B)&nbsp;that cannot be cancelled or terminated by the Company without penalty with at least sixty (60)&nbsp;days prior written notice; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) any Company Contract with a Material Customer or Material Supplier; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any Company Contract that requires the Company or any of its Affiliates to purchase the Company&#146;s or such Affiliate&#146;s total
requirements of any product or service from another Person or contains &#147;take or pay&#148; provisions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) any Company Contract
that grants any &#147;most favored nations&#148; or similar rights; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) any Company Contract that provides for payments based, in whole
or in part, on profits, revenues, fee income, or other financial performance measures of the Company or any of its Affiliates; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) any
dealer, distribution, joint venture, strategic alliance, partnership, or other similar Contract involving <FONT STYLE="white-space:nowrap">co-investment</FONT> with another Person to which the Company is a party or by which the Company or any of the
Company&#146;s Assets is otherwise bound; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) any franchise, agency, sales promotion, market research, marketing, consulting, or
advertising Contract to which the Company is a party or by which the Company or any of the Company&#146;s Assets is otherwise bound; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) any Company Contract that restricts the Company or any of its Affiliates from acquiring any security or business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) any Company Contract that grants any Preferential Right with respect to any securities (including both debt and equity) of the Company
(including the Securities) or any of its Affiliates or any of the Company&#146;s or any of its Affiliates&#146; Assets, business, or operations, or that otherwise limits or purports to limit the ability of the Company or any of its Affiliates to
own, operate, sell, transfer, pledge, or otherwise dispose of any of the Company&#146;s or any of its Affiliates&#146; Assets, businesses, or operations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any Company Contract that involves the liquidation or dissolution of the Company, the issuance or sale of any Securities, the sale of any
Assets of the Company, or the acquisition of any securities or Assets of any Person by the Company, in each case, in any business combination transaction (whether by merger, sale of securities, sale of Assets, or otherwise); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) any Contract to which any Seller or the Company is a party or by which any such Person or any of such Person&#146;s Assets is otherwise
bound that (A)&nbsp;provides for any options, warrants, calls, rights, convertible or exchangeable securities, stock appreciation rights, phantom stock, profit participation rights, or other rights or obligations of any character with respect to any
Securities, or (B)&nbsp;requires any payments, directly or indirectly (in whole or in part), based on the price or value of any Securities by the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) any Company Contract that provides for the payment of any cash or other compensation or benefits upon or in connection with the
execution and delivery of any of the Transaction Documents or the consummation and performance of the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) any Company
Contract pursuant to which the Company is a (sub)lessor, (sub)lessee, or guarantor of (A)&nbsp;any machinery, equipment, motor vehicles, office furniture, fixtures, or other personal property that by its terms requires the payment of more than
$25,000 during any twelve (12)&nbsp;month period, or (B)&nbsp;any real property, including the Real Property Leases; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiv) any
outstanding note, indenture, loan agreement, credit agreement, financing agreement, security agreement, mortgage, guarantee, or other evidence of Indebtedness or Company Contract (A)&nbsp;relating to the borrowing of money by, or extension of credit
to, the Company (other than trade payables in the Ordinary Course), (B)&nbsp;relating to any guarantee made by the Company in favor of any Person guaranteeing obligations of such Person, or (C)&nbsp;pursuant to which the Company pledged the
Company&#146;s credit on, or otherwise could become responsible for, any Liability of another Person (except for the negotiation or collection of negotiable instruments in the Ordinary Course), or any letter of credit issued for the account of the
Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xv) any Company Contract that provides for capital expenditures or the acquisition or construction of fixed Assets involving
the future payment in excess of $25,000; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvi) any fidelity or surety bond covering the Company or any of its directors, officers, or
employees; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xvii) any Company Contract with any Union, including with respect to collective
bargaining; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xviii) any Company Contract with any Governmental Authority; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xix) any settlement, conciliation, or similar Contract to which the Company is a party or by which the Company or any of the Company&#146;s
Assets is otherwise bound and either (A)&nbsp;contains ongoing or future obligations on the part of the Company or any of its Affiliates or (B)&nbsp;has a value or involves payments in excess of $25,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xx) any Company Contract containing covenants that in any way purports to (A)&nbsp;restrict the business activity of the Company or any of
its Affiliates, or (B)&nbsp;limit the freedom of the Company or any of its Affiliates to engage in any line of business, to compete with any Person, or to solicit any potential customer, supplier, distributor, lessor, lessee, licensor, licensee,
employee, independent contractor, or any other Person (other than commercial Contracts containing industry standard employee <FONT STYLE="white-space:nowrap">non-solicitation</FONT> provisions entered into by the Company in the Ordinary Course);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxi) any Company Contract that provides for the indemnification of any Person (other than as required by applicable Legal Requirements)
or the assumption or guarantee of any Tax, environmental, or other Liability of any Person (other than commercial Contracts containing industry standard indemnification obligations entered into by the Company in the Ordinary Course); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxii) any power of attorney or proxy (revocable or irrevocable) granted by or on behalf of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiii) any Company Contract that relates to the creation, development, sale, transfer, distribution, or license of any Intellectual Property
Rights, including the License Agreements; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxiv) any Company Contract with any current or former employee or independent contractor of
the Company or any current or former Related Person; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxv) any Company Contract related to the sale or issuance of the Company Options
or any incentive equity, equity purchase, option plan or similar plan; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xxvi) each binding commitment to enter into any of the
foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has made available to Buyer in the Virtual Data Room accurate and complete copies of each written Material
Company Contract, and has made available to Buyer in the Virtual Data Room an accurate and complete description of the material terms of each oral Material Company Contract. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) (i)&nbsp;Each of the Material Company Contracts is in full force and effect, and is a legal, valid, binding, and enforceable (except as
enforceability is limited by the Enforceability Exceptions) obligation of the Company and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, each other party thereto, (ii)&nbsp;the Company and, to the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, each other party to the Material Company Contracts have complied with the terms of the Material Company Contracts in all material respects, and (iii)&nbsp;the Company and, to the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, each other party to the Material Company Contracts (A)&nbsp;have performed all material obligations required to be performed by them as of the Closing Date respectively under the Material Company
Contracts and (B)&nbsp;are not currently, and for the prior two (2)&nbsp;years have not been, in breach of or default under the Material Company Contracts in any material respect, and (iv)&nbsp;none of Sellers or the Company has received or given
any written notice of (A)&nbsp;breach or default </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or (B)&nbsp;force majeure, impossibility of performance, frustration of purpose, or similar notices of <FONT STYLE="white-space:nowrap">non-performance,</FONT> in each case with respect to the
foregoing clauses&nbsp;(iv)(A) and (iv)(B), with respect to any Material Company Contract, and, to Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no event has occurred or circumstance exists (including execution, delivery,
and performance of the Transaction Documents and consummation and performance of the Transactions) that, with or without notice or lapse of time or both, (A)&nbsp;would give rise to, or serve as a basis for, any such breach or default or would give
any Person the right to declare a default or exercise any remedy under, accelerate the maturity or performance of or payment under, or cancel, terminate, or modify any Material Company Contract, or (B)&nbsp;would cause any Material Company Contract
to not be in full force and effect and a legal, valid, binding, and enforceable (except as enforceability is limited by the Enforceability Exceptions) obligation of the parties thereto. During the prior two (2)&nbsp;years, the Company has not
released or waived any material rights under any Material Company Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There are no renegotiations regarding or outstanding
rights to negotiate any amounts to be paid or payable to or by the Company under any of the Material Company Contracts, except in the Ordinary Course. The Company does not have any outstanding bid or sale or service proposal that was bid as a known
loss leader or anticipated or reasonably likely to result in a loss to the Company upon fulfillment. None of the Company Contracts contemplate or require that the Company or any of the Company&#146;s equity holders has been, is currently, or will be
qualified for any special contracting status (e.g., disabled veteran, minority owned business, woman owned business, small business owner, etc.). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_15"></A><B>3.10</B> <B><U>Insurance</U></B>. <U>Schedule</U><U></U><U>&nbsp;3.10</U> to the Disclosure Letter sets
forth an accurate and complete list of all policies of insurance (including &#147;self-insurance&#148; programs) covering the Company (collectively, the &#147;<U>Insurance Policies</U>&#148;), including policy numbers, names of insurers, liability
or risk covered, amounts of coverage, limitations and deductions, and expiration dates and the Company has made to Buyer in the Virtual Data Room accurate and complete copies of each Insurance Policy (including all written amendments, supplements,
waivers of rights, and other modifications thereto). All of the Insurance Policies are (a)&nbsp;in full force and effect, (b)&nbsp;are sufficient for compliance in all material respects by the Company with all applicable Legal Requirements and
Company Contracts, (c)&nbsp;are valid, outstanding, and enforceable policies, and (d)&nbsp;fully paid, and the Company is not in default in any material respect thereunder. None of Sellers or the Company has received any written notice from any
applicable insurance company cancelling or materially amending any Insurance Policy and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no such cancellation or amendment is threatened. The Assets of the Company are
insured to full replacement cost value. During the past five (5)&nbsp;years, no policy limits of the Insurance Policies (or any predecessor insurance policies) have been exhausted or materially eroded or reduced and insurance policies providing
substantially similar insurance coverage as the Insurance Policies have been in effect continuously during such five (5)&nbsp;year period. <U>Schedule</U><U></U><U>&nbsp;3.10</U> to the Disclosure Letter sets forth an accurate and complete list of
all pending claims and all claims made or paid under the Insurance Policies (and any predecessor insurance policies) since January&nbsp;1, 2019, and no insurer with which any such claim is pending is insolvent. To the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, there are no threatened claims under any Insurance Policy and no circumstances exist that could give rise to a claim under any Insurance Policy. No insurer has ever denied, rejected, questioned, or
disputed or made any reservation of rights regarding any pending claims under any of the Insurance Policies (or any predecessor insurance policies). The Company has never failed to give notice or present any claims under any of the Insurance
Policies (or any predecessor insurance policies) in a due and timely manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.11</B> <B><U>Proceedings; Orders</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) There is no, and for the past six (6)&nbsp;years there has been no, Proceeding pending or, to the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened by or against the Company, or any Affiliate of the Company and relating to the Company, and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no event has
occurred or circumstance exists that, with or without notice or lapse of time or both, would give rise to, or serve as a basis for, any such Proceeding. There are no Proceedings pending or, to the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened by or against any Seller or the Company that challenge, or that would reasonably be expected to have the effect of preventing, delaying, making illegal, or otherwise interfering
with, any of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There is no Order to which any Seller or the Company is subject or bound, or that otherwise affects
the Assets, Liabilities, or business activities of the Company, and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no event has occurred or circumstance exists that, with or without notice or lapse of time or both,
would give rise to, or serve as a basis for, any such Order. There is no Order to which any Seller or the Company is subject or bound that would reasonably be expected to have the effect of preventing, delaying, making illegal, or otherwise
interfering with any of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_16"></A><B>3.12</B> <B><U>Governmental Authorizations</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company holds in its name and, as applicable, has submitted, Governmental Authorizations necessary to own or lease, operate, and use
the Company&#146;s Assets and carry on and conduct the Company&#146;s businesses and operations as currently conducted (collectively the &#147;<U>Company Governmental Authorizations</U>&#148;). Set forth on <U>Schedule</U><U></U><U>&nbsp;3.12(a)</U>
to the Disclosure Letter is an accurate and complete list of all of the material Company Governmental Authorizations, along with the issuance and expiration date of each of the Company Governmental Authorizations and the identity of the Governmental
Authority that issued each of the Company Governmental Authorizations. Each of the material Company Governmental Authorizations is (and, since the date of grant, has been) in good standing, valid, and in full force and effect, and the execution,
delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions will not terminate or adversely affect any of the Company Governmental Authorizations. None of Sellers or the Company has received any
written notice from any Governmental Authority (i)&nbsp;asserting any unresolved violation of, or failure to comply with, any requirement of any of the Company Governmental Authorizations or (ii)&nbsp;notifying such Person of the revocation,
withdrawal, termination, suspension, limitation, variation, amendment, or <FONT STYLE="white-space:nowrap">non-renewal</FONT> of any of the Company Governmental Authorizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i)&nbsp;The Company is currently, and at all times within the six (6)&nbsp;years prior to Closing, has been, in compliance in all
material respects with all of the terms and requirements of each of the Company Governmental Authorizations, (ii)&nbsp;no conditions, penalties, or other disciplinary sanctions have been imposed in relation to any of the Company Governmental
Authorizations, and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no event has occurred or circumstance exists that, with or without notice or lapse of time or both, would give rise to, or serve as a basis for,
(A)&nbsp;the revocation, withdrawal, termination, suspension, limitation, variation, amendment, or <FONT STYLE="white-space:nowrap">non-renewal</FONT> of any of the Company Governmental Authorizations or (B)&nbsp;any penalty or other disciplinary
sanction in connection with any of the Company Governmental Authorizations, and (iii)&nbsp;all applications required to have been filed for the renewal of each of the Company Governmental Authorizations have been duly filed on a timely basis with
the appropriate Governmental Authorities, and all other Filings required to have been made with respect to such Company Governmental Authorizations have been duly made on a timely basis with the appropriate Governmental Authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_17"></A><B>3.13</B> <B><U>Compliance with Laws; Anti-Bribery and Anti-Money Laundering Laws</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is, and at all times within the six (6)&nbsp;years prior to Closing, has been, in compliance in all material respects with all
applicable Legal Requirements. None of Sellers or the Company has received any written notice from any Governmental Authority or other Person (i)&nbsp;regarding any actual, alleged, or potential violation of or failure to comply with any material
Legal Requirement by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company, or (ii)&nbsp;requiring the Company to enter into or consent to the issuance of any cease and desist order or formal Contract in connection with any alleged violation or <FONT
STYLE="white-space:nowrap">non-compliance</FONT> by the Company. To the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no investigation or inquiry is being or has been conducted by any Governmental Authority with respect to
the Company or any of the Company&#146;s businesses or operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of the Company&#146;s Affiliates or
any of the Company&#146;s or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, its Affiliates&#146; respective Representatives (with respect to any matter relating to the Company) has, directly or indirectly,
(i)&nbsp;taken any action that would constitute a violation of any applicable Anti-Bribery Laws, (ii)&nbsp;made, agreed to make, or offered the payment or giving of, directly or indirectly, any bribe, rebate, payoff, influence payment, kickback,
contribution, loan, donation, or other payment of gift of money or anything of value (including meals and entertainment) to any (A)&nbsp;official, officer, employee, or ceremonial office holder of any (1)&nbsp;Governmental Authority or
instrumentality thereof, (2)&nbsp;supra-national organization (such as the United Nations), or (3)&nbsp;political party or political campaign (including to any political candidate or otherwise relating to any political activity), (B)&nbsp;any royal
family member, or (C)&nbsp;any other Person who is connected or associated personally with any of the foregoing, in each case, that is prohibited under any applicable Legal Requirement or otherwise for the purpose of influencing any act or decision
of such beneficiary in such beneficiary&#146;s official capacity, inducing such beneficiary to do or omit from doing any act in violation of such beneficiary&#146;s lawful duty, securing any improper advantage, or inducting such beneficiary to use
such beneficiary&#146;s influence with a Governmental Authority or instrumentality thereof to affect or influence any act or decision of such Governmental Authority or instrumentality (each, a &#147;<U>Prohibited Payment</U>&#148;),
(iii)&nbsp;failed, with respect to any financial statement, billing statement, Filing, or Tax Return associated with such Person&#146;s business, to render such financial statement, billing statement, Filing, or Tax Return so as to reflect properly
the facts about all payments made, services performed, and transactions handled by, for, or on behalf of the Company, or (iv)&nbsp;been subject to any investigation by any Governmental Authority with regard to any actual or alleged Prohibited
Payment. The Company has instituted and maintained policies, procedures, and controls designed to ensure continued compliance with all applicable Anti-Bribery Laws by the Company and by the Company&#146;s Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The operations of the Company are, and at all times have been, conducted in compliance with all applicable Anti-Money Laundering Laws.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_18"></A><B>3.14</B> <B><U>Environmental Matters</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is, and at all times within the six (6)&nbsp;years prior to Closing, has been, in compliance in all material respects with all
applicable Environmental Laws. None of Sellers or the Company has received from any Person any (i)&nbsp;Environmental Notice or Environmental Claim, or (ii)&nbsp;written request for information in connection with noncompliance or alleged
noncompliance of any Environmental Law. No Environmental Claim is currently pending or has been filed against the Company alleging any failure to comply with any Environmental Law or any term or condition of any Environmental Permit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company has not treated, stored, disposed of, arranged or permitted the disposal of, transported, handled, or Released any substances,
including any Hazardous Materials, in a manner that has given or would give rise to any Environmental Claim, including any claim for response costs, corrective action costs, personal injury, property damage, or natural resource damage, pursuant to
any applicable Environmental Law. There has been no Release of Hazardous Materials in contravention of any applicable Environmental Law by the Company or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, involving any
real property currently or formerly owned or leased by the Company, including the Leased Real Property, and none of Sellers or the Company has received any Environmental Notice that any such real property or any
<FONT STYLE="white-space:nowrap">off-site</FONT> real property owned by any Person (including soils, groundwater, surface water, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
buildings, structures, improvements, fixtures, building systems and equipment, and all components thereof, located on any such real property) has been contaminated with any Hazardous Material
that would reasonably be expected to result in an Environmental Claim against, or a violation of any applicable Environmental Law or any term or condition of any Environmental Permit by, the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has not, either expressly or by operation of law, assumed or undertaken any Liability or Environmental Claim, including any
obligation for corrective or remedial action, of any Person relating to any Environmental Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_19"></A><B>3.15</B> <B><U>Business Associates</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers have made available in the Virtual Data Room an accurate and complete list of
all employees (including those on leave of absence, furlough, or layoff status) and independent contractors of the Company (collectively, the &#147;<U>Business Associates</U>&#148;), and sets forth for each of the Business Associates the following
information, as applicable: (i)&nbsp;name; (ii)&nbsp;title or position (including whether full or part time); (iii) license, registration, or authorization status; (iv)&nbsp;hire or engagement date; (v)&nbsp;current annual base compensation rate or
fee rate; and (vi)&nbsp;commission, bonus, or other incentive-based compensation received for 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The employment of each employee
and engagement of each independent contractor of the Company is terminable at the will of the Company, and the Company is not a party to any employment, independent contractor, <FONT STYLE="white-space:nowrap">non-competition,</FONT> or severance
Contract with any current or former employee or independent contractor of the Company under which the Company has any ongoing obligations or Liability. All compensation, including wages, commissions, and bonuses, due and payable to the Business
Associates for services performed have been paid in full or have been fully accrued as Current Liabilities in the calculation of Estimated Net Working Capital. No offer of employment or engagement has been made by the Company that has not yet been
accepted, or that has been accepted where the employment or engagement has not yet begun. No Business Associate has given written notice terminating such Business Associate&#146;s employment or engagement or is under notice of dismissal and, to the
Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no Business Associate has any plans to terminate employment or engagement with the Company within the three (3)&nbsp;months following the Closing, including as a result of the
Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company is and, at all times within the six (6)&nbsp;years prior to Closing, has been in compliance in all material
respects with all applicable Legal Requirements relating to the Company&#146;s employment of the Company&#146;s employees and engagement of the Company&#146;s independent contractors and their conduct, including the CARES Act, the Families First
Act, Section&nbsp;1981 of the Civil Rights Act of 1866, Title&nbsp;VII of the Civil Rights Act of 1964, Americans with Disabilities Act, Age Discrimination in Employment Act, Equal Pay Act, Fair Labor Standards Act, Family Medical Leave Act,
National Labor Relations Act, and the Occupational Safety and Health Act, or otherwise relating to compensation (including overtime pay), bonuses, consumer protection, labor relations, equal employment opportunities, fair employment practices,
employment discrimination, harassment, retaliation, reasonable accommodation, disability rights and benefits, immigration, wages, hours, overtime, child labor, hiring, promotion and termination of employees, working conditions, meal and break
periods, privacy, health and safety, workers&#146; compensation, leaves of absence, and unemployment insurance. All Business Associates are either citizens of the United States or have the requisite authorizations to legally work in the United
States and, as applicable, are duly licensed, certified, and authorized by all applicable Governmental Authorities to carry out their respective job functions and engagement with the Company. All individuals characterized and treated by the Company
as independent contractors are properly treated as independent contractors under all applicable Legal Requirements. All Business Associates classified as exempt under the FLSA and state and local wage and hour Legal Requirements are properly
classified. There are no </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material Proceedings (whether individually or in the aggregate) pending, or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened against the Company
(A)&nbsp;by any current or former employee or independent contractor of the Company with respect to any accident or injury that is not fully covered by the Insurance Policies, or (B)&nbsp;by any Governmental Authority or any current or former
applicant, employee, or independent contractor of the Company with respect to any claim relating to licensing, authorization, compensation, bonuses, consumer protection, unfair labor practices, employment discrimination, harassment, retaliation,
equal pay, wages and hours, employee benefits, or any other employment related matter arising under applicable Legal Requirements. To the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no event has occurred or circumstance
exists that, with or without notice or lapse of time or both, would give rise to, or serve as a basis for, any such Proceeding. During the immediately prior six (6)&nbsp;years, no formal written allegations of sexual or any other form of harassment,
in each such case, whether or not constituting harassment under applicable Legal Requirements, has been made to the human resources department of the Company against any Business Associate, and the Company has not entered into any written settlement
Contracts related to allegations of sexual or any other form of harassment within the six (6)&nbsp;years prior to Closing.<B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
The Company is not, and never has been, a party to, bound by, or negotiating any collective bargaining or other Contract with any Union, and there is not, and has never been, any Union representing or purporting to represent any employees of the
Company, and, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no Union or group of employees of the Company is seeking or has sought to organize employees of the Company for the purpose of collective bargaining. There
has never been nor, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, has there been any threat of any strikes, lockouts, work stoppages, work interruptions, slowdowns, concerted refusal to work overtime, or other similar
labor disruption or dispute involving a group of employees of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, none of the Business Associates is subject to any Contract containing covenants that in any way purports to restrict such Business Associate from engaging in any line of business, competing
with any Person, or soliciting any potential customer, supplier, distributor, lessor, lessee, licensor, licensee, employee, independent contractor, or any other Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_20"></A><B>3.16</B> <B><U>Benefit Plans</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule</U><U></U><U>&nbsp;3.16(a)</U> to the Disclosure Letter sets forth a complete and accurate list of all material benefits
received from the Company by any current employee or independent contractor of the Company, or former employee or independent contractor of the Company within the last three (3)&nbsp;years, as well as a list of all employee welfare benefit plans (as
defined in Section&nbsp;3(1) of ERISA, whether or not subject to ERISA), employee pension benefit plans (as defined in Section&nbsp;3(2) of ERISA, whether or not subject to ERISA), and all other written employment, compensation, consulting, bonus,
stock option, restricted stock grant, stock purchase, other cash or stock-based incentive, profit sharing, savings, retirement, disability, insurance, severance, deferred compensation, and other similar fringe or employee benefit plans, programs,
agreements, or arrangements (i)&nbsp;sponsored, maintained, contributed to, or required to be contributed to, or entered into by the Company or any ERISA Affiliate for the benefit of, or relating to, any current or former director, manager, officer,
employee, or independent contractor of the Company or any ERISA Affiliate, or (ii)&nbsp;under which the Company or any ERISA Affiliate has or could reasonably be expected to have future Liability (collectively, the &#147;<U>Benefit Plans</U>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to each Benefit Plan, the Company has made available to Buyer in the Virtual Data Room accurate and complete copies of
the following: (i)&nbsp;a copy of each Benefit Plan (including all amendments thereto and all administration agreements, insurance policies, investment management, and advisory agreements as currently in effect and all prior Benefit Plan documents,
if </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amended within the last two (2)&nbsp;years); (ii)&nbsp;a copy of the three (3)&nbsp;most recent Form&nbsp;5500 annual reports, if any, required under ERISA or the Code; (iii)&nbsp;a copy of the
most recent summary plan description (and any summary of material modifications), if any, required under ERISA; (iv)&nbsp;if the Benefit Plan is funded through a trust or any third-party funding vehicle, a copy of the trust or other funding Contract
(including any amendments thereto) as currently in effect; (v)&nbsp;if the Benefit Plan is intended to be qualified under Section&nbsp;401(a) of the Code, the most recent determination and/or opinion letter received from the IRS; (vi)&nbsp;the most
recent actuarial reports for the last three (3)&nbsp;plan years, if any; (vii)&nbsp;all correspondence with the IRS or the United States Department of Labor regarding any Benefit Plan, other than that associated with any routine reporting and
disclosure obligations; (viii)&nbsp;all discrimination tests for each Benefit Plan for the three (3)&nbsp;most recent plan years, if any; and (ix)&nbsp;a list of all current and former employees of the Company or any ERISA Affiliate receiving COBRA
benefits as of the Closing Date. The Company does not have any unwritten Benefit Plans. All Benefit Plans have been approved and administered in accordance with the terms of the Benefit Plans and in accordance with all applicable Legal Requirements,
in each case, in all material respects, and are currently in compliance in all material respects with the Legal Requirements currently in effect with respect to such Benefit Plans, including ERISA, the Code, and all similar Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) None of the Company, Sellers, or any ERISA Affiliate, any of their respective Representatives, or, to the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, any other Person has, with respect to any Benefit Plan, engaged in or been a party to any <FONT STYLE="white-space:nowrap">non-exempt</FONT> &#147;prohibited transaction&#148; (as defined in
Section&nbsp;4975 of the Code, Section&nbsp;406&nbsp;of ERISA, or similar foreign Legal Requirements). None of the Company or any ERISA Affiliate, any of their respective Representatives, or, to the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, any other Person has, with respect to any Benefit Plan, breached any fiduciary duty with respect to the investment of the Assets or administration of any Benefit Plan that would reasonably be
expected to result in Liability to the Company or any ERISA Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each Benefit Plan intended to qualify under
Section&nbsp;401(a) of the Code, and the trusts created thereunder intended to be exempt from Tax under the provisions of Section&nbsp;501(a) of the Code, either (i)&nbsp;has received a favorable determination or prototype opinion letter from the
IRS as to the form of such Benefit Plan, (ii)&nbsp;is still within the &#147;remedial amendment period,&#148; as described in Section&nbsp;401(b) of the Code and the regulations thereunder (the &#147;<U>Remedial Amendment Period</U>&#148;), or
(iii)&nbsp;has made application to the IRS for a favorable determination letter within the Remedial Amendment Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All
contributions or payments required to be made or accrued before the Effective Time under the terms of any Benefit Plan will have been made by the Closing or appropriately accrued on the Financial Statements in accordance with GAAP and applicable
Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) No Benefit Plan is (i)&nbsp;a &#147;multiemployer plan&#148; (as defined in Section&nbsp;3(37) of ERISA),
(ii)&nbsp;a plan that is subject to Title&nbsp;IV of ERISA, Section&nbsp;302 of ERISA, or Section&nbsp;412 of the Code, or (iii)&nbsp;a &#147;multiple employer plan&#148; (as defined in Section&nbsp;413(c) of the Code), and neither the Company nor
any ERISA Affiliate has maintained, contributed to, or been required to contribute to any Benefit Plan described in clauses&nbsp;(i), (ii), or (iii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;3.16(f)</U> within the last six (6)&nbsp;years. The
execution, delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions will not result in a withdrawal from any Benefit Plan described in clauses&nbsp;(i), (ii), or (iii)&nbsp;of this
<U>Section</U><U></U><U>&nbsp;3.16(f)</U> and will not result in any withdrawal Liability under ERISA, the Code, other applicable Legal Requirements, or the terms of any Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) No Benefit Plan provides medical, surgical, hospitalization, life insurance, or similar benefits (whether or not insured) for current or
former employees of the Company or any ERISA Affiliate for periods extending beyond their retirement or other termination of service, other than coverage mandated by Section&nbsp;4980B of the Code and applicable Legal Requirements, if any.<B>
</B>The requirements&nbsp;of COBRA have been met with respect to each Benefit Plan that is subject to COBRA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) All required reports (including Form 5500 annual reports, summary annual reports, and
summary plan descriptions) with respect to each Benefit Plan have been properly and timely filed and/or distributed to participants and other applicable individuals in accordance with the applicable requirements of ERISA and the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Except for the ESOP Amendment and Option Agreements, the execution, delivery, and performance of the Transaction Documents and the
consummation and performance of the Transactions will not, either alone or in combination with any other event, (i)&nbsp;entitle any current or former director, manager, officer, employee, or independent contractor of the Company or any ERISA
Affiliate to severance pay or any other payment or benefit, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of compensation due any current or former director, manager, officer, employee, or independent contractor of the
Company or any ERISA Affiliate, (iii)&nbsp;require the Company or any ERISA Affiliate to place in trust or otherwise set aside any amounts in respect of severance pay or any other payment or benefit, or (iv)&nbsp;entitle any employee or independent
contractor of the Company to terminate such employee&#146;s employment or such independent contractor&#146;s engagement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except for
determination letters issued by the IRS with respect to plans intended to qualify under Section&nbsp;401(a) of the Code, neither the Company nor any ERISA Affiliate is a party to any Contract, whether written or unwritten, with the IRS, the United
States Department of Labor, the Pension Benefit Guaranty Corporation, or any similar foreign Governmental Authority in regard to any Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) There are no Contracts between the Company or any ERISA Affiliate, on the one hand, and any director, manager, officer, or employee of
such Person, on the other hand, pursuant to which the Company or any ERISA Affiliate could be required to make any payment that would not be fully deductible under Section&nbsp;280G of the Code or that would otherwise be considered an &#147;excess
parachute payment&#148; (within the meaning of Section&nbsp;280G(b)(2) of the Code). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Each Benefit Plan that is a &#147;nonqualified
deferred compensation plan&#148; (within the meaning of Section&nbsp;409A(d)(1) of the Code) has been operated in compliance in all material respects with Section&nbsp;409A of the Code, IRS Notice <FONT STYLE="white-space:nowrap">2005-1,</FONT>
Treasury Regulations issued under Section&nbsp;409A of the Code, and any subsequent guidance relating thereto, and no additional Tax under Section&nbsp;409A(a)(1)(B) of the Code has been or is reasonably expected to be incurred by a participant in
any such Benefit Plan, and no director, manager, officer, or employee of the Company or any ERISA Affiliate is entitled to any <FONT STYLE="white-space:nowrap">gross-up,</FONT> reimbursement, equalization, or similar payment from, or otherwise
entitled to be indemnified by, the Company or any ERISA Affiliate for any violation of Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) There are no
pending or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened Proceedings that have been asserted relating to any Benefit Plan by any employee or other beneficiary covered under any Benefit Plan or otherwise
involving any Benefit Plan (other than routine claims for benefits). No examination, voluntary correction proceeding, or audit of any Benefit Plan by any Governmental Authority is in progress or, to the Knowledge of the <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) Neither the Company nor any ERISA Affiliate has used the services of
workers provided by third party contract labor suppliers, temporary employees, &#147;leased employees&#148; (as that term is defined in Section&nbsp;414(n) of the Code), or individuals who have provided services as independent contractors, to an
extent that would reasonably be expected to result in the disqualification of any of the Benefit Plans or the imposition of penalties or excise Taxes with respect to any of the Benefit Plans by the IRS, the United States Department of Labor, the
Pension Benefit Guaranty Corporation, or any similar foreign Governmental Authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The Company, each ERISA Affiliate, and each Benefit Plan that is a &#147;group health
plan&#148; (as defined in Section&nbsp;733(a)(1) of ERISA) is currently in compliance in all material respects with the ACA and all regulations and guidance issued thereunder. None of the Company, any ERISA Affiliate, or any Benefit Plan has
incurred any penalty or Tax under Sections&nbsp;4980D or 4980H of the Code or the ACA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) Neither the Company nor any Seller has taken
any actions with respect to employees, compensation, or Benefit Plans in response to the Pandemic, including employee terminations, furloughs, salary, or other pay reductions, pay increases, deferrals of compensation, or deferrals of employer
funding contributions to or amendments to any Benefit Plan. To the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, no employee of the Company who is critical to the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations of the Company is unable to perform such employee&#146;s duties and responsibilities as a result (directly or indirectly) of <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_21"></A><B>3.17</B> <B><U>ESOP Matters</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The ESOP and the Trust, taken together, are now and at all relevant times have been an employee stock ownership plan described in
Section&nbsp;4975(e)(7) of the Code and the regulations thereunder. The ESOP and the Trust have been maintained and administered in material compliance with ERISA, the Code, and all other applicable Legal Requirements. No prior purchase of Company
Capital Stock by the Trust, or distribution or sale of Company Capital Stock by the Trust, has adversely affected the qualified status of the ESOP under Section&nbsp;401(a) of the Code or the status of the ESOP as an employee stock ownership plan
under Section&nbsp;4975(e)(7) of the Code. The shares of Company Capital Stock acquired by the ESOP and held by the Trust are and at all times have been &#147;employer securities&#148; under Section&nbsp;407(d)(1) of ERISA and Section&nbsp;409(l) of
the Code and &#147;qualifying employer securities&#148; for purposes of Section&nbsp;407(d)(5) of ERISA and Section&nbsp;4975(e)(8) of the Code. The Trust is a trust duly formed in accordance with applicable state Legal Requirements and is, and at
all times has been, a trust described in Section&nbsp;501(a) of the Code. The ESOP received a favorable determination letter (&#147;<U>Determination Letter</U>&#148;) for its last applicable cycle filing under the IRS&#146; (now discontinued)
determination letter program, and the Company satisfied all conditions contained in the Determination Letter in order to retain reliance on the Determination Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Trust borrowed certain funds from the Original Stockholder on or about November&nbsp;30, 2005, and applied those proceeds to the
payment of the purchase price of a portion of the Company Shares held by the Trust (the &#147;<U>ESOP Formation Transaction</U>&#148;). The Company Shares purchased by the Trust were purchased for no more than &#147;adequate consideration&#148;
within the meaning of Section&nbsp;3(18) of ERISA in accordance with all other requirements of Section&nbsp;408(e) of ERISA and the terms of the ESOP Formation Transaction, including the sale of the Company Shares to the Trust and the terms of the
loans from Original Stockholder, were fair to the ESOP and its participants from a financial point of view. Neither the acquisition of the Company Shares by the Trust under the ESOP Formation Transaction nor any related or other loan to the ESOP
constituted a <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction for purposes of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code. The overall ESOP Formation Transaction, including the sale of the Company Shares to
the Trust, and the terms of the loan to the Trust were effected in compliance in all material respects with applicable Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In connection with the ESOP Formation Transaction, the original Trustee was advised by counsel and an independent financial advisor, both
of its own choosing. All trustees for the Trust have performed and complied with all the terms, provisions, agreements and conditions required to be performed or complied with by such trustees, and no unmatured default or breach of any covenant by
any party exists thereunder. The board of directors of the Company complied in all material respects with all the duties and responsibilities imposed on the board of directors of the Company under the ESOP and applicable Legal Requirements in
connection with the selection and appointment of the Trustee.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Trustee has received the Fairness Opinion as of the Closing Date, in a form
satisfactory to the Trustee, from Columbia Financial Advisors, Inc., who is independent of all parties to the Transactions, including the Company and its Affiliates, and any other &#147;party in interest&#148; within the meaning of
Section&nbsp;3(14) of ERISA with respect to the ESOP and who meets the requirements of an &#147;independent appraiser&#148; under Section&nbsp;401(a)(28)(C) of the Code, to the effect that (i)&nbsp;the consideration to be received by the ESOP
pursuant to this Agreement is not less than &#147;adequate consideration&#148; within the meaning of Section&nbsp;3(18) of ERISA, and (ii)&nbsp;the terms and conditions of the Transactions, taken as a whole, are fair to the ESOP from a financial
point of view. A true, correct and complete copy of the Fairness Opinion has been provided to Buyer as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The
Company has made available to Buyer complete and accurate copies of (i)&nbsp;all fairness and valuation opinions received by the Trustee or the Company with respect to the Trust, including all fairness and valuation opinions received by the Trustee
or the Company in connection with the ESOP Formation Transaction; (ii)&nbsp;any schedules for releases of Company Capital Stock from suspense accounts; (iii)&nbsp;any allocation records evidencing actual releases of Company Capital Stock from
suspense accounts and subsequent allocations of Company Capital Stock to participants&#146; accounts; (iv)&nbsp;any releases of Liens with respect to Company Capital Stock; (v)&nbsp;any opinion letters or other legal correspondence issued to the
Trustee with respect to any Company Capital Stock transactions, including opinion letters or other legal correspondence received in connection with the ESOP Formation Transaction; (vi)&nbsp;any documents that provide for indemnification of the
fiduciaries of the ESOP at any time within the preceding six&nbsp;(6) years; and (vii)&nbsp;any opinion letters received by it in connection with the ESOP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither the ESOP nor the Trust currently has any Indebtedness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company has delivered or made available to Buyer with respect to the ESOP and Trust a complete and accurate copy of all records
maintained by the plan administrator of the ESOP and the Trustee with respect to any pass-through of voting rights to participants in the ESOP that has been required in order to comply with any applicable Legal Requirements, including
Sections&nbsp;401(a)(22) and 409(e) of the Code for any plan year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Trustees have complied in all material respects with all of
the responsibilities and duties imposed on the Trustees under the ESOP and the Trust, and all applicable Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The
Trustee has determined that (A)&nbsp;the consideration received by the ESOP pursuant to this Agreement is not less than &#147;adequate consideration&#148; within the meaning of Section&nbsp;3(18) of ERISA, and (B)&nbsp;the terms and conditions of
the overall transactions contemplated by this Agreement, taken as a whole, are fair to the ESOP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Except as provided in the ESOP
Amendment there has been no change to the vesting schedule for the ESOP since its inception. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) At no time has the ESOP been notified in
writing that it is subject to an audit or investigation by either the IRS or the Department of Labor, except for the review of the ESOP made by the IRS in connection with the ESOP&#146;s application for a favorable determination letter. To the
Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, there are no threatened audits or investigations by the IRS or Department of Labor with respect to the ESOP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) There has been no finding, holding, ruling or other determination made by any court or
Governmental Authority, and there has been no assertion by any fiduciary of the ESOP or the Trust, concerning any matter with respect to the ESOP or the Trust contrary to or inconsistent with any covenant or representation set forth in this
Agreement. There is no investigation or review by any Governmental Authority, or action, suit, proceeding or arbitration, pending or concluded, concerning any matter with respect to the ESOP or the Trust relevant as to whether any representation
contained in this Agreement was, or has or will at any time become inaccurate or breached. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Company has made available to Buyer a
true, correct and complete copy of the Trust&#146;s Constitutive Documents, Governing Documents, and all Contracts between the Trust and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The consummation by the Trustee of the transactions contemplated by this Agreement will not involve any
<FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction that is subject to the prohibitions of Section&nbsp;406 of ERISA or in connection with which a Tax may be imposed pursuant to Section&nbsp;4975(c) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_22"></A><B>3.18</B> <B><U>Taxes</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has made available to Buyer in the Virtual Data Room accurate and complete copies of all Tax Returns and all amendments to
such Tax Returns filed by or on behalf of, or which include, the Company for the three (3)&nbsp;most recent Tax years prior to the Closing Date. The Company has timely and duly filed all Tax Returns required to be filed by the Company (which are
true, accurate, and complete in all material respects) and has timely paid in full, or caused to be paid in full, all Taxes and all assessments of any kind or nature whatsoever (whether or not shown on any Tax Return) allocable to any period ending
prior to the Closing and required to be paid by the Company. Without limiting the generality of the foregoing, no such Tax Return contains any position that is, or would be, subject to penalties under Section&nbsp;6662 of the Code (or any
corresponding or similar Legal Requirement). The Company is not currently the beneficiary of any extension of time within which to file any Tax Return. The Company has timely withheld and paid all Taxes required to have been withheld and paid in
connection with any amounts paid or owing to any employee, independent contractor, creditor, shareholder, or other Person, and all Forms <FONT STYLE="white-space:nowrap">W-2</FONT> and 1099 (and any state equivalent forms) required with respect
thereto have been properly completed in all material respects and timely filed with the appropriate Governmental Authority. Neither the Company nor any of its shareholders, directors, officers, or employees is subject to Liability as a
&#147;responsible person&#148; under Section&nbsp;6672 of the Code. All sales, goods and services, and value added Taxes required to be collected and remitted by the Company have been properly collected and timely remitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A list of each jurisdiction where the Company files Tax Returns and remits sales or use Taxes is set forth on
<U>Schedule</U><U></U><U>&nbsp;3.18(b)</U> to the Disclosure Letter. All necessary sales Tax exemption certificates have been obtained by the Company and all such certificates have been properly completed and maintained. The Company has not received
any written notice that it has engaged in any activity that creates a taxable nexus or establishment in any jurisdiction where the Company does not file Tax Returns, and no claim has ever been made in writing or, to the Knowledge of <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, in any other manner by any Governmental Authority in a jurisdiction where the Company does not file Tax Returns that the Company is or could be subject to taxation by such jurisdiction. There are
no Encumbrances (other than Permitted Encumbrances) on any of the Assets of the Company or otherwise affecting the Company that arose from any failure (or alleged failure) to pay any Tax. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No examination or audit of any Tax Return of the Company by any Governmental Authority
is currently in progress or, to the Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened. No assessment or other Proceeding by any Governmental Authority is pending or, to the Knowledge of
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers, threatened with respect to the Taxes or Tax Returns of the Company. There is no dispute or claim concerning any Liability of the Company for additional Taxes claimed or raised by any
Governmental Authority in any written notice or communication provided to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The unpaid Taxes of the Company did not, as of
the Interim Balance Sheet Date, exceed the reserve for Tax Liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the face of the Interim Balance Sheet (rather than in
any notes to the Interim Balance Sheet). The unpaid Taxes of the Company will not, as of the Closing Date, exceed such reserve for Tax Liability (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax
income) as adjusted for the passage of time in the Ordinary Course (and which reserves will not exceed comparable amounts incurred in similar periods in prior years). Since the Interim Balance Sheet Date, the Company has not incurred any Liability
for Taxes outside the Ordinary Course. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company has not participated in, and the IRS has not approached the Company with respect
to, any &#147;reportable transaction&#148; within the meaning of <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4</FONT> of the Treasury Regulations. Neither the Company nor any of its shareholders, directors, officers, or employees is or has
been a &#147;material advisor&#148; under Section&nbsp;6111 of the Code. The Company is not a party to or bound by any Tax allocation, sharing, or similar Contract (including any advance pricing agreement, closing agreement, voluntary disclosure
agreement, or other Contract relating to Taxes with any Governmental Authority) and has no current or potential contractual or legal obligation to indemnify any other Person with respect to Taxes. The Company has not (i)&nbsp;been a member of an
&#147;affiliated group&#148; within the meaning of Section&nbsp;1504(a) of the Code (or any corresponding or similar Legal Requirement) filing a consolidated federal income Tax Return (or any other Tax Return) or (ii)&nbsp;had any Liability for the
Taxes of any Person (A)&nbsp;under <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> of the Treasury Regulations (or any corresponding or similar Legal Requirement), (B)&nbsp;as a transferee or successor, (C)&nbsp;by Contract, or
(D)&nbsp;otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Company has not made any payment, is not obligated to make any payment, and is not party to any Contract that
under any circumstance could obligate the Company to make any payment that would not be fully deductible under Section&nbsp;280G of the Code (or any corresponding or similar Legal Requirement) or that would otherwise be considered an &#147;excess
parachute payment&#148; (within the meaning of Section&nbsp;280G(b)(2) of the Code (or any corresponding or similar Legal Requirement)). No Company Contract requires the Company to <FONT STYLE="white-space:nowrap">gross-up,</FONT> reimburse,
equalize, or make any similar payment to, or otherwise indemnify, any Person with respect to any <FONT STYLE="white-space:nowrap">Tax-related</FONT> payments, including with respect to any Taxes arising under Section&nbsp;409A, Section&nbsp;280G, or
Section&nbsp;4999 of the Code, or, in each case, any corresponding or similar Legal Requirement. The Company will not be required to include any item of income in, or exclude any item of deduction from, taxable income for any Tax period ending on or
after the Closing Date as a result of any (i)&nbsp;change in accounting method for any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Periods under Section&nbsp;481 of the Code (or any corresponding or similar Legal Requirement),
(ii)&nbsp;written Contract with a Governmental Authority with regard to the Tax Liability of the Company for any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Periods, (iii)&nbsp;installment sale or open transaction disposition made on or
prior to the Closing Date, (iv)&nbsp;prepaid amount received on or prior to the Closing Date, or (v)&nbsp;election under Section&nbsp;108(i) of the Code. The Company has not distributed Securities to another Person, nor had Securities distributed by
another Person, in a transaction that was purported or intended to be governed in whole or in part by Sections&nbsp;355 or 361 of the Code. None of the Assets of the Company is property that the Company is or will be required to treat as being owned
by another Person under provisions of Section&nbsp;168(f)(8) of the Code (as in effect prior to amendment by the Tax Reform Act of 1986) or is <FONT STYLE="white-space:nowrap">&#147;tax-exempt</FONT> use property&#148; within the meaning of
Section&nbsp;168 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Schedule</U><U></U><U>&nbsp;3.18(g)</U> to the Disclosure Letter sets forth an
accurate and complete list of all elections that have been made (or are pending) and actions that have been taken (or are pending) by the Company pursuant to Sections&nbsp;2301-2308 of the CARES Act or Sections&nbsp;7001-7005 of the Families First
Act. The Company has (i)&nbsp;properly complied with all requirements of applicable Legal Requirements in order to defer the amount of the employer&#146;s share of any &#147;applicable employment taxes&#148; under Section&nbsp;2302 of the CARES Act
and (ii)&nbsp;to the extent applicable, properly complied in all material respects with all requirements of applicable Legal Requirements and duly accounted for any available Tax credits under Sections&nbsp;7001 through 7005 of the Families First
Act and Section&nbsp;2301 of the CARES Act. The Company has not sought (nor has any Affiliate that would be aggregated with the Company and treated as one employer for purposes of Section&nbsp;2301 of the CARES Act sought) a covered loan under
paragraph&nbsp;(36) of Section&nbsp;7(a) of the Small Business Act (15 U.S.C. 636(a)), as added by Section&nbsp;1102 of the CARES Act. The Company has not deferred any payroll tax obligations pursuant to any U.S. presidential memorandum, executive
order, or similar publication or document permitting or requiring the deferral of any payroll Taxes (including those imposed by Section&nbsp;3101(a) and 3201 of the Code). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company has not executed any outstanding waivers or comparable Consents regarding the application of the statute of limitations with
respect to any Taxes or Tax Returns or agreed to any extension of time with respect to a Tax assessment or deficiency. No power of attorney currently in force has been granted by the Company concerning any Taxes or Tax Return. The Company has not
received or been the subject of a private Tax ruling or a request for private Tax ruling. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has not (i)&nbsp;been a
&#147;United States real property holding corporation&#148; as defined in Section&nbsp;897(c)(2) of the Code during the applicable period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code, (ii)&nbsp;been a stockholder of a &#147;controlled
foreign corporation&#148; as defined in Section&nbsp;957 of the Code (or any corresponding or similar Legal Requirement), (iii)&nbsp;been a &#147;personal holding company&#148; as defined in Section&nbsp;542 of the Code (or any corresponding or
similar Legal Requirement), (iv)&nbsp;been a stockholder of a &#147;passive foreign investment company&#148; within the meaning of Section&nbsp;1297 of the Code, or (v)&nbsp;engaged in a trade or business, had a permanent establishment (within the
meaning of an applicable Tax treaty), or otherwise become subject to Tax jurisdiction in a country other than the country of the Company&#146;s incorporation. No Seller is a &#147;foreign person&#148; as defined in
<FONT STYLE="white-space:nowrap">Section&nbsp;1.1445-2(b)</FONT> of the Treasury Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) The Company is not a party to any joint
venture, partnership, or other Contract that could be treated as a partnership for federal income tax purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) No statutory Tax
holidays or <FONT STYLE="white-space:nowrap">Tax-advantaged</FONT> rulings have been granted by any Governmental Authority in favor of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Schedule</U><U></U><U>&nbsp;3.18(l)</U> to the Disclosure Letter sets forth, with respect to the Company, the estimated amount of any
(i)&nbsp;net operating loss carryforward, (ii)&nbsp;net capital loss carryforward, and (iii)&nbsp;unused investment, foreign, general business, or other Tax credit, together with the amount of any limitation on any of the foregoing under
Section&nbsp;269, Section&nbsp;382, Section&nbsp;383, Section&nbsp;384, or Section&nbsp;1502 of the Code (or any corresponding or similar Legal Requirement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) Since January&nbsp;1, 2011, neither the Company nor any predecessor of the Company has been an &#147;S corporation&#148; within the
meaning given to such term in Section&nbsp;1361 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) None of the Company Shares for which a valid election under
Section&nbsp;83(b) of the Code has not been made is <FONT STYLE="white-space:nowrap">non-transferrable</FONT> and subject to a substantial risk of forfeiture within the meaning of Section&nbsp;83 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_23"></A><B>3.19</B> <B><U>Related Persons</U></B>. No Related Person
(a)&nbsp;is or, at any time on or after January&nbsp;1, 2019, has been, directly or indirectly, an owner of more than five percent (5%), or an Affiliate, of any Material Customer or Material Supplier or otherwise involved in any business arrangement
or relationship with the Company or any Material Customer or Material Supplier, other than employment arrangements with the Company entered into in the Ordinary Course, (b)&nbsp;owns, or on or after January&nbsp;1, 2019, has owned, directly or
indirectly, any material Asset or right, tangible or intangible, used by the Company, or (c)&nbsp;is engaged, or at any time has engaged, directly or indirectly, in competition with the Company. None of Sellers or any other Related Person has, to
the Knowledge of the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Seller, made any claim against the Company, either directly or indirectly, for which the Company has or could have Liability to any Seller or any other Related Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.20</B> <B><U>Powers of Attorney; Bank Accounts</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has not granted any power of attorney or proxy (revocable or irrevocable) to any Person for any purpose whatsoever. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Schedule</U><U></U><U>&nbsp;3.20(b)</U> to the Disclosure Letter sets forth an accurate and complete list of the name of each
institution in which the Company has a bank account, securities account, safe-deposit box, lockbox account, or any other account (the &#147;<U>Bank Accounts</U>&#148;), the title and account number for each of the Bank Accounts, and the names of all
Persons authorized to draw funds from the Bank Accounts or have access to the Bank Accounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_24"></A><B>3.21</B>
<B><U>Absence of Certain Changes, Events and Conditions</U></B>. During the period from and including January&nbsp;1, 2021 through the Closing Date, (i)&nbsp;the Company has (A)&nbsp;conducted the Company&#146;s businesses and operations solely in
the Ordinary Course and (B)&nbsp;used commercially reasonable efforts to (1)&nbsp;preserve the Company&#146;s businesses and operations intact, (2)&nbsp;keep available the services of the Company&#146;s employees and independent contractors, and
(3)&nbsp;preserve the goodwill of the Company&#146;s customers, suppliers, distributors, lessors, lessees, licensors, licensees, creditors, employees, and independent contractors, as well as all others having business dealings or relations with the
Company, and (ii)&nbsp;there has not been any: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Company Material Adverse Effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) amendment of the Constitutive Documents or Governance Documents of the Company except pursuant to the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) split, combination, or reclassification of any equity interests or other securities of the Company, including the Securities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) declaration, setting aside, or payment of any distribution of cash or other Asset with respect to any equity interests or other securities
of the Company, including the Securities; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) issuance, delivery, transfer, grant, sale, purchase, or pledge, or authorization or
proposal to do any of the foregoing, by the Company of any equity interests or other securities (including securities convertible into, or subscriptions, rights, warrants, or options to acquire, or other Contracts of any character obligating the
issuance of any equity securities or other securities) of, or other ownership interests in, the Company, or repurchase, redemption, or other acquisition, or amendment of any term, by the Company of any outstanding equity interests or other
securities of, or other ownership interests in, the Company, including, in each case, the Securities; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) entry into any new line of business, entry into any Contract, or other action taken with
respect to the opening, relocation, or closing of any branch, office, servicing, or other facility by, or abandonment or discontinuance of any existing lines of business of, the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) sale or other disposition of any Asset reflected on the Interim Balance Sheet other than in the Ordinary Course, and except to Buyer
pursuant to the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) acquisition by merger or consolidation with, or by purchase of a substantial portion of the Assets or
equity of, or by any other manner, any Person or any business or division of such Person by the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) purchase, lease, license, or
other acquisition of the right to own, lease, license, operate, or use any Assets by the Company for an amount in excess of $50,000, individually (in the case of a lease or license, per annum), or $50,000 in the aggregate (in the case of a lease or
license, for the entire term of the lease or license, respectively), except to Buyer pursuant to the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) transfer,
assignment, sale, lease, license, or other disposition of, or Encumbrance (other than Permitted Encumbrances) placed upon, any of the Assets of the Company, except in the Ordinary Course and except to Buyer pursuant to the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) material damage, destruction, theft, or loss, or any material interruption in use, of any of the Assets of the Company, or any personal
injury loss affecting the Company, in each case, whether or not covered by insurance; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) transfer, assignment, sale, lease, license, or
other disposition of any material rights under or with respect to any Company IP Rights or disclosure of any confidential or proprietary information regarding the Company or any of its businesses or operations (other than <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses associated with the sale of Company Products in the Ordinary Course), except to Buyer pursuant to the Transactions; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) failure to spend funds for any planned or budgeted capital expenditure projects of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) material change in any method of accounting, accounting practice, or Tax reporting methods of the Company, except as required by GAAP or
applicable Legal Requirements; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) change in the cash management practices and policies, practices, and procedures of the Company with
respect to collection of accounts and notes receivable, establishment of reserves for uncollectible accounts and notes receivable, accrual of accounts and notes receivable, payment of accounts and notes payable, inventory control, prepayment of
expenses, or deferral of revenue, including (i)&nbsp;taking (or omitting to take) any action that would have the effect of accelerating revenues, accelerating cash receipts, or accelerating the collection of accounts receivable or notes receivable
to <FONT STYLE="white-space:nowrap">pre-Closing</FONT> periods that would otherwise be expected to take place or be incurred in post-Closing periods, or (ii)&nbsp;taking (or omitting to take) any action that would have the effect of delaying or
postponing the payment of any accounts payable or notes payable to post-Closing periods that would otherwise be expected to be paid in <FONT STYLE="white-space:nowrap">pre-Closing</FONT> periods; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) action by the Company to make, change, or rescind any Tax election or amend any Tax Return, or closing agreement or voluntary disclosure
agreement entered into, settlement of any Tax claim or assessment, consent to any extension or waiver of the limitation period applicable to any Tax claim or assessment, or other similar action relating to the filing of any Tax Return or the payment
of any Tax by the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) incurrence, assumption, or guarantee of any Indebtedness by the Company, except
unsecured current accounts payable incurred in the Ordinary Course; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) cancellation of any material debts, entitlements, or claims or
amendment, termination, or waiver of any material rights constituting Assets of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) amendment, modification, waiver,
renewal, termination, cancellation, or assignment of, any Material Company Contract, Company Governmental Authorization, or any other Contract or Governmental Authorization that, but for such amendment, modification, waiver, termination,
cancellation, or assignment, would have been a Material Company Contract or Company Governmental Authorization; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) except as explicitly
required by the terms of this Agreement, adoption, modification, or termination of any (i)&nbsp;employment, severance, retention, or other Contract with any current or former director, officer, employee, or independent contractor of the Company,
(ii)&nbsp;Benefit Plan or other fringe or employee benefit plan, program, or Contract that, but for such modification or termination, would have been a Benefit Plan, or (iii)&nbsp;collective bargaining or other Contract with a Union, in each case
whether written or oral; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) (i)&nbsp;grant of any bonuses, whether monetary or otherwise, or material increase (other than annual wages
or salary increases in the Ordinary Course) in any wages, salary, severance, pension, or other compensation or benefits in respect of any of the employees or independent contractors of the Company, (ii)&nbsp;change in the terms of employment or
engagement for any employee or independent contractor of the Company, (iii)&nbsp;termination of any employees of the Company, (iv)&nbsp;hiring or promoting of any employee or independent contractor of the Company, or (v)&nbsp;action to accelerate
the vesting or payment of any compensation or benefit for any employee or independent contractor of the Company, except, in each case, in the Ordinary Course or as explicitly required by the terms of this Agreement (including the accelerated vesting
under the ESOP); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) loan to, or forgiveness of any loan to, or entry into any other Contract or transaction with, any Related Person;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) commencement, compromise, or settlement of any Proceeding by or against the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) adoption of any plan of merger, consolidation, reorganization, liquidation, or dissolution or filing of a petition in bankruptcy under any
provisions of federal or state bankruptcy Legal Requirements or consent to the filing of any bankruptcy petition against the Company under similar Legal Requirement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) entry into any Contract to do any of the foregoing or take any action or omit from taking any action that could reasonably be expected to
result in any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.22</B> <B><U>Brokers or Finders</U></B>. No investment banker, financial advisor, broker, finder, or
other intermediary has been retained by or is authorized to act on behalf of any Seller or the Company that could be entitled to any fee, commission, or other similar payment from Buyer, any Seller, the Company, or any of their respective Affiliates
with respect to the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_25"></A><B>3.23</B> <B><U>No Other Representations or
Warranties</U></B>. Except for the representations and warranties contained in this <U>Article</U><U></U><U>&nbsp;III</U> (including the related portions of the Disclosure Letter), <U>Section</U><U></U><U>&nbsp;7.12(b)</U>, or any of the other
Transaction Documents, and except with respect to fraud, neither Sellers nor the Company has made or makes any other express or implied representation or warranty, either written or oral, on behalf of Sellers or the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.24</B> <B><U>ESOP Representations</U></B>. The ESOP, by and through Great Bank Trust Company, as the current Trustee, represents and
warrants to the Buyer as of the Closing as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Authority; No Conflict</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) This Agreement has been duly and validly executed by the Trustee on behalf of the ESOP, and this Agreement (assuming due authorization,
execution, and delivery by the other parties hereto) constitutes the legal, valid, and binding obligation of the ESOP enforceable against the Trust and the ESOP in accordance with its terms, except as enforceability is limited by ERISA and the
Enforceability Exceptions. Upon the delivery (and execution, if applicable) by the Trustee of each of the Seller Closing Documents to which the ESOP is a party, each of such Seller Closing Documents (assuming due authorization, execution, and
delivery by the other party or parties thereto, if applicable) will constitute the legal, valid, and binding obligation of the ESOP, enforceable against the ESOP in accordance with the terms thereof, except as enforceability is limited by ERISA and
the Enforceability Exceptions. The Trustee has the right, power, authority, and capacity to execute and deliver on behalf of the ESOP, this Agreement and the Seller Closing Documents to which the ESOP is a party and to perform the ESOP&#146;s
obligations under this Agreement and the Seller Closing Documents to which the ESOP is a party, and such actions have been duly authorized by all necessary company or other governing action by the Trustee, the Trust, and the ESOP, as applicable.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Neither the execution, delivery, or performance of this Agreement or any of the other Transaction Documents by the Trustee, the
ESOP, or the Trust nor the consummation or performance of any of the Transactions by the Trustee, the ESOP, or the Trust will, directly or indirectly (with or without notice or lapse of time or both), (i)&nbsp;contravene, conflict with, or result in
a violation or breach of any provision of any of the Constitutive Documents or Governance Documents of the Trustee or the ESOP, (ii)&nbsp;contravene, conflict with, or result in a violation or breach of any Legal Requirement to which the ESOP is
subject, (iii)&nbsp;contravene, conflict with, or result in a material violation or material breach of, constitute a material default under, or give any Governmental Authority the right to revoke, withdraw, suspend, cancel, terminate, or modify any
Governmental Authorization held by the ESOP, (iv)&nbsp;contravene, conflict with, or result in a violation or breach of, in each case, in any material respect, or constitute a material default under, or give any Person the right to declare a
material default or exercise any remedy under, accelerate the maturity or performance of or payment under, or cancel, terminate, or modify any material Contract to which the ESOP is a party or by which any of the ESOP&#146;s Assets is otherwise
bound, or (v)&nbsp;result in the creation or imposition of any Encumbrance upon any of the Assets of the ESOP (other than Permitted Encumbrances), including the Company Shares held by the ESOP (other than Statutory Transfer Restrictions). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Except as contemplated under this Agreement, the ESOP will not be required to give any notice to, make any Filing with, or obtain any
Consent from any Person in connection with the execution, delivery, and performance of this Agreement or any of the other Transaction Documents, or the consummation and performance of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Knowledge and Experience</U>.&nbsp;The Trust, either alone or with the assistance of its professional advisors, has such knowledge and
experience in financial and business matters that it is capable of evaluating the merits and risks of its entering into the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Further Representations</U>.&nbsp;The Trustee also represents and warrants as provided in <U>Sections 3.22</U> and <U>3.23</U>
above.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPRESENTATIONS AND WARRANTIES REGARDING BUYER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Buyer hereby represents and warrants to Sellers as of the Closing as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_27"></A><B>4.1</B> <B><U>Organization and Good Standing</U></B>. Buyer is duly incorporated, validly existing, and in
good standing under the Legal Requirements of the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2</B> <B><U>Authority, No Conflict</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement has been duly and validly executed by Buyer, and this Agreement (assuming due authorization, execution, and delivery by
Sellers, the Securityholder Representative, and the Company) constitutes the legal, valid, and binding obligation of Buyer, enforceable against Buyer in accordance with its terms, except as enforceability is limited by the Enforceability Exceptions.
Upon the delivery (and execution, if applicable) by Buyer of each of the Buyer Closing Documents, each of the Buyer Closing Documents (assuming due authorization, execution, and delivery by the other party or parties thereto, if applicable) will
constitute the legal, valid, and binding obligation of Buyer, enforceable against Buyer in accordance with the terms thereof, except as enforceability is limited by the Enforceability Exceptions. Buyer has the right, power, and authority to execute
and deliver this Agreement and the Buyer Closing Documents and to perform Buyer&#146;s obligations under this Agreement and the Buyer Closing Documents, and such actions have been duly authorized by all necessary corporate or other governing action
by Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the execution, delivery, or performance of this Agreement or any of the other Transaction Documents by Buyer nor
the consummation or performance of any of the Transactions by Buyer will, directly or indirectly (with or without notice or lapse of time or both) (i)&nbsp;contravene, conflict with, or result in a violation or breach of any provision of any of the
Constitutive Documents or Governance Documents of Buyer, or (ii)&nbsp;contravene, conflict with, or result in a violation or breach of any Legal Requirement to which Buyer is subject, except for any such contravention, conflict, violation, or
breach, in each case, that would not reasonably be expected to cause a Buyer Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Buyer is not nor will be
required to give any notice to, make any Filing with, or obtain any Consent from any Person in connection with the execution, delivery, and performance of this Agreement or any of the other Transaction Documents, or the consummation and performance
of the Transactions, except (i)&nbsp;for any such notice, Filing, or Consent that has already been given, made, or obtained or will be given, made, or obtained as of the Closing or (ii)&nbsp;in the event any failure to give such notice, make such
Filing, or obtain such Consent, in each case, would not reasonably be expected to cause a Buyer Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_28">
</A><B>4.3</B> <B><U>Proceedings; Orders</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) There are no Proceedings pending by or against Buyer that challenge, or that would
have the effect of preventing, delaying, making illegal, or otherwise interfering with, any of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) There is no Order to
which Buyer is subject or bound that would have the effect of preventing, delaying, making illegal, or otherwise interfering with any of the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_29"></A><B>4.4</B> <B><U>Brokers or Finders</U></B>. No investment
banker, financial advisor, broker, finder, or other intermediary has been retained by or is authorized to act on behalf of Buyer that could be entitled to any fee, commission, or other similar payment from Buyer, any Seller, the Company, or any of
their respective Affiliates with respect to the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.5</B> <B><U>No Other Representations or Warranties</U></B>. Except for
the representations and warranties contained in this <U>Article</U><U></U><U>&nbsp;IV</U>, and except with respect to fraud, neither Buyer nor any of Buyer&#146;s Affiliates has made or makes any other express or implied representation or warranty,
either written or oral, on behalf of Buyer. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COVENANTS AND AGREEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_31">
</A><B>5.1</B> <B><U>Tax Returns</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Without the prior written consent of Buyer, Sellers shall not, and Sellers shall not permit
any of their respective Representatives to, make, change, or rescind any Tax election, amend any Tax Return, or take any position on any Tax Return, take any action, omit to take any action, or enter into any other transaction that could have the
effect of increasing the Tax Liability or reducing any Tax Asset of the Company in respect of any Post-Closing Tax Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
Securityholder Representative, at the sole cost and expense of Securityholders, shall prepare, or cause to be prepared, all income Tax Returns required to be filed by the Company after the Closing Date for all Tax years or other Tax periods of the
Company ending on or before the Closing Date, and all costs and expenses to prepare such income Tax Returns shall be drawn from the Securityholder Expense Escrow Account and Buyer and the Securityholder Representative shall promptly instruct the
Escrow Agent accordingly. The Securityholder Representative shall prepare, or cause to be prepared, each such income Tax Return consistently with the past practices of the Company in filing the Company&#146;s comparable income Tax Returns, except as
otherwise required by applicable Legal Requirements. The Securityholder Representative shall provide Buyer with a draft of each such income Tax Return (including relevant schedules and work papers) at least thirty (30)&nbsp;days prior to the due
date for the filing of such income Tax Return. The Securityholder Representative shall permit Buyer to review, comment on, and approve in writing (such approval not to be unreasonably withheld, conditioned, or delayed) each such income Tax Return
prior to finalizing such income Tax Return. No fewer than two (2)&nbsp;Business Days prior to the due date for filing each such income Tax Return, (i)&nbsp;the Securityholder Representative shall deliver to Buyer the finalized form of such income
Tax Return and (ii)&nbsp;the amount of Taxes shown on each such income Tax Return as required to be paid, except to the extent that such Taxes constituted a Current Liability in the Final Net Working Capital, shall be drawn from the Securityholder
Expense Escrow Account, and Buyer and the Securityholder Representative shall promptly instruct the Escrow Agent to disburse such amount to Buyer. If the then current balance of the Securityholder Expense Escrow Amount is insufficient to cover the
entire amount required to be paid, then the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, Jointly/Severally, shall promptly pay to Buyer the unpaid portion of such amount by wire transfer of immediately available funds to the
account designated by Buyer to the Securityholder Representative in writing. Subject to the Securityholder Representative&#146;s compliance with this <U>Section</U><U></U><U>&nbsp;5.1(b)</U>, and subject to <U>Article</U><U></U><U>&nbsp;VI</U>,
including <U>Section</U><U></U><U>&nbsp;6.2(d)</U>, Buyer shall timely file, or cause to be timely filed, with the applicable Governmental Authority, each such income Tax Return. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Buyer shall prepare, or cause to be prepared, all
<FONT STYLE="white-space:nowrap">non-income</FONT> Tax Returns required to be filed by the Company after the Closing Date for all Tax years or other Tax periods of the Company ending on or before the Closing Date, and all costs and expenses to
prepare such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Returns shall be drawn from the Securityholder Expense Escrow Account and Buyer and the Securityholder Representative shall promptly instruct the Escrow Agent accordingly. Buyer
shall prepare, or cause to be prepared, each such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return consistently with the past practices of the Company in filing the Company&#146;s comparable
<FONT STYLE="white-space:nowrap">non-income</FONT> Tax Returns, except as otherwise required by applicable Legal Requirements. Buyer shall provide the Securityholder Representative with a draft of each such
<FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return (including relevant schedules and work papers) at least thirty (30)&nbsp;days prior to the due date for the filing of such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return.
Subject to the last sentence of this <U>Section</U><U></U><U>&nbsp;5.1(c)</U>, Buyer shall permit the Securityholder Representative to review, comment on, and approve in writing (such approval not to be unreasonably withheld, conditioned, or
delayed) each such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return prior to finalizing such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return. Any amount of Taxes shown on each such
<FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return as required to be paid, except to the extent that such Taxes constituted a Current Liability in the Final Net Working Capital, shall be drawn from the Securityholder Expense Escrow
Account, and Buyer and the Securityholder Representative shall promptly instruct the Escrow Agent to disburse such amount to Buyer. If the then current balance of the Securityholder Expense Escrow Amount is insufficient to cover the entire amount
required to be paid, then the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, Jointly/Severally, shall promptly pay to Buyer the unpaid portion of such amount by wire transfer of immediately available funds to the account
designated by Buyer to the Securityholder Representative in writing. Subject to <U>Article</U><U></U><U>&nbsp;VI</U>, including <U>Section</U><U></U><U>&nbsp;6.2(d)</U>, Buyer shall timely file, or cause to be timely filed, with the applicable
Governmental Authority, each such <FONT STYLE="white-space:nowrap">non-income</FONT> Tax Return. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Buyer shall prepare, or cause to be
prepared, all Tax Returns required to be filed by the Company after the Closing Date for any Straddle Period (&#147;<U>Straddle Period Tax Returns</U>&#148;). Buyer shall prepare, or cause to be prepared, each such Straddle Period Tax Return
consistently with the past practices of the Company in filing the Company&#146;s comparable Tax Returns, except as otherwise required by applicable Legal Requirements. Buyer shall provide the Securityholder Representative with a draft of each such
Straddle Period Tax Return (including relevant schedules and work papers) at least thirty (30)&nbsp;days prior to the due date for the filing of such Straddle Period Tax Return. Subject to the last sentence of this
<U>Section</U><U></U><U>&nbsp;5.1(d)</U>, Buyer shall permit the Securityholder Representative to review, comment on, and approve in writing (such approval not to be unreasonably withheld, conditioned, or delayed) each such Straddle Period Tax
Return prior to finalizing such Straddle Period Tax Return. Any portion of the amount of Taxes shown on each such Straddle Period Tax Return as required to be paid that relates to the portion of such Straddle Period through the end of the Closing
Date, except to the extent that such Taxes constituted a Current Liability in the Final Net Working Capital, shall be drawn from the Securityholder Expense Escrow Account, and Buyer and the Securityholder Representative shall promptly instruct the
Escrow Agent to disburse such amount to Buyer. If the then current balance of the Securityholder Expense Escrow Amount is insufficient to cover the entire amount required to be paid, then the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders, Jointly/Severally, shall promptly pay to Buyer the unpaid portion of such amount by wire transfer of immediately available funds to the account designated by Buyer to the Securityholder Representative in writing. With respect to any
Straddle Period, the amount of any Taxes based on or measured by income, receipts, or payroll of the Company for any portion of such Straddle Period through the end of the Closing Date will be determined based on an interim closing of the books as
of the close of business on the Closing Date (and for such purpose, the taxable period of any partnership or other pass-through entity in which the Company holds a beneficial interest will be deemed to terminate at such time) and the amount of other
Taxes of the Company for any portion of such Straddle Period through the end of the Closing Date will be determined to be the amount of such Tax for such entire Straddle Period, multiplied by a fraction, the numerator of which is the number of days
in that portion of such Straddle Period through the end of the Closing Date, and the denominator of which is the number of days in such entire Straddle Period. Subject to <U>Article</U><U></U><U>&nbsp;VI</U>, including
<U>Section</U><U></U><U>&nbsp;6.2(d)</U>, Buyer shall timely file, or cause to be timely filed, with the applicable Governmental Authority, each such Straddle Period Tax Return. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the extent permitted by applicable Legal Requirements, Sellers shall include any income, gain, loss, deduction, or other Tax items for
all applicable <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Periods on their respective Tax Returns in a manner consistent with the <FONT STYLE="white-space:nowrap">Schedule&nbsp;K-1s</FONT> prepared for such applicable <FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Securityholder Representative, on the one hand, and Buyer, on the other hand, shall
provide each other with such cooperation and information as either of them reasonably requests of the other in filing any Tax Return pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> or in connection with any audit or other Proceeding in respect
of Taxes of the Company. Such cooperation and information includes providing copies of relevant Tax Returns or portions thereof, together with accompanying schedules, related work papers, and documents relating to rulings or other determinations by
Tax authorities. The Securityholder Representative, on the one hand, and Buyer, on the other hand, shall retain all Tax Returns, schedules, work papers, and other material documents in such Party&#146;s respective possession relating to Tax matters
of the Company for any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period until the expiration of the statute of limitations of the <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Periods to which such Tax Returns relate, without
regard to extensions, except to the extent notified by the other Party in writing of such extensions for the respective <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_32"></A><B>5.2</B> <B><U>Amended Tax Returns and Carrybacks</U></B>. Without the prior written consent of the
Securityholder Representative (such consent not to be unreasonably withheld, conditioned, or delayed), unless otherwise required by applicable Legal Requirements, Buyer shall not cause or permit any amendment of any income Tax Return of the Company
for any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, or cause or permit any carryback of any Tax attributes from any Post-Closing Tax Period to any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_33"></A><B>5.3</B> <B><U>Tax Refunds</U></B>. Any refund of Taxes of the Company paid with respect to any Tax period
ending on or before the Closing Date (a &#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund</U>&#148;), will be for the account of Securityholders, except to the extent such <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax
Refund constituted a Current Asset in the Final Net Working Capital or arises as the result of a carryback beginning after the Closing Date. Within fifteen (15)&nbsp;Business Days of the receipt of any
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund by Buyer or any of Buyer&#146;s Affiliates, Buyer shall pay to each Securityholder such Securityholders&#146; Pro Rata Percentage of such
<FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund, net of any Taxes thereon and any cost to Buyer and Buyer&#146;s Affiliates attributable to obtaining and receipt of such <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund.
If any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund or portion thereof is subsequently disallowed or required to be returned to the applicable Governmental Authority, then the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders, Jointly/Severally, shall promptly return all such amounts (plus any interest in respect of such amounts owed to the applicable Governmental Authority) to Buyer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4</B> <B><U>Tail Insurance</U></B>. Buyer shall obtain and pay for, at or prior to the Closing, &#147;tail&#148; coverage under the
Company&#146;s existing directors&#146; and officers&#146; liability and fiduciary liability insurance policies (the &#147;<U>Tail Policies</U>&#148;) in respect of Effects occurring at or prior to the Closing (including for acts or omissions
occurring in connection with the consummation and performance of the Transactions) covering claims asserted within six (6)&nbsp;years after the Closing Date (the &#147;<U>Tail Policies</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_34"></A><B>5.5</B> <B><U>Confidentiality</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) For the duration of the Restricted Period, each Seller shall ensure that no confidential and proprietary information concerning the
Company and the Company&#146;s respective businesses and operations that such Seller, the Securityholder Representative, any of such Seller&#146;s respective Affiliates, or any of the Representatives of any of the foregoing now possess or hereafter
create or obtain, including any confidential or proprietary information relating to the financial condition, results of operations, businesses, Assets, Liabilities, or future prospects of the Company or relating to any customer, supplier,
distributor, lessor, licensor, licensee, or creditor of the Company, is published, disclosed, or made accessible by any of them to any other Person at any time or used by any of them without the prior written consent of Buyer (such consent to be
given in Buyer&#146;s sole discretion); provided, however, that the restrictions of this <U>Section</U><U></U><U>&nbsp;5.5</U> do not apply to the extent such information has otherwise become </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
publicly available other than as the result of a breach by any Seller of such Seller&#146;s obligations under this Agreement. Notwithstanding the foregoing, pursuant to 18&nbsp;U.S.C.
Section&nbsp;1833(b), none of Sellers will be held criminally or civilly liable under any federal or state trade secret Legal Requirement for the disclosure of a trade secret that is made: (i)&nbsp;in confidence to a federal, state, or local
Governmental Authority, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of a Legal Requirement; or (ii)&nbsp;in a complaint or other Filing filed in a lawsuit or other
Proceeding, if such document is made under seal. Further, if any Seller files a lawsuit for retaliation by an employer for reporting a suspected violation of a Legal Requirement, such Seller is permitted to disclose the trade secret to the attorney
of such Seller and use the trade secret information in the court proceeding, if Seller files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. Nothing in this Agreement,
including this <U>Section</U><U></U><U>&nbsp;5.5</U>, is intended to limit or will be used in any way to limit a Seller&#146;s rights to communicate or cooperate with, or provide information to, any Governmental Authority, as provided for, protected
under, or warranted by applicable Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Sellers shall not release any Person from the confidentiality provisions of any
Contract (each, a &#147;<U>Seller Confidentiality Agreement</U>&#148;) to which such Seller or Representative is a party with respect to (i)&nbsp;any transfer, sale, or issuance of equity interests or other securities (including the Securities) of
the Company or any transfer or sale of any material portion of the Assets of the Company, (ii)&nbsp;the issuance of any equity or debt interests or other securities (other than trade accounts or notes payable in the Ordinary Course) of the Company,
or (iii)&nbsp;any acquisition, business combination, amalgamation, change of control, merger, recapitalization, or other similar transaction involving the Company, whether structured as an Asset sale, equity sale, merger, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything in the Confidentiality Agreement or the Letter of Intent to the contrary, Sellers agree that, immediately and
automatically upon the Closing, none of Buyer or any of Buyer&#146;s Affiliates, or any of their respective Representatives, will have any further obligations to Sellers, the Securityholder Representative, or any of Sellers&#146; respective
Affiliates under, or be subject to the restrictions in, the Confidentiality Agreement or the Letter of Intent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.6</B> <B><U>Public
Announcements and Other Communications</U></B>. Unless required by applicable Legal Requirements, none of the Parties shall make any public disclosure or permit any of such Party&#146;s Affiliates or Representatives to make any public disclosure
(whether or not in response to an inquiry) with respect to the Transaction Documents and the Transactions unless previously approved by Buyer and the Securityholder Representative in writing. Nothing in this Agreement, including the foregoing
sentence, shall prevent Buyer or any of its Affiliates from filing a copy of this Agreement as an exhibit to a Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> (describing the Transactions) with the SEC and issuing a press
release, in each case, as required by the Exchange Act and applicable stock exchange listing standards (as determined by Buyer in its reasonable discretion). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_35"></A><B>5.7</B> <B><U>Restrictive Covenants</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) During the Restricted Period, each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder identified on Annex G (each a
&#147;<U>Restricted Securityholder</U>&#148;) shall not, whether on such Restricted Securityholder&#146;s own behalf or on behalf of, or in conjunction with, or through any other Person (other than Buyer in the performance of any such Seller&#146;s
employment duties on behalf of Buyer, if applicable), directly or indirectly, (i)&nbsp;engage in, or assist other Persons in engaging in, a Restricted Business in a Restricted Area, (ii)&nbsp;acquire any interest in, or render services to, any
Person that engages in, directly or indirectly, a Restricted Business in a Restricted Area in any capacity, including as a partner, principal, equity holder, creditor, trustee, or other Representative, (iii)&nbsp;interfere with, or attempt to
interfere with, any of the business relationships (whether formed before, on, or after the Closing Date) between Buyer, the Company, or any of the Affiliates of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the foregoing (collectively, the &#147;<U>Buyer Group</U>&#148;) and any of the customers, suppliers, distributors, lessors, lessees, licensors, licensees, or creditors of any Person within
the Buyer Group, or any others having business dealings or relations with any Person within the Buyer Group (including by bidding, quoting, or accepting the business of any customer or potential customer of any Person within the Buyer Group).
Notwithstanding the foregoing, each Restricted Securityholder is permitted to, directly or indirectly, own, solely as an investment, securities of any Person engaged in a Restricted Business in a Restricted Area that are publicly traded on a
national securities exchange solely if such Seller (A)&nbsp;is not a controlling person of, or a member of a group that controls, such Person, (B)&nbsp;does not, directly or indirectly, own one (1%) or more of any class of securities of such Person,
and (C)&nbsp;has no active participation in the business of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the Restricted Period, each <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder shall not, whether on such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s own behalf or on behalf of, or in conjunction with, or through any other Person (other than
Buyer in the performance of any such Seller&#146;s employment duties on behalf of Buyer, if applicable), directly or indirectly, (i)&nbsp;solicit, induce, or encourage, or attempt to solicit, induce, or encourage (other than a general solicitation
that is not directed at any current or former employee or independent contractor of any Person within the Buyer Group), any employee or independent contractor of any Person within the Buyer Group to leave such employee&#146;s employment or
independent contractor&#146;s engagement with such Person, (ii)&nbsp;hire, employ, or otherwise engage, or attempt to hire, employ, or otherwise engage, any employee of any Person within the Buyer Group as an employee, independent contractor, or
otherwise, or (iii)&nbsp;otherwise interfere with, or attempt to interfere with, the relationship between any Person within the Buyer Group and any employee or independent contractor of such Person. Notwithstanding the foregoing, each Seller is
permitted to hire or engage any such employee or independent contractor whose employment or engagement with all Persons within the Buyer Group has been terminated after one (1)&nbsp;year from the date of such termination, subject, in each case, to
any <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality, and other similar Contracts between any Person within the Buyer Group and such employee or independent
contractor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees that the provisions of this
Agreement are (i)&nbsp;reasonable and not any greater than reasonably necessary to protect the Buyer Group, and (ii)&nbsp;in consideration of (A)&nbsp;the Transactions, including such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholder&#146;s right to receive the portion of the Purchase Price payable to such Seller, and (B)&nbsp;additional good and valuable consideration as set forth in this Agreement and the other Transaction Documents. Each <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees that the Purchase Price is sufficient to support such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s obligations under this
<U>Section</U><U></U><U>&nbsp;5.7</U>. In addition, each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees (1)&nbsp;that the business of the Buyer Group is or could be conducted throughout the Restricted Area,
and (2)&nbsp;the Buyer Group has business activities and valuable business relationships within the Buyer Group&#146;s industries throughout the Restricted Area. Each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and
agrees that the potential harm to the Buyer Group of the <FONT STYLE="white-space:nowrap">non-enforcement</FONT> of any provision of this <U>Section</U><U></U><U>&nbsp;5.7</U> outweighs any potential harm to such
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder of its enforcement by injunction or otherwise. Each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees that such
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder has carefully read this Agreement, or has had this Agreement carefully read on such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s behalf, and consulted with
legal counsel of such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s choosing regarding the contents of this Agreement, has given careful consideration to the restraints imposed upon such
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder by this <U>Section</U><U></U><U>&nbsp;5.7</U>, and is in full accord as to the necessity of such restraints for the reasonable and proper protection of confidential and proprietary
information of the Buyer Group now existing or to be developed in the future. Each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees that each and every restraint imposed by this
<U>Section</U><U></U><U>&nbsp;5.7</U> is reasonable with respect to subject matter, duration, scope, and geographical area. Particularly, each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder acknowledges and agrees that, despite any
presumptively reasonable timeframes set forth in the Legal Requirements of any jurisdiction, the Restricted Period, as applicable to this <U>Section</U><U></U><U>&nbsp;5.7</U>, is reasonable under these particular circumstances in light of the
amount of consideration being provided to such Seller in connection with this Agreement, as well as the nature and value of the ongoing goodwill and business operations of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) It is expressly acknowledged and agreed that although the Parties consider the
restrictions contained in this <U>Section</U><U></U><U>&nbsp;5.7</U> to be reasonable and not any greater than reasonably necessary to protect the Buyer Group, if a court of competent jurisdiction makes a final judicial determination that any
restriction regarding the subject matter, duration, scope, or geographical area or any other restriction contained in this <U>Section</U><U></U><U>&nbsp;5.7</U> is an unenforceable restriction against any
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, then the provisions of this <U>Section</U><U></U><U>&nbsp;5.7</U> are not to be rendered void and, with respect to such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder,
such court is expressly empowered to reform such restriction, and such restriction will be deemed reformed, in such jurisdiction to apply as to such maximum subject matter, duration, scope, and geographical area and to such maximum extent as such
court judicially determines to be enforceable against such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder. Alternatively, in the event any court of competent jurisdiction finds that any restriction contained in this
<U>Section</U><U></U><U>&nbsp;5.7</U> is unenforceable against any <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, and such restriction cannot be reformed so as to make it enforceable against such
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, such finding will not affect the enforceability against such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder of any other restriction contained in this
<U>Section</U><U></U><U>&nbsp;5.7</U> in such jurisdiction or any of the restrictions in this <U>Section</U><U></U><U>&nbsp;5.7</U> in any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the event of a breach of this <U>Section</U><U></U><U>&nbsp;5.7</U> by a <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholder, the Restricted Period as it applies to such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder will be extended by the duration of such breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_36"></A><B>5.8</B> <B><U>Indemnification of Directors and Officers</U></B>. Until the six (6)&nbsp;year anniversary of
the Closing Date or such time as the Company is no longer a controlled Affiliate of Buyer, Buyer shall cause the Company to indemnify and advance expenses to current and former directors and officers of the Company in a manner substantially similar
to the manner provided for by the director and officer indemnification provisions of the Constitutive Documents and/or Governance Documents of the Company, as applicable, in effect as of immediately prior to the Closing Date, except as otherwise
prohibited by applicable Legal Requirements. Notwithstanding anything in this Agreement to the contrary, no such current or former director or officer is entitled to any limitation of liability, exculpation, indemnification, contribution, or
advancement or reimbursement of expenses from Buyer or any of Buyer&#146;s Affiliates under any of their respective Constitutive Documents or Governance Documents, this <U>Section</U><U></U><U>&nbsp;5.8</U>, or otherwise with respect to any
Third-Party Claim or Direct Claim for which indemnification is sought by a Buyer Indemnified Person in accordance with <U>Article</U><U></U><U>&nbsp;VI</U>. Notwithstanding anything in this Agreement to the contrary, this
<U>Section</U><U></U><U>&nbsp;5.8</U> is binding upon and inures solely to the benefit of the Parties, and nothing in this <U>Section</U><U></U><U>&nbsp;5.8</U>, express or implied, confers upon any Person any rights or remedies of any nature
whatsoever under or by reason of this <U>Section</U><U></U><U>&nbsp;5.8</U>. Until the six (6)&nbsp;year anniversary of the Closing Date Buyer shall not amend the Constitutive Documents and/or Governance Documents of the Company in any way that
diminishes or eliminates any rights of indemnification for current or former directors and officers of the Company, subject to the provisions of this <U>Section</U><U></U><U>&nbsp;5.8</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.9</B> <B><U>ESOP Covenants</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Effective as of the Closing, the Company shall amend and terminate the ESOP, pursuant to a form of amendment reasonably satisfactory to
Buyer (the &#147;ESOP Amendment&#148;): (i) to provide that the ESOP no longer is an &#147;employee stock ownership plan&#148; within the meaning of Section 4975 of the Code; (ii) to freeze the eligible ESOP participation as of the Closing Date and
provide that after the Closing Date no contributions shall be made to the ESOP; (iii) to permit distributions to participants of their ESOP account balances as provided in subparagraph (c) below; (iv) to fully vest all accounts under the ESOP; and
(v)&nbsp;to make any other necessary changes required by applicable Legal Requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Following the Closing, Buyer intends to cause the Company to apply for a favorable
determination from the IRS with respect to the Company&#146;s application on IRS Form 5310 submitted in conjunction with the termination of the ESOP (the &#147;<U>IRS Determination</U>&#148;). All reasonable expenses and reasonable costs associated
with the termination of the ESOP, including the preparation and filing for the IRS Determination shall be paid by the Trust to the extent permissible by the terms of the ESOP, the Trust and applicable Legal Requirements. The Company shall provide to
Trustee a preliminary draft of the IRS Determination application for review and comment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Prior to the receipt of the IRS
Determination, the Trustee shall distribute (or cause to be rolled over to another qualified retirement plan or individual retirement account, as directed by each ESOP participant) up to seventy percent&nbsp;(70%) of the value of the account
balances of the ESOP participants (&#147;<U>Initial Distributions</U>&#148;). As soon as practicable following the later of (i)&nbsp;the receipt of the IRS Determination or (ii)&nbsp;the final release of the then-current balance of the Primary
Indemnification Escrow Amount, the then-current balance of the Securityholder Expense Escrow Amount, and the then-current balance of the Adjustment Escrow Amount, the Trustee, at the direction of the ESOP plan administrator, shall distribute (or
cause to be rolled over to another qualified retirement plan or IRA, as directed by each ESOP participant) all remaining ESOP account balances.(d) In no event shall the Company have any obligation to defend or indemnify any Seller against or for any
Proceedings, Damages, or Liabilities with respect to any Third-Party Claim or Direct Claim for which indemnification is sought by a Buyer Indemnified Person in accordance with <U>Article</U><U></U><U>&nbsp;VI</U> arising in connection with or
relating to such Seller&#146;s service as a Trustee, and each Seller does hereby waive and release any such right to defense or indemnity arising under any Contract (including but not limited to the ESOP and the Healthcare Resource Group, Inc.
Employee Stock Ownership Trust Agreement) with the Company or otherwise, solely with respect to an obligation described in this <U>Section</U><U></U><U>&nbsp;5.9(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the extent permitted by the terms of the Trust, the ESOP, and applicable Legal Requirements, the Trust shall bear the costs and
expenses in connection with the administration and winding up of the ESOP for periods after the Closing Date, including Trustee&#146;s fees, administration fees, ESOP audit fees, and legal fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_37"></A><B>5.10</B> <B><U>Further Assurances</U></B>. Following the Closing, the Parties shall reasonably cooperate
with each other and with their respective Representatives in connection with any steps required to be taken as part of their respective obligations under this Agreement, and the Parties agree (a)&nbsp;to furnish upon request to the other Parties
such further information, (b)&nbsp;to execute and deliver to each other Party such other documents, and (c)&nbsp;to do such other acts and things, all as the other Parties reasonably request, for the purpose of carrying out the intent of this
Agreement and the Transactions. In addition, without limiting the generality of the foregoing, Sellers shall, and Sellers shall cause their respective Representatives to, cooperate with Buyer, as reasonably requested by Buyer, in connection with any
updates to the legal or equitable ownership records with respect to any registrations (or applications for registration) of the Company IP Rights to reflect the Company or the Company&#146;s designee as the holder of the same. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_38">
</A><B>6.1</B> <B><U>Survival</U></B>. All representations, warranties, covenants, obligations, and agreements in this Agreement, and the right to commence any claim with respect thereto, will survive the Closing and the consummation and performance
of the Transactions and continue in full force and effect for the time periods set forth in <U>Section</U><U></U><U>&nbsp;6.4</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2</B> <B><U>Indemnification Obligations of </U></B><B><U>Securityholders</U></B>. From
and after the Closing and subject to the limitations set forth in this <U>Article</U><U></U><U>&nbsp;VI</U>, Securityholders, Jointly/Severally, shall indemnify Buyer and Buyer&#146;s Affiliates, their respective equity holders, and the
Representatives of each of the foregoing (collectively, the &#147;<U>Buyer Indemnified Persons</U>&#148;), and shall save and hold each of them harmless against, and shall pay, compensate, and reimburse each of them for, any Damages that any such
Buyer Indemnified Person suffers, sustains, or becomes subject to, directly or indirectly, as a result of, in connection with, or related to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any (i)&nbsp;inaccuracy in or breach of any representation or warranty made by any Seller in <U>Article</U><U></U><U>&nbsp;III</U> or
<U>Section</U><U></U><U>&nbsp;7.12(b)</U> regardless of whether such Damages relate to a Third-Party Claim, (ii)&nbsp;Third-Party Claim that, if meritorious, would constitute or give rise to any inaccuracy in or breach of any representation or
warranty made by any Seller in <U>Article</U><U></U><U>&nbsp;III</U> or <U>Section</U><U></U><U>&nbsp;7.12(b)</U>, or (iii)&nbsp;inaccuracy in or breach of the certificate delivered to Buyer pursuant to <U>Section</U><U></U><U>&nbsp;2.4(a)(xii)</U>;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any nonfulfillment, nonperformance, or other breach of any covenant, obligation, or agreement of any Securityholder or the Company in
the Transaction Documents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) any unpaid Closing Indebtedness or Closing Transaction Expenses; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) any (i)&nbsp;Taxes (or the <FONT STYLE="white-space:nowrap">non-payment</FONT> thereof) of the Company in relation to the conduct of the
businesses and operations of the Company for any <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period, including those Taxes set forth on the Tax Returns contemplated by <U>Section</U><U></U><U>&nbsp;5.1</U> (subject to the penultimate
sentence of <U>Section</U><U></U><U>&nbsp;5.1(d)</U> with respect to Straddle Period Tax Returns), (ii)&nbsp;Taxes of any member of an affiliated, consolidated, combined, or unitary group of which the Company (or any predecessor of the Company) is
or was a member on or prior to the Closing Date, including pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> of the Treasury Regulations or any analogous or similar Legal Requirement, (iii)&nbsp;Taxes of any Person (other
than the Company) that relate to an event or transaction occurring on or before the Closing Date that are imposed on the Company as a transferee or successor, by Contract, or pursuant to any Legal Requirement, (iv)&nbsp;Taxes or other Damages
incurred by Buyer or the Company pursuant to Section&nbsp;280G of the Code in connection with the Transactions, (v)&nbsp;Taxes of the Company with respect to a <FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period that have been deferred
under the CARES Act and are not paid in full to the appropriate Governmental Authority prior to the Closing, or (vi)&nbsp;Taxes of Buyer or its Affiliates attributable to (A)&nbsp;the forgiveness of all or a portion of the PPP Loan including as a
result of the treatment of such forgiveness as giving rise to cancellation of indebtedness income for income Tax purposes or resulting in a disallowance of deductions for income Tax purpose or (B)&nbsp;Tax credits claimed by the Company under
Sections&nbsp;7001 through 7005 of the Families First Act; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) any current or former director or officer of the Company seeking or
obtaining limitation of liability, exculpation, indemnification, contribution, or advancement or reimbursement of expenses from Buyer or any of Buyer&#146;s Affiliates under any of their respective Constitutive Documents or Governance Documents,
<U>Section</U><U></U><U>&nbsp;5.8</U>, or otherwise with respect to any Third-Party Claim or Direct Claim for which indemnification is sought by a Buyer Indemnified Person in accordance with this <U>Article</U><U></U><U>&nbsp;VI</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) any Liability under Title&nbsp;IV of ERISA or under COBRA that is imposed on the Company as a result of the Company being a Seller ERISA
Affiliate; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) any claims relating to the allocation of the Purchase Price among Securityholders; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) any amount payable to any Optionholder in respect of the Company Options in excess of
such holder&#146;s Option Payment; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any of the matters set forth on <U>Annex</U><U></U><U>&nbsp;F</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_39"></A><B>6.3</B> <B><U>Indemnification Obligations of Buyer</U></B>. From and after the Closing and subject to the
limitations set forth in this <U>Article</U><U></U><U>&nbsp;VI</U>, Buyer shall indemnify Securityholders and their respective Representatives (collectively, the &#147;<U>Securityholder Indemnified Persons</U>&#148;), and shall save and hold each of
them harmless against, and shall pay, compensate, and reimburse each of them for, any Damages that any such Securityholder Indemnified Person suffers, sustains, or becomes subject to, directly or indirectly, as a result of, in connection with, or
related to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) any (i)&nbsp;inaccuracy in or breach of any representation or warranty made in <U>Article</U><U></U><U>&nbsp;IV</U>
regardless of whether such Damages relate to a Third-Party Claim, (ii)&nbsp;Third-Party Claim that, if meritorious, would constitute or give rise to any inaccuracy in or breach of any representation or warranty made in
<U>Article</U><U></U><U>&nbsp;IV</U>, or (iii)&nbsp;inaccuracy in or breach of the certificate delivered to the Securityholder Representative pursuant to <U>Section</U><U></U><U>&nbsp;2.4(b)(iii)</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any nonfulfillment, nonperformance, or other breach of any covenant, obligation, or agreement of Buyer in the Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4</B> <B><U>Time Limitations</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders shall have no
Liability under <U>Section</U><U></U><U>&nbsp;6.2(a)</U> (other than with respect to the Seller Excluded Representations), unless on or before the eighteen (18)&nbsp;month anniversary of the Closing Date, Buyer delivers to the Securityholder
Representative a Claim Notice with respect thereto. Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.2(a)</U>
(solely with respect to the Seller Excluded Representations), <U>Section</U><U></U><U>&nbsp;6.2(b)</U> <U>Section</U><U></U><U>&nbsp;6.2(c)</U>, <U>Section</U><U></U><U>&nbsp;6.2(d)</U>, <U>Section</U><U></U><U>&nbsp;6.2(e)</U>,
<U>Section</U><U></U><U>&nbsp;6.2(f)</U>, <U>Section</U><U></U><U>&nbsp;6.2(g)</U>, or <U>Section</U><U></U><U>&nbsp;6.2(h)</U> unless on or before the four (4)&nbsp;year anniversary of the Closing Date, Buyer delivers to the Securityholder
Representative a Claim Notice with respect thereto. Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.2(i)</U>
unless on or before the six (6)&nbsp;year anniversary of the Closing Date, Buyer delivers to the Securityholder Representative a Claim Notice with respect thereto. The ESOP shall have no liability under <U>Section</U><U></U><U>&nbsp;6.2</U> unless
on or before the eighteen (18)&nbsp;month anniversary of the Closing Date, Buyer delivers to the Securityholder Representative a Claim Notice with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Buyer shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> (other
than with respect to the Buyer Fundamental Representations), unless on or before the eighteen (18)&nbsp;month anniversary of the Closing Date, the Securityholder Representative deliver a Claim Notice to Buyer with respect thereto. Subject to
<U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Buyer shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> (solely with respect to the Buyer Fundamental Representations) or <U>Section</U><U></U><U>&nbsp;6.3(b)</U>, unless on or before
the four (4)&nbsp;year anniversary of the Closing Date, the Securityholder Representative delivery a Claim Notice to Buyer with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Upon the giving of notice as contemplated by <U>Section</U><U></U><U>&nbsp;6.4(a)</U> or <U>Section</U><U></U><U>&nbsp;6.4(b)</U>, as
applicable, the Indemnified Person&#146;s rights with respect to the claim or potential claim specified in such notice shall survive the time at which such claim or potential claim would otherwise terminate pursuant to this Agreement (regardless of
when the Damages in respect of such claim or potential claim are actually incurred), and such Indemnified Person shall be entitled to commence a Proceeding subsequent to the applicable survival date for the enforcement of such Indemnified
Person&#146;s rights under this <U>Article</U><U></U><U>&nbsp;VI</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_40"></A><B>6.5</B> <B><U>Certain Other Limitations and
Guidelines</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Securityholders shall have no Liability under
<U>Section</U><U></U><U>&nbsp;6.2(a)</U> (other than with respect to the Seller Excluded Representations, to which such limitation does not apply) for any Damages related thereto for which Securityholders would be liable, but for this sentence,
until the aggregate amount of all such Damages equals or exceeds on a cumulative basis a dollar amount equal to the Deductible Amount, in which event Securityholders shall be liable for all such Damages in excess of the Deductible Amount. Subject to
<U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Securityholders shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.2(a)</U> (other than with respect to the Seller Excluded Representations, to which such limitation does not apply) for any
Damages related thereto for which Securityholders would be liable, but for this sentence, that exceed a dollar amount equal to the Primary Cap Amount. Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U> (and without limiting the application of the
Primary Cap Amount to Damages arising under <U>Section</U><U></U><U>&nbsp;6.2(a)</U> (other than with respect to the Seller Excluded Representations) as set forth in the immediately preceding sentence), the Securityholders shall have no Liability
under <U>Section</U><U></U><U>&nbsp;6.2</U> (except under (i)<U>&nbsp;Section</U><U></U><U>&nbsp;6.2(a)</U>, solely with respect to the Seller Ownership and Authority Representations, and (ii)<U>&nbsp;Section</U><U></U><U>&nbsp;6.2(i)</U>, in each
case, to which such limitation does not apply) for any Damages related thereto for which the Securityholders would be liable, but for this sentence, that exceed a dollar amount equal to the Incremental Cap Amount. Subject to
<U>Section</U><U></U><U>&nbsp;6.5(g)</U> (and without limiting the application of the Primary Cap Amount and the Incremental Cap Amount as set forth in this <U>Section</U><U></U><U>&nbsp;6.5</U>), no Securityholder shall have any Liability under
<U>Section</U><U></U><U>&nbsp;6.2(a)</U>, solely with respect to the Seller Ownership and Authority Representations, or under <U>Section</U><U></U><U>&nbsp;6.2(i)</U> for any Damages related thereto for which such Securityholder would be liable, but
for this sentence, that exceed a dollar amount equal to such Securityholder&#146;s Ultimate Cap Amount. Notwithstanding anything to the contrary in this <U>Section</U><U></U><U>&nbsp;6.5(a)</U>, the ESOP shall have no liability under
<U>Section</U><U></U><U>&nbsp;6.2</U> for Damages in excess of the Primary Cap Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to
<U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Buyer shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> (other than with respect to the Buyer Fundamental Representations, to which such limitation does not apply) for any Damages
related thereto for which Buyer would be liable, but for this sentence, until the aggregate amount of all such Damages equals or exceeds on a cumulative basis a dollar amount equal to the Deductible Amount, in which event Buyer shall be liable for
all such Damages in excess of the Deductible Amount. Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U>, Buyer shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> (other than with respect to the Buyer Fundamental Representations,
to which such limitation does not apply) for any Damages related thereto for which Buyer would be liable, but for this sentence, that exceed a dollar amount equal to the Primary Cap Amount. Subject to <U>Section</U><U></U><U>&nbsp;6.5(g)</U> (and
without limiting the application of the Primary Cap Amount to Damages arising under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> (other than with respect to the Buyer Fundamental Representations) as set forth in the immediately preceding sentence),
Buyer shall have no Liability under <U>Section</U><U></U><U>&nbsp;6.3(a)</U> for any Damages related thereto for which Buyer would be liable, but for this sentence, that exceed a dollar amount equal to the Purchase Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) An Indemnifying Person&#146;s indemnification obligation with respect to Damages owed pursuant to <U>Section</U><U></U><U>&nbsp;6.2</U> or
<U>Section</U><U></U><U>&nbsp;6.3</U>, as applicable, shall be reduced by (i)&nbsp;insurance proceeds or third-party indemnity payments, in each case, that are actually received by the Indemnified Person with respect to such Damages (net of any
related costs incurred in connection therewith, including costs of recovery, deductibles, retroactive premiums, and premium increases), and (ii)&nbsp;any Tax Benefit actually recognized by the applicable Indemnified Person or any Affiliate thereof
within two (2)&nbsp;years after the Tax year in which the related Damages are incurred (net of any related costs incurred in connection therewith). Each Indemnified Person shall use commercially reasonably efforts to recover under applicable
insurance policies or for any Damages covered by such insurance policies or third-party indemnities; provided, however, such Indemnified Person shall not be required to make any claim under any such insurance policy or for any third-party indemnity
prior to making a claim for indemnification under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties agree that an Indemnified Person&#146;s rights to indemnification or other
remedy with respect thereto or otherwise under <U>Section</U><U></U><U>&nbsp;6.2</U> or <U>Section</U><U></U><U>&nbsp;6.3</U>, as applicable, are part of the basis of the bargain contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Parties intend for each representation, warranty, covenant, obligation, and agreement contained in this Agreement to have independent
significance. If an inaccuracy exists in, or any Party has breached, any representation, warranty, covenant, obligation, or agreement contained in this Agreement in any respect, the fact that there exists another representation, warranty, covenant,
agreement, or obligation relating to the same subject matter (regardless of the relative levels of specificity) that is accurate or such Party has not breached will not detract from or mitigate the fact that an inaccuracy exists in, or such Party is
in breach of, such first representation, warranty, covenant, obligation, or agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For purposes of calculating the amount of
Damages to which a Buyer Indemnified Person is entitled under this <U>Article</U><U></U><U>&nbsp;VI</U>, the term &#147;material&#148;, &#147;materially&#148;, &#147;material adverse effect&#148;, and &#147;Company Material Adverse Effect&#148; and
other similar qualifications will be disregarded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Notwithstanding anything in this Agreement to the contrary, nothing in this
Agreement, including <U>Section</U><U></U><U>&nbsp;6.4</U> and this <U>Section</U><U></U><U>&nbsp;6.5</U>, limits the survival of any claim or potential claim (including any Third-Party Claim or Direct Claim) or the Liability of any Indemnifying
Person to an Indemnified Person for fraud. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_41"></A><B>6.6</B> <B><U>Procedure for Indemnification &#150;
Third-Party Claims</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If any Indemnified Person receives notice of the assertion or commencement of any Proceeding made or
brought by or on behalf of any Person who is not a Party or an Affiliate of a Party (a &#147;<U>Third-Party Claim</U>&#148;) against such Indemnified Person with respect to which the Indemnifying Person is obligated to provide indemnification under
this Agreement, then such Indemnified Person shall give the Indemnifying Person prompt written notice of such Third-Party Claim in the form of a Claim Notice. The failure to give such prompt written Claim Notice will not, however, relieve the
Indemnifying Person of the Indemnifying Person&#146;s indemnification obligations, except and only to the extent that the Indemnifying Person is materially prejudiced by reason of such failure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Indemnifying Person shall have the right to participate in or, by giving written notice to the Indemnified Person within thirty
(30)&nbsp;days after being notified of a Third-Party Claim by the Indemnified Person in accordance with <U>Section</U><U></U><U>&nbsp;6.6(a)</U> and unconditionally and irrevocably acknowledging in writing the Indemnifying Person&#146;s
indemnification obligations to the Indemnified Person with respect to such Third-Party Claim, to assume the defense of such Third-Party Claim at the Indemnifying Person&#146;s expense and by the Indemnifying Person&#146;s own counsel (such counsel
must be reasonably acceptable to the Indemnified Person), and the Indemnified Person shall cooperate in good faith in such defense. If the Indemnifying Person assumes the defense of such Third-Party Claim in accordance with the immediately preceding
sentence, then the Indemnified Person shall have the right, at the Indemnified Person&#146;s own cost and expense, to participate in the defense of any Third-Party Claim with counsel selected by the Indemnified Person subject to the Indemnifying
Person&#146;s right to control the defense thereof and, in any event, the Indemnifying Person shall keep the Indemnified Person fully apprised as to the status of such defense. If the Indemnifying Person elects not to assume the defense of such
Third-Party Claim or fails to timely notify the Indemnified Person in writing of the Indemnifying Person&#146;s election to assume the defense of such Third-Party Claim within the time period prescribed in this
<U>Section</U><U></U><U>&nbsp;6.6(b)</U> or fails to unconditionally and irrevocably acknowledge in writing the Indemnifying Person&#146;s indemnification obligations to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnified Person with respect to such Third-Party Claim, then the Indemnified Person, subject to <U>Section</U><U></U><U>&nbsp;6.6(d)</U>, shall be entitled to pay, compromise, and defend such
Third-Party Claim and seek indemnification for any and all Damages based upon, arising out of, with respect to, or by reason of such Third-Party Claim, in accordance with the limitations and conditions of this <U>Article</U><U></U><U>&nbsp;VI</U>.
Buyer, on the one hand, and the Securityholders and the Securityholder Representative, on the other hand, shall cooperate with each other in all reasonable respects in connection with the defense of any Third-Party Claim. Notwithstanding the
foregoing sentence, no Party will be required to disclose, or cause the disclosure of, any information to another Party if such disclosure would, in the reasonable opinion of legal counsel to such first Party, (i)&nbsp;constitute a waiver of any
legal privilege or (ii)&nbsp;contravene any applicable Legal Requirement or binding Contract; provided, that such first Party shall promptly inform such other Party to the extent information is excluded pursuant to this sentence, and such first
Party shall use commercially reasonable efforts to provide such other Party with the maximum amount of information reasonably requested, including providing such information subject to the attorney-client privilege under joint defense privilege or
seeking waiver of any applicable confidentiality restrictions. In furtherance of the foregoing, with respect to any Third-Party Claim, the Parties agree to cooperate in such a manner as to preserve in full (to the extent possible) the
confidentiality of all confidential information and applicable legal privileges. In connection therewith, each Party agrees that (A)&nbsp;such Party will use commercially reasonable efforts, with respect to any Third-Party Claim in which such Party
has assumed or participated in the defense, to avoid production of confidential information of the other Parties (consistent with applicable Legal Requirements and rules of procedure), and (B)&nbsp;all communications between any Party and counsel
responsible for or participating in the defense of any Third-Party Claim shall, to the extent practicable, be made so as to preserve any applicable legal privilege. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything in this Agreement to the contrary, if (i)&nbsp;the Indemnifying Person is given notice of a Third-Party Claim in
compliance with <U>Section</U><U></U><U>&nbsp;6.6(a)</U> and fails to timely notify the Indemnified Person in writing of the Indemnifying Person&#146;s election to assume the defense of such Third-Party Claim within the time period prescribed in
<U>Section</U><U></U><U>&nbsp;6.6(b)</U> or fails to unconditionally and irrevocably acknowledge in writing the Indemnifying Person&#146;s indemnification obligations to the Indemnified Person with respect to such Third-Party Claim, (ii)&nbsp;the
claim for indemnification is based upon, arises out of, is with respect to, or is by reason of any criminal or quasi-criminal Proceeding, (iii)&nbsp;the relief sought in connection with the Third-Party Claim is not solely monetary damages,
(iv)&nbsp;the Indemnified Person reasonably concludes, based upon advice of counsel, that either a conflict exists between the Indemnifying Person and the Indemnified Person in connection with the defense of the Third-Party Claim or there are legal
defenses available to the Indemnified Person that are different from or additional to those available to the Indemnifying Person, (v)&nbsp;Buyer, if acting as the Indemnified Person, reasonably concludes that the Damages relating to the Third-Party
Claim could exceed the then current balance of the Indemnification Escrow Amount, (vi)&nbsp;the Third-Party Claim is asserted by or on behalf of a Person that is a material customer, supplier, distributor, lessor, licensor, licensee, or creditor of
the Indemnified Person, (vii)&nbsp;the Third-Party Claim relates to or is otherwise in respect of any Taxes or Tax Returns of the Company, or (viii)&nbsp;the defense of the Third-Party Claim is not instituted and continuously maintained in good
faith by the Indemnifying Person, then, in any such case, the Indemnified Person is entitled to assume the defense of such Third-Party Claim and assert a claim against the Indemnifying Person for indemnification with respect to such Third-Party
Claim pursuant to the terms of this <U>Article</U><U></U><U>&nbsp;VI</U>, with the reasonable costs and expenses of such defense to be included in the amount of Damages sought pursuant to such indemnification. The Indemnifying Person shall cooperate
in good faith with the Indemnified Person with respect to the transfer of the defense of such Third-Party Claim from the Indemnifying Person to the Indemnified Person in accordance with this <U>Section</U><U></U><U>&nbsp;6.6(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything in this Agreement to the contrary, neither the Indemnifying
Person nor the Indemnified Person shall enter into a settlement of any Third-Party Claim without the prior written consent of the Indemnified Person or Indemnifying Person, respectively (such consent not to be unreasonably withheld, conditioned, or
delayed), except as provided in this <U>Section</U><U></U><U>&nbsp;6.6(d)</U>. If a firm offer is made to settle a Third-Party Claim without leading to Liability or the creation of a financial or other obligation on the part of the Indemnified
Person and provides, in customary form, for the unconditional release of each Indemnified Person, each Indemnified Person&#146;s Affiliates, and the Representatives of each of the foregoing from all Liabilities in connection with such Third-Party
Claim and the Indemnifying Person desires to accept and agree to such firm settlement offer, then the Indemnifying Person shall give written notice to that effect to the Indemnified Person. If the Indemnified Person fails to consent in writing to
such firm settlement offer within fifteen (15)&nbsp;days after the Indemnified Person&#146;s receipt of such notice, then the Indemnified Person shall be entitled to continue to contest or defend such Third-Party Claim and in such event, the maximum
Liability of the Indemnifying Person as to such Third-Party Claim will not exceed the amount of such firm settlement offer. If the Indemnified Person fails to consent to such firm settlement offer and also fails to timely assume defense of such
Third-Party Claim, then the Indemnifying Person shall be entitled to settle the Third-Party Claim upon the terms set forth in such firm settlement offer (including such unconditional release described above). If the Indemnified Person has assumed
the defense of any Third-Party Claim pursuant to <U>Section</U><U></U><U>&nbsp;6.6(b)</U> or <U>Section</U><U></U><U>&nbsp;6.6(c)</U> and the Indemnifying Person has unconditionally and irrevocably acknowledged in writing the Indemnifying
Person&#146;s indemnification obligations to the Indemnified Person with respect to such Third-Party Claim, then the Indemnified Person shall not agree to any settlement of such Third-Party Claim without the written consent of the Indemnifying
Person (such consent not to be unreasonably withheld, conditioned, or delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_42"></A><B>6.7</B><B><U>
Procedure for Indemnification &#150; Direct Claims</U></B>. Any claim or potential claim by an Indemnified Person on account of Damages that do not result from a Third-Party Claim (a &#147;<U>Direct Claim</U>&#148;) shall be asserted by the
Indemnified Person by giving the Indemnifying Person prompt written notice thereof in the form of a Claim Notice. The failure to give such prompt Claim Notice shall not, however, relieve the Indemnifying Person of the Indemnifying Person&#146;s
indemnification obligations, except and only to the extent that the Indemnifying Person is materially prejudiced by reason of such failure. The Indemnifying Person will have thirty (30)&nbsp;days after the Indemnifying Person&#146;s receipt of such
notice to respond in writing to such Direct Claim. If the Indemnifying Person does not so respond within such thirty (30)&nbsp;day period, then the Indemnifying Person will be deemed to have rejected such Direct Claim, in which case the Indemnified
Person will be entitled to pursue such remedies as are available to the Indemnified Person on the terms and subject to the provisions of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.8</B> <B><U>Payment</U></B><B><U> of Indemnification Obligations</U></B>. After (a)&nbsp;any final Order has been rendered by a
Governmental Authority of competent jurisdiction, (b)&nbsp;a settlement has been consummated in accordance with this <U>Article</U><U></U><U>&nbsp;VI</U>, or (c)&nbsp;the Indemnified Person and the Indemnifying Person have arrived at a mutually
binding Contract, in each case, with respect to a Third-Party Claim or a Direct Claim, the Indemnified Person shall forward to the Indemnifying Person notice of any amounts due and owing by the Indemnifying Person in accordance with this
<U>Article</U><U></U><U>&nbsp;VI</U>. Any amounts due and owing by Securityholders to any Buyer Indemnified Person in accordance with this <U>Article</U><U></U><U>&nbsp;VI</U>, shall be first paid by Securityholders, Jointly/Severally, by release of
funds to the applicable Buyer Indemnified Person from the Indemnification Escrow Account by the Escrow Agent in accordance with the Escrow Agreement (and Buyer and the Securityholder Representative shall promptly instruct the Escrow Agent
accordingly), and if the remaining balance of the Indemnification Escrow Account is insufficient to pay in full any such amounts due and owing by Securityholders to any Buyer Indemnified Person pursuant to<U> Article</U><U></U><U>&nbsp;VI</U>, then
the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, Jointly/Severally, shall pay to the applicable Buyer Indemnified Person, within ten (10)&nbsp;Business Days after the occurrence of the earliest event to occur that is described
in the first sentence of this <U>Section</U><U></U><U>&nbsp;6.8</U>, all such remaining amounts due and owing by Securityholders to the applicable Buyer Indemnified Person by wire transfer of immediately available funds to the account designated by
Buyer to the Securityholder Representative in writing. For the avoidance of doubt, other than for fraud, the liability of the ESOP under this <U>Article VI</U> shall be solely limited to the ESOP&#146;s Pro Rata Percentage of the Primary
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnification Escrow Amount. If any amounts are due and owing by Buyer to any Securityholder Indemnified Person in accordance with this <U>Article</U><U></U><U>&nbsp;VI</U>, then Buyer shall
pay to the applicable Securityholder Indemnified Person, within ten (10)&nbsp;Business Days after the occurrence of the earliest event to occur that is described in the first sentence of this <U>Section</U><U></U><U>&nbsp;6.8</U>, all such amounts
due and owing by Buyer to the applicable Securityholder Indemnified Person by wire transfer of immediately available funds to the account designated by the Securityholder Representative to Buyer in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_43"></A><B>6.9</B> <B><U>Exclusive Remedies</U></B>. Subject to <U>Section</U><U></U><U>&nbsp;2.5</U>,
<U>Section</U><U></U><U>&nbsp;7.8</U>, and <U>Section</U><U></U><U>&nbsp;7.13</U>, the Parties acknowledge and agree that the remedies provided for in this <U>Article</U><U></U><U>&nbsp;VI</U> are their sole and exclusive remedies with respect to
any claims arising out of the matters covered by this Agreement, other than claims based upon, arising out of, with respect to, or by reason of (a)&nbsp;fraud, (b)&nbsp;any other Transaction Document, or (c)&nbsp;breach of the confidentiality
restrictions in <U>Section</U><U></U><U>&nbsp;5.5</U> or the restrictive covenants in <U>Section</U><U></U><U>&nbsp;5.7</U>. Nothing in this <U>Section</U><U></U><U>&nbsp;6.9</U> will (i)&nbsp;interfere with or impede the operation of
<U>Section</U><U></U><U>&nbsp;2.5</U> (including with respect to the resolution of the Disputed Matters by the Parties and the Independent Accounting Firm), (ii)&nbsp;limit any Person&#146;s right to seek and obtain any equitable relief to which any
Person is entitled pursuant to <U>Section</U><U></U><U>&nbsp;7.8</U> or to seek any remedy on account of fraud or under any other Transaction Document, (iii)&nbsp;interfere with or impede the operation of <U>Section</U><U></U><U>&nbsp;7.13</U>
(including with respect to Buyer&#146;s set off or hold back rights set forth therein), or (iv)&nbsp;limit Buyer&#146;s available remedies in the event of a breach of the confidentiality restrictions in <U>Section</U><U></U><U>&nbsp;5.5</U> or the
restrictive covenants in <U>Section</U><U></U><U>&nbsp;5.7</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.10</B> <B><U>Tax Treatment of Indemnification Payments</U></B>. The
Parties shall treat each payment made under this <U>Article</U><U></U><U>&nbsp;VI</U> as an adjustment to the Purchase Price for Tax purposes, unless (a)&nbsp;a final &#147;determination&#148; (as that term is defined for purposes of
Section&nbsp;1313 of the Code or corresponding applicable state Legal Requirements) with respect to any such payment causes such payment not to be treated as an adjustment to the Purchase Price for Tax purposes or (b)&nbsp;as otherwise required by
applicable Legal Requirements. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_45">
</A><B>7.1</B> <B><U>Expenses</U></B>. Except as otherwise expressly provided in this Agreement and, with respect to the ESOP, to the extent permitted by the Legal Requirements, each Party shall bear such Party&#146;s respective expenses incurred in
connection with the preparation and execution of the Transaction Documents, and consummation and performance of the Transactions, including all fees and expenses of such Party&#146;s Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.2</B> <B><U>Successors and Assigns; No Third Party Beneficiaries</U></B>. Subject to the terms of this
<U>Section</U><U></U><U>&nbsp;7.2</U>, this Agreement will apply to, be binding in all respects upon, and inure to the benefit of the successors and permitted assigns of the Parties. None of Sellers or the Company shall assign any of such
Party&#146;s rights or delegate any of such Party&#146;s obligations under this Agreement without the prior written consent of Buyer. Buyer shall not assign any of Buyer&#146;s rights or delegate any of Buyer&#146;s obligations under this Agreement
without the prior written consent of the Securityholder Representative, except that Buyer is permitted to assign any of Buyer&#146;s rights and delegate any of Buyer&#146;s obligations under this Agreement, without the prior written consent of the
Securityholder Representative, (a)&nbsp;to any Affiliate of Buyer, (b)&nbsp;in connection with the sale of all or substantially all of the ownership interests or Assets of, or any business combination transaction involving, Buyer or any of
Buyer&#146;s Affiliates, and (c)&nbsp;as collateral to any financial institution providing financing to Buyer or any of Buyer&#146;s Affiliates. No assignment or delegation will relieve any of the Parties of any of such Party&#146;s obligations
under this Agreement. Any purported assignment or delegation in violation or breach of this <U>Section</U><U></U><U>&nbsp;7.2</U> will be void <I>ab initio</I>. Nothing in this Agreement will be construed to give any Person other than the Parties
any legal or equitable right under or with respect to this Agreement or any provision of this Agreement, except such rights as will inure to a successor or permitted assignee pursuant to this <U>Section</U><U></U><U>&nbsp;7.2</U> and except as
contemplated by <U>Section</U><U></U><U>&nbsp;5.5</U>, <U>Section</U><U></U><U>&nbsp;5.7</U>, or <U>Article</U><U></U><U>&nbsp;VI</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_46"></A><B>7.3</B> <B><U>Notices</U></B>. All notices, Consents, and
other communications between or among the Parties under this Agreement must be in writing and will be deemed to have been duly given when (a)&nbsp;delivered by hand (with written confirmation of receipt), (b)&nbsp;sent by electronic mail during
regular business hours, or if not during regular business hours, the next Business Day; provided, that no &#147;error&#148; message or other electronic notification of <FONT STYLE="white-space:nowrap">non-delivery</FONT> is promptly received by the
Party sending such electronic mail, (c)&nbsp;received or refused by the addressee, if sent by certified mail, return receipt requested, or (d)&nbsp;received or refused by the addressee, if sent by a nationally recognized overnight delivery service,
return receipt requested, in each case to the appropriate addresses set forth below (or to such other addresses as a Party designates by notice to the other Parties in accordance with this <U>Section</U><U></U><U>&nbsp;7.3</U>): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If to Buyer or to the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Computer Programs and Systems, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">54 St. Emanuel Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Mobile,
Alabama 36602 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Boyd Douglas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> Boyd.douglas@cpsi.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which does not constitute notice to Buyer or the Company): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Maynard, Cooper&nbsp;&amp; Gale, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1901 Sixth Avenue North </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite
1700 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Birmingham, Alabama 35203 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Bradley H. Wood </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:10pt; font-family:Times New Roman">D.
Trice Stabler </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:16%; font-size:10pt; font-family:Times New Roman">Timothy W. Gregg </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Electronic Mail: bwood@maynardcooper.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">tstabler@maynardcooper.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20%; font-size:10pt; font-family:Times New Roman">tgregg@maynardcooper.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">If to
any Securityholder or to the Securityholder Representative: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Steven McCoy </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">17329 E. Hidden Green Ct. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Rio
Verde, AZ 85263 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Electronic Mail: stevendwmccoy@gmail.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to (which does not constitute notice to any Securityholder or the Securityholder Representative): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">ESOP Law Group, LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">445 Market
Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite 1940 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San
Francisco, CA 94105 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Lynn Dubois </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Electronic Mail: ldubois@esoplawgroup.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.4</B> <B><U>Entire Agreement; Modification</U></B>. This Agreement and the other
Transaction Documents constitute the final, complete, entire, and exclusive agreement among the Parties and supersede all prior agreements and understandings (including the Letter of Intent), whether written or oral, among the Parties with respect
to the subject matter hereof. Any amendment of this Agreement must be pursuant to a written agreement signed by the Parties. No course of dealing between or among any Persons having any interest in this Agreement will be deemed effective to modify,
amend, or discharge any part of this Agreement or any rights or obligations of any Person under or by reason of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_47">
</A><B>7.5</B> <B><U>Waiver</U></B>. No waiver of any provisions of this Agreement by any Party will be effective unless explicitly set out in writing by such Party granting such waiver. Neither the failure nor any delay by any of the Parties in
exercising any right under this Agreement will operate as a waiver of such right, and no single or partial exercise of any such right will preclude any other or further exercise of such right or the exercise of any other right. No waiver of any of
the provisions of this Agreement will be deemed or will constitute a waiver of any other provisions of this Agreement, whether or not similar, nor will any waiver constitute a continuing waiver. No waiver of any condition based on the accuracy of
any representation or warranty, or based on the performance of or compliance with any covenant or obligation, will affect the right to indemnification, reimbursement, or other remedy based on such representation, warranty, covenant, obligation, or
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.6</B> <B><U>Severability</U></B>. Subject to <U>Section</U><U></U><U>&nbsp;5.7(d)</U>, any term or provision of this
Agreement that is invalid or unenforceable in any jurisdiction will be, as to that jurisdiction, ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms or provisions of this
Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction. Subject to <U>Section</U><U></U><U>&nbsp;5.7(d)</U>, upon such determination that any term or provision of this
Agreement is invalid or unenforceable, the Parties shall negotiate in good faith to modify this Agreement so as to give effect to the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the
Transactions be consummated as originally contemplated to the greatest extent possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_48"></A><B>7.7</B>
<B><U>Governing Law; Venue; Waiver of Jury Trial</U></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement, as well as all matters in dispute among the Parties,
whether arising from or relating to this Agreement or arising from or relating to alleged extra-contractual facts prior to, during, or subsequent to this Agreement, including fraud, misrepresentation, negligence, or any other alleged tort or
violation of this Agreement, regardless of the legal theory upon which such matter is asserted, will be governed by, construed under and enforced in accordance with the Legal Requirements of the State of Delaware (explicitly including the Delaware
statute of limitations) without regard to any choice of laws or conflicts of laws provisions, rules, or principles that would require the application of any other Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in <U>Section</U><U></U><U>&nbsp;2.5</U>, any dispute, controversy, or question of interpretation arising under, out
of, in connection with or in relation to this Agreement or any amendments hereof, or any breach or default hereunder, shall be litigated exclusively in the Court of Chancery of the State of Delaware and the appellate courts having jurisdiction of
appeals in such court or, if none of the foregoing courts has subject matter jurisdiction, then the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such court or, if none of the
foregoing courts has subject matter jurisdiction, then the Superior Court of the State of Delaware and the appellate courts having jurisdiction of appeals in such court. Each of the Parties hereby irrevocably consents and submits to the exclusive
jurisdiction and venue of any such court and each of the Parties hereby irrevocably waives all objections and defenses that such Party may have based on improper venue or forum <I>non conveniens</I> to the maintenance of any such action in any such
court. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) THE PARTIES HEREBY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR
IN ANY WAY PERTAINING TO THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, OR THE TRANSACTIONS, WHETHER NOW OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE. ANY PARTY IS PERMITTED TO FILE A COPY OF THIS
<U>SECTION</U><U></U><U>&nbsp;7.7(c)</U> WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY, AND BARGAINED FOR AGREEMENT AMONG THE PARTIES TO IRREVOCABLY WAIVE TRIAL BY JURY, AND THAT ANY PROCEEDING WHATSOEVER AMONG THE PARTIES RELATING TO
THIS AGREEMENT, THE OTHER TRANSACTION DOCUMENTS, OR THE TRANSACTIONS IS INSTEAD TO BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_49"></A><B>7.8</B> <B><U>Enforcement of Agreemen</U></B><B><U>t; Remedies</U></B>. The Parties agree that each Party
would be damaged irreparably in the event any of the provisions of this Agreement is not performed in accordance with its specific terms and that any breach of this Agreement by any Party could not be adequately compensated by monetary damages.
Accordingly, each Party agrees that, in addition to any other right or remedy to which a Party is entitled, at law or in equity, each Party is entitled to enforce any provision of this Agreement by a decree of specific performance and to temporary,
preliminary, and permanent injunctive relief to prevent breaches or threatened breaches of the provisions of this Agreement, without posting any bond or other undertaking or proving Damages. The rights and remedies of the Parties are cumulative and
not alternative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.9</B> <B><U>Counterparts; Execution of Agreement</U></B>. The Parties are permitted to execute this Agreement in
one or more counterparts, each of such counterparts is deemed to be an original copy of this Agreement and all of which, when taken together, are deemed to constitute one and the same agreement. The exchange of copies of this Agreement and of
signature pages by facsimile, electronic mail, or other means of electronic transmission (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000,<I> e.g.</I>, www.docusign.com and www.simplyagree.com) constitutes
effective execution and delivery of this Agreement as to the Parties. Signatures of the Parties transmitted by facsimile, electronic mail, or other means of electronic transmission (including pdf or any electronic signature complying with the U.S.
federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com and www.simplyagree.com) are deemed to be their original signatures for all purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_50"></A><B>7.10</B> <B><U>Rules of Construction</U></B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise explicitly specified in this Agreement to the contrary, (i)&nbsp;references to an Article, Section, or Annex mean an
Article or Section of, or Annex to, this Agreement, unless another agreement is specified, (ii)&nbsp;the word &#147;including&#148; will be construed as &#147;including, without limitation&#148; and will not be construed to limit any general
statement that it follows to the specific or similar items or matters immediately following it, (iii)&nbsp;the words &#147;to the extent&#148; mean the degree to which and not simply &#147;if&#148;, (iv)&nbsp;the words &#147;herein&#148;,
&#147;hereof&#148;, &#147;hereby&#148;, &#147;hereto&#148;, and &#147;hereunder&#148; refer to this Agreement as a whole, (v)&nbsp;words in the singular or plural form include the plural and singular form, respectively, (vi)&nbsp;pronouns are deemed
to refer to the masculine, feminine, or neuter, as the identity of the Person or Persons requires, (vii)&nbsp;the words &#147;asset&#148; and &#147;property&#148; will be construed to have the same meaning and effect and to refer to all tangible and
intangible assets and properties, including cash, securities, accounts, contract rights, and real and personal property, (viii)&nbsp;references to a particular Person include such Person&#146;s successors and permitted assigns, (ix)&nbsp;references
to a particular statute, rule, or regulation include all rules and regulations thereunder and any predecessor or successor statutes, rules, or regulations, in each case as amended or otherwise modified from time to time, (x)&nbsp;references to a
particular Contract, document, instrument, or certificate mean such Contract, document, instrument, or certificate as amended, supplemented, or otherwise modified from time to time if permitted by the provisions thereof, (xi)&nbsp;references to
&#147;Dollars&#148; or &#147;$&#148; are references to United States Dollars, (xii)&nbsp;an accounting term not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise defined in this Agreement has the meaning ascribed to such term in accordance with GAAP, (xiii)&nbsp;references to &#147;written&#148; or &#147;in writing&#148; include electronic form,
and (xiv)&nbsp;any reference in this Agreement to a &#147;day&#148; or a number of &#147;days&#148; (without explicit reference to &#147;Business Days&#148;) will be interpreted as a reference to a calendar day or number of calendar days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The headings of Articles, Sections, and Annexes, as well as Schedules to the Disclosure Letter, are provided for convenience only and will
not affect the construction or interpretation of this Agreement or the Disclosure Letter. The Annexes and the Disclosure Letter are incorporated into this Agreement to the same extent as though fully set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Schedule to the Disclosure Letter qualifies the correspondingly numbered and lettered Section of
<U>Article</U><U></U><U>&nbsp;III</U> and any other Section of <U>Article</U><U></U><U>&nbsp;III</U> to the extent it is reasonably apparent that the disclosure on such Schedule is responsive to such other Section of
<U>Article</U><U></U><U>&nbsp;III</U>. The Disclosure Letter is intended only to clarify, define and qualify and limit the representations and warranties of the Company contained in the Agreement and shall not be deemed to expand in any way the
scope or effect of any such representations or warranties. Inclusion of any item in the Disclosure Letter (i)&nbsp;does not constitute a determination by the Seller or the Company that such matters are material or establish a standard of materiality
or modify any definition of materiality in this Agreement, (ii)&nbsp;does not represent a determination that such item did not arise in the Ordinary Course, (iii)&nbsp;does not represent an admission or indication that there are any obligations
remaining to be performed or any rights that may be exercised under such item, (iv)&nbsp;relating to any possible breach or violation of any Contract, Law or regulation shall not be construed as an admission or indication to any third-party that any
such breach or violation exists or has actually occurred, and (v)&nbsp;shall not constitute, or be deemed to be, an admission to any third party concerning such item. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Whenever this Agreement indicates that any Seller or the Company has &#147;made available&#148; (or any other word or phrase of similar
meaning) any information or document to Buyer, such statement is deemed to be a statement that such Seller or the Company has posted, or caused to be posted, such information or document to the Virtual Data Room (i)&nbsp;prior to the second (2<SUP
STYLE="font-size:85%; vertical-align:top">nd</SUP>) Business Day immediately prior to the Closing Date or (ii)&nbsp;during the two (2)&nbsp;Business Day period immediately prior to the Closing Date (but in any event, prior to the Closing Date) in
response to Buyer identifying or requesting such information or document during such period, and, in each case with respect to clauses (i)&nbsp;and (ii), such information or document was not subsequently removed from the Virtual Data Room prior to
the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If any period for giving notice or taking action under this Agreement expires on a day that is not a Business Day, the
time period will be automatically extended to the Business Day immediately following such day. When calculating the period of time before which, within which, or following which any act is to be done or step taken pursuant to this Agreement, the
date that is the reference date in calculating such period will be excluded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Parties have participated jointly in the negotiation
and drafting of this Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the Parties and no presumption or burden of proof will arise favoring or disfavoring
any Party by virtue of the authorship of any of the provisions of this Agreement. Prior drafts of this Agreement or the fact that any provisions have been added, deleted, or otherwise modified from any prior drafts of this Agreement will not be used
as an aid of construction or otherwise constitute evidence of the intent of the Parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_51"></A><B>7.11</B> <B><U>Securityholder Representative</U></B>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Securityholders agree that it is desirable to designate the Securityholder Representative as the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to act for and on behalf of Securityholders, and for the taking by the Securityholder Representative of any actions and the making by the Securityholder Representative of any decisions
required or permitted to be taken by Securityholders under or contemplated by this Agreement or any of the other Transaction Documents, including any amendment or waiver of the terms hereof or thereof. Securityholders have designated Steven McCoy as
the initial Securityholder Representative, and the execution and delivery of this Agreement by Securityholders constitutes, to the maximum extent permitted under applicable Legal Requirements, irrevocable ratification and approval of such
designation by Securityholders and authorization of the Securityholder Representative to serve in such capacity (including to negotiate and settle any and all disputes with Buyer and its Affiliates under this Agreement), and also constitutes a
reaffirmation, approval, acceptance, and adoption of, and an agreement to comply with and perform, all of the acknowledgments and agreements made by the Securityholder Representative on behalf of Securityholders in this Agreement and the other
Transaction Documents. By executing this Agreement, the Securityholder Representative accepts the foregoing designation. The Securityholder Representative may resign at any time and the Securityholder Representative may be removed by the vote of
those Securityholders whose aggregate Pro Rata Percentages exceed fifty percent (50%) of the aggregate Pro Rata Percentages of all Securityholders. The designation of the Securityholder Representative is coupled with an interest and, except as set
forth in the immediately preceding sentence, such designation is irrevocable and will not be affected by the death, incapacity, illness, bankruptcy, dissolution, or other inability to act of any Securityholder. In the event that a Securityholder
Representative has resigned or been removed, a new Securityholder Representative shall be promptly appointed by the vote of those Securityholders whose aggregate Pro Rata Percentages exceed fifty percent (50%) of the aggregate Pro Rata Percentages
of all Securityholders, such appointment to become effective upon the written acceptance thereof by the new Securityholder Representative. Written notice of any such resignation, removal, or appointment of a Securityholder Representative shall be
delivered by the Securityholder Representative to Buyer promptly after such action is taken, and neither Buyer nor any of its Affiliates will be charged with knowledge of such resignation, removal, or appointment until Buyer&#146;s actual receipt of
such written notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Securityholder Representative will have such powers and authority as are necessary or appropriate to carry
out the functions assigned to the Securityholder Representative under this Agreement and in any other Transaction Document. Buyer and its Affiliates are entitled to rely on the actions taken by the Securityholder Representative without independent
inquiry into the capacity of the Securityholder Representative to so act. All actions, notices, communications, and determinations by the Securityholder Representative to carry out such functions will conclusively be deemed to have been authorized
by, and will be binding upon, Securityholders, and no Securityholder has any right to object, dissent, protest, or otherwise consent to the same. Neither the Securityholder Representative nor any of its Representatives will have any Liability to
Securityholders with respect to actions taken or omitted to be taken by the Securityholder Representative in such capacity (or by any of its Representatives in connection therewith), except with respect to the Securityholder Representative&#146;s
willful misconduct. The Securityholder Representative will be entitled to engage such counsel, experts, and other agents and consultants as the Securityholder Representative deems necessary in connection with exercising the Securityholder
Representative&#146;s powers and performing the Securityholder Representative&#146;s function hereunder and (in the absence of willful misconduct on the part of the Securityholder Representative) is entitled to conclusively rely on the opinions and
advice of such Persons. The Securityholder Representative is entitled to full reimbursement for all expenses, disbursements, and advances (including fees and disbursements of counsel, experts, and other agents and consultants) incurred by the
Securityholder Representative in such capacity, and to full indemnification against any Damages arising out of actions taken or omitted to be taken in its capacity as Securityholder Representative (except for those arising out of the Securityholder
Representative&#146;s willful misconduct), including the costs and expenses of investigation and defense of claims, from Securityholders. In furtherance of the foregoing, notwithstanding anything in this Agreement to the contrary, the Securityholder
Representative has the power and authority </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to set aside and retain additional funds paid to or received by the Securityholder Representative, or direct payment of additional funds to be paid to any of Securityholders pursuant to this
Agreement at the Closing or thereafter, to satisfy such Damages (including to establish such reserves as the Securityholder Representative determines in good faith to be appropriate for such costs and expenses that are not then known or
determinable). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The provisions of this <U>Section</U><U></U><U>&nbsp;7.11</U> in no way impose any obligations on Buyer or any of its
Affiliates. In particular, notwithstanding any notice received by Buyer or any of its Affiliates to the contrary, Buyer and its Affiliates (i)&nbsp;are fully protected in relying upon and are entitled to rely upon, and will have no Liability to any
Securityholder with respect to, actions, omissions to act, decisions, and determinations of the Securityholder Representative, (ii)&nbsp;are entitled to assume that all actions, omissions to act, decisions, and determinations of the Securityholder
Representative are fully authorized by Securityholders, and (iii)&nbsp;are entitled to deal exclusively with the Securityholder Representative on all matters relating to this Agreement and the other Transaction Documents. All deliveries made by
Buyer or any of its Affiliates to the Securityholder Representative or at the direction of the Securityholder Representative are made on behalf of Securityholders and constitute full performance of the delivery obligations of Buyer and its
Affiliates under this Agreement and the other Transaction Documents. Neither Buyer nor any of its Affiliates will be liable for allocation of particular deliveries and payments of such amounts at the direction of the Securityholder Representative.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><A NAME="ex2_1toc301274_52"></A><B>7.12</B> <B><U>Certain Waivers and Releases</U></B>. Effective as of the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders (i)&nbsp;shall not, and shall not permit any of their respective
Affiliates or any of the Representatives of any of the foregoing (each, together with the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, a &#147;<U>Releasing Person</U>&#148;) to, commence, directly or indirectly, any Proceeding
(whether for indemnification, contribution, subrogation, or otherwise) with respect to any, and (ii)&nbsp;as of the Closing, on each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders&#146; own behalf and on behalf of the other
Releasing Persons, hereby fully, finally, unconditionally, and irrevocably waive, release, acquit, and forever discharge the Company, the Company&#146;s Affiliates, and the Representatives (solely in their capacities as such) of each of the
foregoing (each, a &#147;<U>Released Person</U>&#148;) from all, (x)&nbsp;debts, covenants, torts, Damages, Liabilities, demands, claims, suits, defenses, judgments, and offsets of every name and nature whatsoever, past, present or future, at law or
in equity (including with respect to conduct that is negligent, grossly negligent, willful, intentional, with or without malice, or a breach of any duty or violation of any Legal Requirement), whether known or unknown, whether concealed or hidden,
whether disclosed or undisclosed, whether fixed, contingent, or otherwise, whether asserted or unasserted, whether accrued or unaccrued, whether matured or unmatured, whether liquidated or unliquidated, whether due or to become due, and whether
secured or unsecured, that have been or could have been asserted against any Released Person by any Releasing Person, in each case that are based upon, arise out of, or in any way relate to any Effect, action, or omission occurring or existing at or
prior to the Closing (excluding any rights or obligations explicitly arising under this Agreement or the other Transaction Documents, but specifically including any claim for limitation of liability, exculpation, indemnification, contribution, or
advancement or reimbursement of expenses under any of the Constitutive Documents or the Governance Documents of the Company or any of the Company&#146;s Affiliates, <U>Section</U><U></U><U>&nbsp;5.8</U>, or otherwise with respect to any Third-Party
Claim or Direct Claim for which indemnification is sought by a Buyer Indemnified Person in accordance with <U>Article</U><U></U><U>&nbsp;VI</U> that a Releasing Person would otherwise have but for the foregoing waivers and releases set forth in this
<U>Section</U><U></U><U>&nbsp;7.12</U>), and (y)&nbsp;Liabilities of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders under this Agreement, including <U>Section</U><U></U><U>&nbsp;2.5</U>, <U>Section</U><U></U><U>&nbsp;5.1</U>,
<U>Section</U><U></U><U>&nbsp;5.3</U>, or <U>Article</U><U></U><U>&nbsp;VI</U>, or any of the other Transaction Documents (clauses (i)&nbsp;and (ii), collectively, &#147;<U>Causes of Action</U>&#148;). The
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders hereby acknowledge and agree that the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders do not have any claim or right to indemnity or contribution from any of the
Released Persons with respect to any amounts paid by Securityholders pursuant to this Agreement, any of the other Transaction Documents, or otherwise. The <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders agree that in no event will
Buyer, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any of Buyer&#146;s Affiliates, any of the Representatives of any of the foregoing, or any of the other Released Persons have any liability whatsoever to the
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders for any inaccuracies, breaches, nonfulfillment, or nonperformance of the representations, warranties, covenants, obligations, or agreements of Securityholders or the Company under this
Agreement or any of the other Transaction Documents, and that the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders shall not seek to recover any amounts in connection therewith or thereunder from Buyer, any of Buyer&#146;s
Affiliates, any of the Representatives of any of the foregoing, or any of the other Released Persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Sellers hereby represent and
warrant to the Released Persons that (i)&nbsp;none of Sellers or any other Releasing Person has assigned any Causes of Action or possible Causes of Action against any Released Person, (ii)&nbsp;the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders and each other Releasing Person hereby fully releases, and intends to fully release, all Causes of Action against the Released Persons including unknown and contingent Causes of Action, (iii)&nbsp;Sellers have consulted with counsel
and each other Releasing Person has had the opportunity to consult with counsel with respect to the execution and delivery of this Agreement and the consequences of this <U>Section</U><U></U><U>&nbsp;7.12</U>, and (iv)&nbsp;none of the Releasing
Persons has any ongoing or potential Cause of Action against any Released Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, on his, her, or its own behalf and on behalf of each of the other Releasing Persons, hereby acknowledge and agree that this <U>Section</U><U></U><U>&nbsp;7.12</U> includes a full and
final release covering all Causes of Actions, including all known and unknown, suspected or unsuspected injuries, debts, claims, or other Damages that have arisen or may arise from any matters, acts, omissions, or dealings actually released in this
<U>Section</U><U></U><U>&nbsp;7.12</U>. The <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders, on his, her, or its own behalf and on behalf of each of the other Releasing Persons, hereby acknowledge and agree that there is a risk that
after the Closing, such Releasing Person may discover a Cause of Action that is released under this <U>Section</U><U></U><U>&nbsp;7.12</U>, but that is presently unknown to such Releasing Person, and such Releasing Person assumes such risk and
understands that this release will apply to any such Cause of Action. The foregoing release is intended to be effective as a general release of, and bar to, all such claims, whether presently known or unknown. Accordingly, each Releasing Person
waives any and all rights and benefits under, or equivalent to, Section&nbsp;1542 of the Civil Code of the State of California, which states as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor
at the time of executing the release and that, if known by him or her, would have materially affected his or her settlement with the debtor or released party.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.13</B> <B><U>Set Off</U></B>. Notwithstanding anything in this Agreement to the contrary, Buyer is entitled to (a)&nbsp;set off any
amount payable by any <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder to Buyer or any other Buyer Indemnified Person under this Agreement (including <U>Section</U><U></U><U>&nbsp;2.5</U>, <U>Section</U><U></U><U>&nbsp;5.1</U>,
<U>Section</U><U></U><U>&nbsp;5.3</U>, and <U>Article</U><U></U><U>&nbsp;VI</U>) or (b)&nbsp;hold back pending resolution of the related claim or potential claim the amount of any unresolved claim or potential claim for Damages payable by any <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder to Buyer or any other Buyer Indemnified Person under <U>Article</U><U></U><U>&nbsp;VI</U>, in each case, against any amount payable by Buyer or the Company to such <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder under this Agreement (including <U>Section</U><U></U><U>&nbsp;2.5</U>, <U>Section</U><U></U><U>&nbsp;5.3</U>, <U>Section</U><U></U><U>&nbsp;5.8</U>, and <U>Article</U><U></U><U>&nbsp;VI</U>),
and all amounts set off in accordance with this <U>Section</U><U></U><U>&nbsp;7.13</U> will be deemed paid to such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder and no set off or hold back effectuated in accordance with this
<U>Section</U><U></U><U>&nbsp;7.13</U> will constitute or be deemed to constitute a breach of any of Buyer&#146;s obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Pages Follow] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Parties, intending to be legally bound, has either duly executed this Agreement
or caused an authorized Representative of such Party to duly execute this Agreement on behalf of such Party, as of the Closing Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>BUYER:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer Programs and Systems, Inc.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ J. Boyd Douglas</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">J. Boyd Douglas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Stock Purchase Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SELLERS:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Healthcare Resource Group, Inc. Employee Stock Ownership Plan and Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">GreatBanc Trust Company, not in its corporate capacity, but solely in its capacity as Trustee of the Healthcare Resource Group, Inc.Employee Stock Ownership Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Lynn Archer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Lynn Archer, not in her individual capacity but solely as the authorized officer of GreatBanc Trust Company</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Steven McCoy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven McCoy</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Gregory West</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Gregory West</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Stock Purchase Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Healthcare Resource Group, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steven McCoy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Steven McCoy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Stock Purchase Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>SECURITYHOLDER REPRESENTATIVE:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steven McCoy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Steven McCoy</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Stock Purchase Agreement] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Annex <FONT STYLE="white-space:nowrap">A-1</FONT> </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sellers </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Healthcare Resources Group, Inc. Employee Stock Ownership Plan and Trust </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Steven McCoy </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Gregory West </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A-1-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Annex&nbsp;B </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Defined Terms </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following definitions will apply in connection with the interpretation of this Agreement: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Adjustment Escrow Amount</U>&#148;
means a dollar amount equal to $600,000 plus all interest accrued thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ACA</U>&#148; the Patient Protection and Affordable
Care Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Accounts Payable</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Accounts Receivable</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, with respect to a specified Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such specified Person. The term &#147;control&#148; means (a)&nbsp;the possession, directly or indirectly, of the power to vote ten percent (10%) or more of the securities of a Person having ordinary voting
power, (b)&nbsp;the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a Person, by Contract or otherwise, or (c)&nbsp;being a director, manager, officer, executor, trustee, or fiduciary
(or their equivalents) of a Person or a Person that controls such Person. For purposes of this Agreement, prior to the Closing, the Company and each Seller are deemed Affiliates and, immediately after the Closing, the Company and Buyer are deemed
Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Agreement</U>&#148; is defined in the introductory paragraph of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Allocable Share</U>&#148; means, with respect to each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, the proportion
(expressed as a percentage) of (a)&nbsp;Company Shares owned by such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder plus the Company Shares that are the subject of Company Options held by such
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder as of immediately prior to the Closing, relative to (b)&nbsp;the Company Shares owned by all <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders in the aggregate plus the
Company Shares that are the subject of the Company Options held by all <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders in the aggregate as of immediately prior to the Closing. Each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholder&#146;s Allocable Share is set forth opposite such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s name on <U>Annex <FONT STYLE="white-space:nowrap">A-3</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Bribery Laws</U>&#148; means the Foreign Corrupt Practices Act of 1977 and all other similar Legal Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Anti-Money Laundering Laws</U>&#148; means all anti-money laundering Legal Requirements and all related financial record keeping and
reporting requirements, rules, regulations, and guidelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset</U>&#148; means any asset or property of any kind, nature,
character, or description whatsoever (whether known or unknown, whether real or personal or mixed, and whether tangible or intangible) and wherever situated, including the goodwill related thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bank Accounts</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.20(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Base Cash Price</U>&#148; means a dollar amount equal to $44,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Benefit Plans</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.16(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Associates</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.15(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day except Saturday, Sunday, or any other day on
which commercial banks located in Mobile, Alabama are authorized or required by applicable Legal Requirements to be closed for business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer</U>&#148; is defined in the introductory paragraph of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Closing Documents</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.4(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Fundamental Representations</U>&#148; means those representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.1</U> (Organization and Good Standing), <U>Section</U><U></U><U>&nbsp;4.2</U> (Authority; No Conflict), and <U>Section</U><U></U><U>&nbsp;4.4</U> (Brokers or Finders). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Group</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.7(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Indemnified Persons</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Buyer Material Adverse Effect</U>&#148; means any Effect that is, or would reasonably be expected to become, individually or in the
aggregate, materially adverse to the ability of Buyer to consummate the Transactions on a timely basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CARES Act</U>&#148;
means the Coronavirus Aid, Relief, and Economic Security Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Cash and Cash Equivalents</U>&#148; means the aggregate amount of
cash and cash equivalents of the Company determined in accordance with GAAP, plus (a)&nbsp;the dollar amount of all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">deposits-in-transit</FONT></FONT> for the benefit of the Company
(only to the extent there has been a corresponding reduction of accounts receivable of the Company on account of such <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">deposits-in-transit</FONT></FONT> and such reduction is taken
into account in the determination of Current Assets for purposes of calculating Net Working Capital), minus (b)&nbsp;the dollar amount of all (i)&nbsp;outstanding checks and authorized automatic account withdrawals of the Company that have not
cleared (only to the extent there has been a corresponding reduction of accounts payable of the Company on account of such outstanding checks and authorized automatic account withdrawals and such reduction is taken into account in the determination
of Current Liabilities for purposes of calculating Net Working Capital), (ii)&nbsp;Loss Proceeds, and (iii)&nbsp;Trapped Cash. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Causes of Action</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;7.12(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CERCLA</U>&#148; means the Comprehensive Environmental Response, Compensation, and Liability Act of 1980. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Claim Notice</U>&#148; means the written notice of an indemnification claim or potential indemnification claim under <U>Article
VI</U> from an Indemnified Person to an Indemnifying Person specifying the factual basis of such claim or potential claim in reasonable detail to the extent then known by the Indemnified Party, including a reference to the section of this Agreement
that gives rise to such indemnification claim and the dollar amount claimed for such indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing</U>&#148; is
defined in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Cash</U>&#148; means the aggregate amount of all Cash and Cash
Equivalents as of immediately prior to the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Date</U>&#148; is defined in the introductory paragraph of this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Indebtedness</U>&#148; means the aggregate amount of all outstanding Indebtedness as of immediately prior to the
Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Closing Transaction Expenses</U>&#148; means the aggregate amount of all unpaid Transaction Expenses as of immediately
prior to the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>COBRA</U>&#148; means the Consolidated Omnibus Budget Reconciliation Act of 1985. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company</U>&#148; is defined in the introductory paragraph of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Capital Stock</U>&#148; means the authorized capital stock of the Company consisting of 10,000,000 shares of common stock
without par value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Contract</U>&#148; means any Contract to which the Company is a party or by which the Company or any
of the Company&#146;s Assets is otherwise bound. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Data Agreement</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Governmental Authorization</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.12(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company IP Rights</U>&#148; means all of the Intellectual Property Rights owned or
purported to be owned by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Material Adverse Effect</U>&#148; means any Effect that is, or would reasonably be
expected to become, individually or in the aggregate, materially adverse to (a)&nbsp;the businesses, results of operations, financial condition, or Assets of the Company, or (b)&nbsp;the ability of any Seller or the Company to consummate the
Transactions on a timely basis; provided, however, that Company Material Adverse Effect shall exclude any adverse changes or conditions as and to the extent such changes or conditions relate to or result from (i)&nbsp;changes generally affecting the
economy, financial, or securities markets, (ii)&nbsp;declaration of war or terrorist attack, natural disasters and acts of God, including floods, tornados, hurricanes, earthquakes, fires and similar events, (iii)&nbsp;pandemics, epidemics, disease
outbreaks, and other public health emergencies, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak or any variant thereof, (iv)&nbsp;general conditions in the industry in which the Company operates, (v)&nbsp;changes in Law,
including any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures, or (vi)&nbsp;the failure of the Company to meet internal or published projections, forecasts, or revenue or earning predictions for any period (but not the underlying causes of
such failure unless such underlying causes would otherwise be excepted from this definition); provided, further, that any Effect (or portion thereof) relating to or resulting from any change or event referred to in clause (ii)-(v) will be taken into
account in determining the occurrence of, a Company Material Adverse Effect to the extent such change or event has a disproportionate impact on the Company as compared to other companies that operate in the industries in which the Company operates.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Option</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.6</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Privacy Commitments</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.7(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Products</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.6(e)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Shares</U>&#148; is defined in the recitals of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Sites</U>&#148; means internet websites owned, maintained, or operated by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means that certain letter agreement, dated as of September&nbsp;13, 2021, by and between Buyer
and Brentwood Capital Advisors LLC, solely as the Company&#146;s representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Consent</U>&#148; means any consent, approval,
authorization, permission, waiver, clearance, exemption, expiration of any notification requirements, or similar affirmation by any Person pursuant to any Contract, Governmental Authorization, Legal Requirement, or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Constitutive Documents</U>&#148; means, with respect to any Person, the charter, articles or certificate of incorporation,
organization, or formation, or such other constitutive documents of such Person, including those that are required to be registered or kept in the place of incorporation, organization, or formation of such Person, which establish the legal existence
of such Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Contract</U>&#148; means any contract, agreement, instrument, obligation, covenant, commitment, arrangement,
undertaking, understanding, lease, license, plan, mortgage, indenture, note, loan, bond, debenture, guarantee, insurance policy, concession, franchise, purchase or sales order, bid, or other contractual obligation, whether written or oral and
whether express or implied, together with all amendments, supplements, and other modifications thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Copyrights</U>&#148;
means copyrightable works (including advertising and promotional materials, Software, compilations of data, and website content), and any copyrights therefor (whether registered or unregistered), and including common law and statutory rights therein
and therefor, and further including goodwill relating thereto, registrations and renewals thereof, and applications for registration therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT></U>&#148; means the diseases caused by <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> virus or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> or any evolutions or mutations thereof or related and/or associated epidemics, pandemics, or disease outbreaks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</U>&#148; means any quarantine, &#147;shelter in place,&#148; &#147;stay at
home,&#148; workforce reduction, social distancing, shut down, closure, sequester, safety or similar Law, or directive promulgated or issued publicly by any Governmental Authority and applicable to the Company or its business, including the Centers
for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to <FONT STYLE="white-space:nowrap">COVID-19.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Assets</U>&#148; means, as of the Effective Time, the sum of those current Assets of the Company identified on the example
calculation of Net Working Capital on <U>Annex</U><U></U><U>&nbsp;E</U>, calculated in accordance with GAAP (excluding, in all instances, Cash and Cash Equivalents, Loss Proceeds, Trapped Cash, deferred Tax Assets, and receivables from any Related
Person). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Liabilities</U>&#148; means, as of the Effective Time, the sum of those current Liabilities of the Company
identified on the example calculation of Net Working Capital on <U>Annex</U><U></U><U>&nbsp;E</U>, calculated in accordance with GAAP (excluding, in all instances, Transaction Expenses, Indebtedness, and deferred Tax Liabilities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Damage</U>&#148; means any damage, loss, diminution of value, Liability, Tax, royalty, claim, judgment, award, assessment,
settlement, disbursement, deficiency, fine, penalty, cost, or expense of any nature whatsoever (including any costs of investigation and any defense and reasonable attorneys&#146;, consultants&#146; and experts&#146; fees and expenses, in each case,
including in connection with any Direct Claim, Third-Party Claim, or otherwise). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Debt Payoff Letters</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.4(a)(v)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Deductible Amount</U>&#148; means a dollar amount equal to $220,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Determination Letter</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.17(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Direct Claim</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.7</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disclosure Letter</U>&#148; means that certain letter, dated as of the Closing Date, prepared and delivered by Sellers to Buyer
setting forth, among other items, those matters required, necessary, or appropriate to be disclosed by Sellers either in response to an express disclosure requirement contained in this Agreement or as an exception to one or more representations or
warranties in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Disputed Matters</U>&#148; means the specific matters in dispute with respect to the Revised
Closing Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effect</U>&#148; means any event, occurrence, fact, circumstance, condition, development, change, or effect.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Effective Time</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Employment Agreement</U>&#148; is defined <U>Section</U><U></U><U>&nbsp;2.4(a)(iv)</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Encumbrance</U>&#148; means any lien (statutory or otherwise), security interest, Preferential Right, charge, claim, condition,
equitable interest, community property interest, pledge, mortgage, deed of trust, lease, license, right of occupancy, easement, encroachment, right of way, servitude, profit, conservation, zoning, deed restriction, conditional and installment sale
agreement or other title retention device or arrangement, activity and use limitation, restrictive covenant, restriction of any kind or nature, including restriction on the exercise of any attribute of ownership, including use, voting, transfer, and
receipt of income, or any other encumbrance of any nature whatsoever, together with all documents and instruments evidencing or securing such matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Enforceability Exceptions</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Claim</U>&#148; means any Proceeding alleging Liability or responsibility for the costs of enforcement proceedings,
investigations, cleanup, governmental response, removal or remediation, natural resources damages, property damages, personal injuries, medical monitoring, penalties, contribution, indemnification, or injunctive relief arising out of, based on, or
resulting from (a)&nbsp;the presence or Release of any Hazardous Materials, or (b)&nbsp;any actual or alleged <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Environmental Law or any term or condition of any Environmental Permit.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Laws</U>&#148; means all Legal Requirements relative to or that govern or purport to govern air quality, soil
quality, water quality, wetlands, natural resources, solid waste, hazardous waste, hazardous or toxic substances (including Hazardous Materials), pollution, or the protection of public health, human health, or the environment, including CERCLA, the
Hazardous Materials Transportation Act, the Safe Drinking Water Act, the Clean Water Act, the Resource Conservation and Recovery Act, the Clean Air Act, the Toxic Substances Control Act, the Federal Insecticide, Fungicide, and Rodenticide Act, the
Occupational Safety and Health Act, and the Emergency Planning and Community Right to Know Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Notice</U>&#148;
means any written notice of, or with respect to, any Environmental Claim. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Permit</U>&#148; means any Governmental Authorization or other
material action required to be obtained by or on behalf of the Company under any Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the
Employee Retirement Income Security Act of 1974. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means any Person that is considered a single employer
with the Company under Section&nbsp;414 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agent</U>&#148; means Regions Bank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Agreement</U>&#148; means that certain Escrow Agreement, dated as of the Closing Date, by and between Buyer, the
Securityholder Representative, and the Escrow Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Amount</U>&#148; means a dollar amount equal to (a)&nbsp;the
Adjustment Escrow Amount, plus (b)&nbsp;the Indemnification Escrow Amount, plus (c)&nbsp;the Securityholder Expense Escrow Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Escrow Fee</U>&#148; means the fees payable to the Escrow Agent as provided for by the Escrow Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ESOP</U>&#148; means the Healthcare Resource Group, Inc. Employee Stock Ownership Plan and Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ESOP Amendment</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ESOP Expenses</U>&#148; means all expenses of the Trustee and the ESOP, including (a)&nbsp;the Trustee&#146;s financial advisor in
connection with rendering the Fairness Opinion, (b)&nbsp;accountants for the Trustee, the Company, and Sellers, (c)&nbsp;legal counsel or other advisor for the Trustee and the Company and (d)&nbsp;any costs and expenses specified in
<U>Sections</U><U></U><U>&nbsp;5.9(b)</U> and <U>5.9(e)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>ESOP Formation Transaction</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.17(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Cash Consideration</U>&#148; means a dollar amount equal to (a)&nbsp;the
Base Cash Price, plus (b)&nbsp;the Estimated Net Working Capital Surplus, if any, minus (c)&nbsp;the Estimated Net Working Capital Deficit, if any, plus (d)&nbsp;the Estimated Closing Cash, minus (e)&nbsp;the Estimated Closing Indebtedness, minus
(f)&nbsp;the Estimated Closing Transaction Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Closing Cash</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Closing Indebtedness</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Closing Statement</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Closing Transaction Expenses</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Net Working Capital</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;2.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Net Working Capital Deficit</U>&#148; means the amount, if any, by which the
Net Working Capital Target exceeds the Estimated Net Working Capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Estimated Net Working Capital Surplus</U>&#148; means the
amount, if any, by which the Estimated Net Working Capital exceeds the Net Working Capital Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means
the Securities Exchange Act of 1934. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Fairness Opinion</U>&#148; means an opinion rendered by an &#147;independent
appraiser&#148; (within the meaning of Section&nbsp;401(a)(28)(C) of the Code), on which the Trustee is entitled to rely, stating that (i)&nbsp;the consideration to be received by the ESOP for the Company Shares pursuant to the terms of this
Agreement is not less than the fair market value of the Company Shares; and (ii)&nbsp;that the terms and conditions of the transactions contemplated by this Agreement, taken as a whole, are fair to the ESOP from a financial point of view. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Families First Act</U>&#148; means the Families First Coronavirus Response Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Filing</U>&#148; means any report, registration, document, filing, declaration, statement, application, or submission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Cash Consideration</U>&#148; means a dollar amount equal to (a)&nbsp;the Base Cash Price, plus (b)&nbsp;the Final Net Working
Capital Surplus, if any, minus (c)&nbsp;the Final Net Working Capital Deficit, if any, plus (d)&nbsp;the Final Closing Cash, minus (e)&nbsp;the Final Closing Indebtedness, minus (f)&nbsp;the Final Closing Transaction Expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Closing Cash</U>&#148; means the Closing Cash as finally determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Closing Indebtedness</U>&#148; means the Closing Indebtedness as finally determined in accordance with
<U>Section</U><U></U><U>&nbsp;2.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Closing Transaction Expenses</U>&#148; means the Closing Transaction Expenses as
finally determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Net Working Capital</U>&#148; means Net
Working Capital as finally determined in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final Net Working Capital
Deficit</U>&#148; means the amount, if any, by which the Net Working Capital Target exceeds the Final Net Working Capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Final
Net Working Capital Surplus</U>&#148; means the amount, if any, by which the Final Net Working Capital exceeds the Net Working Capital Target. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Financial Statements</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fiscal Year Financial Statements</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>FLSA</U>&#148; means the Fair Labor Standards Act of 1938. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means United States generally accepted accounting practices in effect as of the date in question. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governance Documents</U>&#148; means, with respect to any Person, the bylaws, shareholders agreement, operating agreement, limited
liability company agreement, limited partnership agreement, partnership agreement, or such other governance documents of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authority</U>&#148; means any federal, state, local, municipal, foreign, or other court, legislature, executive, or
regulatory (including self-regulatory and <FONT STYLE="white-space:nowrap">non-governmental</FONT> regulatory) authority, agency, or commission, or other governmental or quasi-governmental entity, authority, organization, or instrumentality, or any
department, agency, subdivision, board, directorate, court, tribunal, or other instrumentality of any of the foregoing, or any arbitrator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Authorization</U>&#148; means any license, permit, franchise,
approval, authorization, registration, certification, qualification, membership, variance, immunity, closure, Consent, or other similar right required by any applicable Legal Requirement to be obtained from a Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Material</U>&#148; means any chemical, material, substance, or waste, whether naturally occurring or manmade, that is
currently regulated by or forms the basis of Liability now or hereafter under any Environmental Laws, including any chemical, material, substance, or waste that is (a)&nbsp;listed or defined a &#147;hazardous&#148; or &#147;toxic&#148; chemical,
material, substance, or waste, &#147;extremely hazardous waste&#148;, &#147;restricted hazardous waste&#148;, &#147;pollutant&#148;, &#147;contaminant&#148;, &#147;hazardous constituent&#148;, &#147;special waste&#148;, &#147;toxic substance&#148;
or other similar term or phrase under any Environmental Laws and (b)&nbsp;any petroleum product, including any fraction or <FONT STYLE="white-space:nowrap">by-product</FONT> thereof, asbestos, polychlorinated biphenyls (PCBs), radioactive material,
or lead-containing paints or coatings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>HIPAA</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.7(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Inbound License Agreement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.6(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Incremental Cap Amount</U>&#148; means a dollar amount equal to $8,800,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indebtedness</U>&#148; means the aggregate amount (including the current portion thereof), without duplication, of (a)&nbsp;the
Company&#146;s indebtedness, contingent or otherwise, for money borrowed from other Persons, purchase money indebtedness of the Company (other than accounts payable by the Company to any Person that is not a Related Person in the Ordinary Course to
the extent such accounts payable are not more than sixty (60)&nbsp;days past due), and reimbursement obligations of the Company with respect to letters of credit, (b)&nbsp;the Company&#146;s obligation to pay rent or other amounts under any lease of
(or other arrangement covering the right to use) real or personal property that is required to be classified and accounted for as a capital (or finance) lease on a consolidated balance sheet of the Company as of such date in accordance with GAAP,
(c)&nbsp;the deferred purchase price of Assets or services incurred outside the Ordinary Course by the Company, (d)&nbsp;all obligations of the Company for any <FONT STYLE="white-space:nowrap">earn-out</FONT> or contingent payment, bonus, deferred
compensation, phantom equity arrangement, or other similar payment or arrangement, (e)&nbsp;all earned or accrued unpaid salaries, wages, commissions, bonuses, incentive compensation, and any other compensation or payroll items of the Business
Associates (including the Pro Rated Bonus Payments but excluding monthly or quarterly commissions to the extent such commissions constitute a Current Liability in the calculation of Estimated Net Working Capital) as well as all payroll and other
employment Taxes with respect to any of the foregoing, (f)&nbsp;all payroll and other employment Taxes deferred by the Company pursuant to Section&nbsp;2302 of the CARES Act, (g)&nbsp;the monetary equivalent of all earned or accrued unused vacation,
personal pay, sick pay, and any other paid time off of the Business Associates in excess of 120 hours, (h)&nbsp;all obligations of the Company or any ERISA Affiliate for underfunded employee pension benefit plans and any unsatisfied obligation for
&#147;withdrawal liability&#148; to a &#147;multiemployer plan&#148; as such terms are defined under ERISA, (i)&nbsp;all <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet financing of the Company, (j)&nbsp;all obligations of the Company
under interest rate hedging, swap Contracts, forward rate Contracts, interest rate cap or collar Contracts, or other financial Contracts entered into for the purpose of limiting or managing interest rate risks, (k)&nbsp;all obligations of the
Company under currency swap transactions (valued at the termination value thereof), (l)&nbsp;all indebtedness and obligations of the Company with respect to bank products, including credit cards, credit card processing services, debit cards, stored
value cards, and purchasing cards (including <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;procurement cards&#148; and <FONT STYLE="white-space:nowrap">&#147;P-Cards&#148;),</FONT> (m)&nbsp;all indebtedness and obligations of the type
described in this definition guaranteed or in effect guaranteed in any manner, directly or indirectly, by the Company, including through a Contract, contingent or otherwise, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to supply funds to, or in any other manner invest in, the debtor, or to purchase indebtedness, or to purchase and pay for Assets if not delivered or pay for services if not performed, primarily
or exclusively, for the purpose of enabling the debtor to make payment of the indebtedness or obligation or to insure the owners of the indebtedness or obligation against loss, but excluding the endorsements of checks and other instruments in the
Ordinary Course, (n)&nbsp;all indebtedness and obligations of the type described in this definition secured by any Encumbrance upon Assets owned by the Company, even though the Company has not in any manner become liable for the payment of such
indebtedness or performance of such obligation, and (o)&nbsp;all accrued but unpaid interest expense and all penalties, fees, charges, and prepayment premiums that are payable, in each case, with respect to any of the indebtedness or obligations
described in this definition, including as a result of the entry into the Transaction Documents and the consummation and performance of the Transactions (including any repayment of Indebtedness at or prior to the Closing); provided, however,
notwithstanding any of the foregoing, the term &#147;<U>Indebtedness</U>&#148; shall not include any amounts to the extent taken into account as a Current Liability in the calculation of Final Net Working Capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnification Escrow Account</U>&#148; means the escrow account into which the Indemnification Escrow Amount is deposited pursuant
to the Escrow Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnification Escrow Amount</U>&#148; means a dollar amount equal to (a)&nbsp;the Primary
Indemnification Escrow Amount, plus (b)&nbsp;the Special Indemnification Escrow Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnified Person</U>&#148; means any
Buyer Indemnified Person or Securityholder Indemnified Person, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Indemnifying Person</U>&#148; means any Party
against whom an indemnification claim is made pursuant to <U>Article</U><U></U><U>&nbsp;VI</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Independent Accounting
Firm</U>&#148; means a nationally recognized independent accounting firm mutually acceptable to Buyer and the Securityholder Representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Information Systems</U>&#148; means all computer hardware, firmware, and Software, data storage systems (including servers), computer
and communications networks (other than the internet) and equipment, interfaces, applications, platforms, firewalls, and other apparatuses that are owned by or leased to the Company and used to create, manipulate, store, transmit, exchange, or
receive information in any electronic form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Insurance Policies</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.10</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property Rights</U>&#148; means intellectual property and/or other proprietary rights, including (a)&nbsp;Marks,
(b)&nbsp;Net Names, (c)&nbsp;Patents, (d)&nbsp;Copyrights, <FONT STYLE="white-space:nowrap">(e)&nbsp;know-how,</FONT> trade secrets, technical, marketing, or pricing information, plans, notes, reports, drawings, photographs, works, devices, computer
hardware, makes, models, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">works-in-progress,</FONT></FONT> research and development, formulas, algorithms, processes, data, designs, layouts, customer and supplier lists, financial
information, inventions, and creations, (f)&nbsp;Software (whether in general release or under development), and (g)&nbsp;all rights to prosecute and perfect any of the foregoing through administrative prosecution, registration, recordation, or
other Proceeding, and all causes of action and rights to sue or seek other remedies arising from or relating to the foregoing, including for any past or ongoing infringement, misuse, or misappropriation, anywhere in the world. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Balance Sheet</U>&#148; means the balance sheet within the Interim
Financial Statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Balance Sheet Date</U>&#148; means the date of the Interim Balance Sheet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Interim Financial Statements</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Invoices</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.4(a)(vii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS</U>&#148; means the United States Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Jointly/Severally</U>&#148; means (a)&nbsp;with respect to the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders&#146;
payment obligations with respect to Purchase Price adjustments as set forth in <U>Section</U><U></U><U>&nbsp;2.5(e)</U> for amounts in excess of the Adjustment Escrow Amount, severally but not jointly for each
<FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder in accordance with such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s Allocable Share, (b)&nbsp;with respect to the Securityholders&#146; payment obligations
with respect to Taxes as set forth in <U>Section</U><U></U><U>&nbsp;5.1</U>, (i) jointly and severally for all Securityholders for all amounts due to be paid from the Securityholder Expense Escrow Amount, and (ii)&nbsp;for amounts in excess of the
Securityholder Expense Escrow Amount, severally but not jointly for each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder in accordance with such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s Allocable Share,
(c)&nbsp;with respect to the Securityholders&#146; obligations in <U>Article VI</U> (and subject to the limitations expressly set forth therein, including, for the avoidance of doubt, the Primary Cap Amount, the Incremental Cap Amount, and the
Ultimate Cap Amount), (i) jointly and severally for all Securityholders for all Damages due to be paid or payable to Buyer or any other Buyer Indemnified Party from the Indemnification Escrow Amount up to the Primary Cap Amount, (ii)&nbsp;jointly
and severally for all <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholders for all Damages due to be paid or payable to Buyer or any other Buyer Indemnified Party from the Indemnification Escrow Amount in excess of the Primary Cap
Amount, and (iii)&nbsp;for amounts in excess of the Indemnification Escrow Amount, (A)&nbsp;other than amounts arising from inaccuracies in or breaches of the Seller Ownership and Authority Representations, severally but not jointly for each <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder in accordance with such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s Allocable Share, and (B)&nbsp;with respect to amounts arising from inaccuracies in or breaches
of the Seller Ownership and Authority Representations, individually for each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Seller for breaches by such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Seller and severally for each <FONT
STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder for breaches by the ESOP in accordance with such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s Allocable Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Key Employees</U>&#148; means Greg West, Jason Coffin, Mark Bell, Cassie Wise, Brandon Hayes, Laura Osborne, Andrea Lowery, John
Green, and Megan Smith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge of <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Sellers</U>&#148; means information that
is actually known or that would be expected to be known by any Steven McCoy, Gregory West, Mark Bell, or any other officer of the Company responsibly performing his or her duties in such capacity, including making reasonable inquiry of direct
reports concerning the subject matter in question. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Leased Real Property</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Legal Requirement</U>&#148; means any federal, state, local, municipal, foreign, or
other law (including common law), statute, code, ordinance, regulation, rule, regulatory, or administrative ruling or guidance, directive, Order, constitution, treaty, or other restriction, requirement, or rule of law of any Governmental Authority.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Lenders</U>&#148; means those lenders identified in the Debt Payoff Letters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Letter of Intent</U>&#148; means that certain Letter of Intent, dated as of October&nbsp;22, 2021, by and between the Company and
Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liability</U>&#148; means any liability, obligation, or commitment of any kind, nature, character, or description
whatsoever (whether primary or secondary, whether direct or indirect, whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether matured or unmatured, whether liquidated or
unliquidated, whether due or to become due, and whether secured or unsecured). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>License Agreements</U>&#148; means the Inbound License Agreements and the Outbound
License Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Loss Proceeds</U>&#148; means all insurance proceeds and condemnation claims and awards received by the
Company prior to the Effective Time as a result of, or with respect to, any Assets of the Company being damaged, destroyed, or condemned to the extent such proceeds, claims, and awards have not been used to repair or replace such Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Marks</U>&#148; means, registered and unregistered, trademarks, logos, logotypes, corporate names, trade names, trade dress, and/or
service marks, including common law and statutory rights therein and therefor, and further including goodwill relating thereto, registrations and renewals thereof, and applications for registration therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Company Contracts</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Customers</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.8(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Suppliers</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Names</U>&#148; means internet web sites and internet domain names, including all related internet protocol addresses, and
including common law and statutory rights therein and therefor, and further including goodwill relating thereto, registrations and renewals thereof, and applications for registration therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Working Capital</U>&#148; means the Current Assets, minus the Current Liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Net Working Capital Target</U>&#148; means $4,131,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder</U>&#148; means each Securityholder other than the ESOP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Seller</U>&#148; means each Seller other than the ESOP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Deadline</U>&#148; means 5:00&nbsp;p.m. (Pacific Time) on the last day of the Objection Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Notice</U>&#148; means a written notice of any good faith objection to the Revised Closing Statement specifying in
reasonable detail the nature and basis of such objection, as well as the specific Disputed Matters and the amount of any proposed adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Objection Period</U>&#148; means&nbsp;the sixty (60)&nbsp;day period immediately following the delivery of the Revised Closing
Statement by Buyer to the Securityholder Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option Cancellation Agreement</U>&#148; means the option cancellation
agreement to be entered into by the Company and each Optionholder, in a form acceptable to Buyer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Optionholder</U>&#148; is
defined in <U>Section</U><U></U><U>&nbsp;2.6</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Option Payment</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.6</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Order</U>&#148; means any order, award, decision, injunction, judgment, ruling,
decree, assessment, charge, writ, subpoena, or verdict entered, issued, made, or rendered by any Governmental Authority or mediator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ordinary Course</U>&#148; means the ordinary course of business of the Company consistent with past custom and practices (including
with respect to quantity and frequency) of the Company, but, in no event, including any (a)&nbsp;breach of Contract or warranty, (b)&nbsp;infringement, (c)&nbsp;professional error or omission, (d)&nbsp;act or event creating a severance obligation,
wrongful discharge claim, or similar Liability, (e)&nbsp;tort, or (f)&nbsp;violation of Legal Requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Original
Shareholder</U>&#148; means Colleen Hays. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Outbound License Agreement</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.6(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pandemic</U>&#148; means the pandemic caused by the outbreak of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> as declared by the World Health Organization on March&nbsp;11, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parties</U>&#148; means Buyer, Sellers, the Securityholder Representative, and the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Patents</U>&#148; means inventions (whether patentable or unpatentable and whether or not reduced to practice), improvements to
inventions, patents, patent applications, and work product therefor, together with any reissuance, division, continuation, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuation-in-part,</FONT></FONT> revision, extension, or
reexamination of any such patent or patent application, and including common law and statutory rights therein and therefor, and further including goodwill relating thereto, registrations and renewals thereof, and applications for registration
therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Encumbrance</U>&#148; means any (a)&nbsp;mechanic&#146;s, materialman&#146;s, or similar lien arising and
incurred in the Ordinary Course (i)&nbsp;that does not result from a breach, default, or violation by the owner of the Asset subject to any such lien, (ii)&nbsp;that is not, individually or in the aggregate, material to the business, operations, and
financial condition of the owner of the Asset subject to any such lien, and (iii)&nbsp;for which the underlying obligations are not past due or payable, or (b)&nbsp;lien for Taxes not yet due or payable or being contested in good faith by
appropriate Proceedings, timely instituted and diligently conducted, and, in each case, for which adequate accruals or reserves have been established on the financial statements (with respect to the Company, the Interim Balance Sheet) of the owner
of the Asset subject to any such lien in accordance with GAAP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means any individual, partnership, limited
partnership, limited liability partnership, limited liability company, corporation, unincorporated association, joint stock company, joint venture, trust, business trust, or other entity, or any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Information</U>&#148; means data that relates to, identifies, describes, or is reasonably capable of being associated with,
or could reasonably be linked, directly or indirectly, with an identified or identifiable individual, device, or household, including name, address, telephone number, electronic mail address, unique government-issued identifier, unique or online
identifier, deterministic or probabilistic identifiers, account number, credit or debit card number, IP address or other electronic network activity information, biometric or health information, protected class information, professional,
employment-related or educational information, geolocation data, commercial information (including products or services or other purchasing or consuming histories or tendencies), inferences drawn from personal information to create a profile, or any
other data that may be used to identify, contact, or precisely locate an individual or is otherwise considered personally identifiable information, personal information, personal data, sensitive data, protected health information, or special
categories of personal data or personal information under Legal Requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Post-Closing Tax Period</U>&#148; means any Tax year or other Tax period of the
Company beginning after the Closing Date and the portion of any Straddle Period beginning after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT
STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Period</U>&#148; means any Tax year or other Tax period of the Company ending on or before the Closing Date and the portion of any Straddle Period through the end of the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">Pre-Closing</FONT> Tax Refund</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferential Right</U>&#148; means any purchase option, call right, right of first refusal, right of first offer, <FONT
STYLE="white-space:nowrap">co-sale</FONT> right, participation right, preemptive right, subscription right, put right, or other similar right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Primary Cap Amount</U>&#148; means a dollar amount equal to $4,400,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Primary Indemnification Escrow Amount</U>&#148; means a dollar amount equal to the Primary Cap Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Privacy Laws</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.7(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Proceeding</U>&#148; means any claim, counterclaim, charge, complaint, allegation, notice of violation, demand, action, cause of
action, enforcement action, lawsuit, litigation, proceeding, hearing, arbitration, mediation, citation, indictment, summons, subpoena, audit, investigation, or written inquiry of any nature (in each case, whether civil, criminal, administrative,
regulatory, investigative, or informal, and whether at law or in equity) commenced, conducted, heard, or pending by or before any Governmental Authority or mediator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Processing</U>&#148; (and the correlative meanings of &#147;<U>Process</U>&#148; and &#147;<U>Processes</U>&#148;) means the receipt,
collection, sharing, selling, disclosing, transferring, renting, retrieval, consultation, analysis, combination, accessing, storage, use, security, transfer, restriction, destruction, or other processing or operations or set of operations performed
on Personal Information, whether or not by automated means. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Prohibited Payment</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.13(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Rata Percentage</U>&#148; means, with respect to each Securityholder, the
proportion (expressed as a percentage) of (a)&nbsp;Company Shares owned by such Securityholder and Company Shares subject to the Company Options held by such Securityholder, relative to (b)&nbsp;the Company Shares owned by all Securityholders in the
aggregate and Company Shares subject to all Company Options in the aggregate. Each Securityholder&#146;s Pro Rata Percentage is.set forth opposite such Securityholder&#146;s name on <U>Annex <FONT STYLE="white-space:nowrap">A-3</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Pro Rated Bonus Payments</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.4(a)(xiv)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.2(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Purchase Price Bank Account</U>&#148; means that certain United States bank account of each Seller designated by the Securityholder
Representative in a written notice to Buyer at least one (1)&nbsp;Business Day prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property
Leases</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.5(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Related Person</U>&#148; means (a)&nbsp;any Affiliate, shareholder, director, or
officer of the Company (including Sellers) and (b)&nbsp;any Affiliate or member of the immediate family of any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Release</U>&#148; means any actual or threatened release, spilling, leaking, pumping, pouring, emitting, emptying, discharging,
injecting, escaping, leaching, dumping, abandonment, disposing, or allowing to escape or migrate into or through the environment (including ambient air (indoor or outdoor), surface water, groundwater, land surface or subsurface strata, or within or
from any building, structure, improvement, fixture, building system and equipment, or any component thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Released
Person</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;7.12(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Releasing Person</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;7.12(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remedial Amendment Period</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.16(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representative</U>&#148; means, with respect to any Person, any director, manager,
officer, employee, independent contractor, consultant, legal counsel, accountant, financial advisor, or other agent or representative of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Area</U>&#148; means anywhere in the United States of America. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Business</U>&#148; means the business of providing Revenue Cycle Management (RCM), Patient Financial Services (PFS) and
Health Information Management (HIM)&nbsp;coding and auditing services to healthcare facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Period</U>&#148;
means for Kristina Ditzler, Steven McCoy and Greg West, the five (5)&nbsp;year period immediately following the Closing Date, and for each other <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, the one (1)&nbsp;year period
immediately following the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Restricted Securityholder</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;5.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Cash Consideration</U>&#148; means a dollar amount equal to (a)&nbsp;the Base
Cash Price, plus (b)&nbsp;the Revised Net Working Capital Surplus, if any, minus (c)&nbsp;the Revised Net Working Capital Deficit, if any, plus (d)&nbsp;the Revised Closing Cash, minus (e)&nbsp;the Revised Closing Indebtedness, minus (f)&nbsp;the
Revised Closing Transaction Expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Closing Cash</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Closing Indebtedness</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Closing Statement</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Closing Transaction Expenses</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Net Working Capital</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;2.5(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Net Working Capital Deficit</U>&#148; means the amount, if any, by which the Net Working Capital Target exceeds the Revised
Net Working Capital. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Revised Net Working Capital Surplus</U>&#148; means the amount, if any, by which the Revised Net Working
Capital exceeds the Net Working Capital Target. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;3.1(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder Indemnified Persons</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder Expense Escrow Account</U>&#148; means the escrow account into which the Securityholder Expense Escrow Amount is
deposited pursuant to the Escrow Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder Expense Escrow Amount</U>&#148; means a dollar amount equal to
$250,000, which amount shall be available to the Securityholder Representative for purposes of satisfying (i)&nbsp;the Securityholders&#146; obligations with respect to Taxes under <U>Section</U><U></U><U>&nbsp;5.1</U>, and (ii)&nbsp;any costs,
expenses or Liabilities incurred by the Securityholder Representative, in his capacity as the Securityholder Representative under this Agreement. On the <FONT STYLE="white-space:nowrap">18-month</FONT> anniversary of the Closing Date, Buyer and the
Securityholder Representative shall instruct the Escrow Agent to pay to the Securityholder Representative (for further distribution to each Securityholder in accordance with such Securityholder&#146;s Pro Rata Percentage) the then current balance of
the Securityholder Expense Escrow Amount in accordance with the Escrow Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller</U>&#148; and
&#147;<U>Sellers</U>&#148; are each defined in the introductory paragraph of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Closing Documents</U>&#148;
is defined in <U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Confidentiality Agreement</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;5.5(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller ERISA Affiliate</U>&#148; means any Person that is considered a single employer
with any Seller under Section&nbsp;414 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Excluded Representations</U>&#148; means the Seller Regulatory
Representations and the Seller Fundamental Representations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Fundamental Representations</U>&#148; means those
representations and warranties set forth in <U>Section</U><U></U><U>&nbsp;3.1</U> (Organization and Good Standing; Capitalization; Subsidiaries), <U>Section</U><U></U><U>&nbsp;3.2(a)</U> (Authority; No Conflict), clause (i)&nbsp;of
<U>Section</U><U></U><U>&nbsp;3.2(b)</U> (Authority; No Conflict); the first sentence of <U>Section</U><U></U><U>&nbsp;3.4</U> (Assets); <U>Section</U><U></U><U>&nbsp;3.22</U> (Brokers or Finders); and <U>Section</U><U></U><U>&nbsp;3.24(a)(i)</U>
(ESOP Representations / Authority; No Conflict); and clause (i)&nbsp;of <U>Section</U><U></U><U>&nbsp;3.24(a)(ii)</U> (ESOP Representations / Authority No Conflict). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Ownership and Authority Representations</U>&#148; means the Seller Fundamental Representations in
<U>Section</U><U></U><U>&nbsp;3.1</U>, <U>Section</U><U></U><U>&nbsp;3.2(a)</U>, <U>Section</U><U></U><U>&nbsp;3.2(b)(i)</U>, to the extent applicable to Sellers, <U>Section</U><U></U><U>&nbsp;3.24(a)(i)</U> (ESOP Representations / Authority; No
Conflict); and clause (i)&nbsp;of <U>Section</U><U></U><U>&nbsp;3.24(a)(ii)</U> (ESOP Representations / Authority No Conflict). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Seller Regulatory Representations</U>&#148; means those representations set forth in <U>Section</U><U></U><U>&nbsp;3.6</U>
(Intellectual Property; Information Systems), <U>Section</U><U></U><U>&nbsp;3.16</U> (Benefit Plans), <U>Section</U><U></U><U>&nbsp;3.17</U> (ESOP Matters), and <U>Section</U><U></U><U>&nbsp;3.18</U> (Taxes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder</U>&#148; means each Seller and each Optionholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securityholder Representative</U>&#148; is defined in the introductory paragraph of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Software</U>&#148; means computer software programs and software systems, including
all databases, compilations, tool sets, compilers, modules, libraries, files, or other components, higher level of &#147;proprietary&#148; languages, source code, object code, and related data, records, documentation, specifications, manuals, user
guides, and materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Special Indemnification Escrow Amount</U>&#148; means a dollar amount equal to $6,600,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Statutory Transfer Restrictions</U>&#148; means, with respect to any security, those transfer restrictions statutorily imposed on
such security under the Securities Act and applicable state securities Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Straddle Period</U>&#148; means any
Tax year or other Tax period of the Company beginning on or before the Closing Date and ending after the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Straddle
Period Tax Return</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.1(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148; means, with respect to
any Person, any corporation, limited liability company, partnership, association, or other business entity of which (a)&nbsp;if a corporation, a majority of the total voting power of shares of stock entitled (without regard to any contingency) to
vote in the election of directors or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b)&nbsp;if a limited liability
company, partnership, association, or other business entity (other than a corporation), a majority of partnership or other similar ownership interest thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more
Subsidiaries of that Person or a combination thereof (for this purpose, a Person owns (or Persons own) a majority ownership interest in such a business entity (other than a corporation) if such Person or Persons shall be allocated a majority of such
business entity&#146;s gains or losses) or is or controls any managing director or general partner of such business entity (other than a corporation). The term &#147;Subsidiary&#148; includes all Subsidiaries of such Subsidiary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tail Policies</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; means any federal, state, county, municipal, local, foreign, or other tax, duty, fee, excise, premium, impost, levy,
assessment, tariff, or other charge of any kind whatsoever imposed, assessed, or collected by a Governmental Authority, including (a)&nbsp;any gross income, net income, gross receipts, business, royalty, capital, capital gains, goods and services,
value added, general service, service use, severance, stamp, franchise, occupation, production, capital stock, sales and use, real property, real property gains, land transfer, personal property, ad valorem, transfer, registration, license, lease,
profits, windfall profits, environmental (including under Section&nbsp;59A of the Code), payroll, employment, unemployment, disability, employer health, pension plan, social security, national insurance contributions, escheat, unclaimed property,
anti-dumping, countervail, excise, recapture, wealth, estate, inheritance, surplus, surtaxes, customs, indebtedness, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum, estimated, or premium tax, (b)&nbsp;any withholding on
amounts paid to or by the relevant Person, (c)&nbsp;any fine, penalty, interest, and addition to tax or installment in respect thereof or with respect to the nonpayment thereof, whether disputed or not, and all interest in respect of such fine,
penalty, and addition, (d)&nbsp;any tax imposed, assessed, or collected or payable pursuant to tax sharing agreements or other Contracts relating to the sharing or payment of taxes, levies, assessments, tariffs, duties, deficiencies, or fees, and
(e)&nbsp;any Liability for any of the foregoing as a transferee, successor, guarantor, or by Contract or by operation of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Benefit</U>&#148; means Tax savings attributable to any deduction, expense, loss, credit or refund and determined on a with or
without basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any return, declaration, report, claim for refund,
information return or statement, or other document (including IRS Form&nbsp;5500) required to be filed with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof, and any return, form, or other document
required to be retained in compliance with applicable Tax reporting and withholding Legal Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third-Party
Claim</U>&#148; is defined in <U>Section</U><U></U><U>&nbsp;6.6(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Third-Party Processor</U>&#148; is defined in
<U>Section</U><U></U><U>&nbsp;3.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement and all other Contracts,
documents, and certificates contemplated by this Agreement, including the Seller Closing Documents and the Buyer Closing Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Expenses</U>&#148; means (a)&nbsp;all of the fees, charges, expenses, and other costs and Liabilities incurred, paid, or
required to be paid by the Company in connection with the negotiation of this Agreement, the performance of the Company&#146;s obligations under the Transaction Documents and the preparation for and consummation and performance of the Transactions,
including (i)&nbsp;all of the fees, charges, expenses, and other costs of legal counsel, accountants, investment bankers, brokers, financial advisors, and other Representatives and consultants of the Company engaged in connection with the
Transactions that are not paid directly by a Seller, whether or not such fees, charges, expenses, or other costs have been assessed or billed prior to the Closing, (ii)&nbsp;all of the fees, charges, expenses and other costs associated with the
Company providing the necessary or appropriate notices, making the necessary or appropriate Filings, or obtaining the necessary or appropriate Consents in connection with the execution, delivery, and performance of the Transaction Documents and the
consummation and performance of the Transactions, and (iii)&nbsp;all of the fees, charges, expenses, and other costs associated with obtaining the release of all Encumbrances on the Assets of the Company and the Company Shares, (b)&nbsp;all
payments, bonuses, and severance, as well as all payroll and other employment Taxes with respect to any of the foregoing, that become due or are otherwise required to be made by the Company as a result of or in connection with the execution,
delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions or as a result of any change of control of the Company as contemplated by this Agreement or other similar Contract provisions that are
triggered by the execution, delivery, and performance of the Transaction Documents and the consummation and performance of the Transactions, (c)&nbsp;payroll, employment, or other Taxes, if any, required to be paid by Buyer with respect to the
amounts payable pursuant to this Agreement, (d)&nbsp;fifty percent (50%) of the Transfer Taxes, and (e)&nbsp;the ESOP Expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; means all of the transactions provided for in this Agreement and the other Transaction Documents, including
the sale by Sellers to Buyer, and the purchase by Buyer from Sellers, of the Company Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer Taxes</U>&#148; means all
provisional and final sales, use, transfer, real estate transfer, recording, documentary, stamp, registration, value added, gross receipts, and all other similar Taxes (including penalties and interest). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trapped Cash</U>&#148; means the aggregate amount of all cash and cash equivalents of the Company that is designated as restricted or
that is not freely useable by the Company as of the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Treasury Regulations</U>&#148; means the United States Treasury
Regulations promulgated under the Code, and any reference to any particular section of the Treasury Regulations is deemed to include any final or temporary revision of or successor to such section regardless of how such section is numbered or
classified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trust</U>&#148; means the &#147;Trust&#148; as defined in the ESOP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Trustee</U>&#148; means the trustee of the ESOP, which is currently GreatBanc Trust Company. For the avoidance of doubt, the
definition of &#147;Trustee&#148; shall include all Persons that have served as trustee of the ESOP since the ESOP Formation Transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Union</U>&#148; means a union, works council, labor organization, or similar organization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ultimate Cap Amount</U>&#148; means (a)&nbsp;with respect to the ESOP, the ESOP&#146;s Pro Rata Percentage of the Primary
Indemnification Escrow Amount, and (b)&nbsp;with respect to each <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder, such <FONT STYLE="white-space:nowrap">Non-ESOP</FONT> Securityholder&#146;s Pro Rata Percentage of the Base Cash Price;
provided, however, the ESOP&#146;s Pro Rata Percentage of the Primary Indemnification Escrow Amount shall not be counted toward the satisfaction of the Ultimate Cap Amount applicable to any of the <FONT STYLE="white-space:nowrap">Non-ESOP</FONT>
Securityholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>Virtual Data Room</U>&#148; means that certain electronic documentation site established by or on behalf of the
Company at https://brentwoodcapital.firmex.com/projects/242/documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-18 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d301274dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g301274g0302061905604.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONTACT </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tracey Schroeder
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Marketing Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Tracey.schroeder@cpsi.com</U>
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(251) <FONT STYLE="white-space:nowrap">639-8100</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CPSI ANNOUNCES THE ACQUISITION OF HEALTHCARE RESOURCE GROUP, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Business Combination Leverages Strength of Leading Providers of Revenue Cycle Management Services </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare Resource Group, Inc. Transaction Highlights: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2021 revenues and adjusted EBITDA of $33.8&nbsp;million and $3.6&nbsp;million, respectively
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2022 expected revenues and adjusted EBITDA of $40.1&nbsp;million and $5.2&nbsp;million, respectively <FONT
STYLE="white-space:nowrap">(pre-synergies)</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Synergies to provide an additional estimated $2.6&nbsp;million margin improvement to 2022 exit rate cost
structure for the combined company </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">91% of revenues are recurring </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">77 customers representing mid to large hospitals across 28 states </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MOBILE, ALA. (March 1, 2022) &#150; CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that it has acquired Healthcare Resource Group, Inc.
(&#147;HRG&#148;). Based in Spokane, Washington, HRG is a leading provider of customized revenue cycle management (&#147;RCM&#148;) solutions and consulting services that enable hospitals and clinics to improve efficiency, profitability, and patient
satisfaction. Founded in 1994, HRG has approximately 400 employees, serving 77 healthcare clients, primarily located in the Pacific Northwest and Southwest, including academic medical centers, tribal organizations, and independent 200+ bed
hospitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition was consummated pursuant to a definitive purchase agreement signed on March&nbsp;1, 2022, and was funded by a combination of
cash on hand and additional borrowing capacity under CPSI&#146;s revolving credit facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The combination of HRG and TruBridge, a subsidiary of CPSI,
will more effectively address the growing demand from healthcare organizations to outsource revenue cycle operations. Healthcare providers face a myriad of challenges in managing billing and payment complexities, as well as recruiting and retaining
qualified RCM staff. With a team of professional and experienced consultants, HRG joins the TruBridge team with a shared commitment to meet this critical demand and improve the financial performance of healthcare organizations of all sizes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boyd Douglas, president and chief executive officer of CPSI, stated, &#147;We are pleased to announce the combination of these two leading providers of RCM
services. Their Peer Reviewed by HFMA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> RCM solutions offer us significant opportunities to leverage our combined scale and extend our market reach. In addition to the TruBridge RCM product
suite, we are excited about the ability to cross-sell other solutions to HRG clients, including TruCode Encoder, our medical coding encoder solution. We also will leverage our gains in artificial intelligence and offshoring to create additional
efficiencies for HRG.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-MORE- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CPSI Announces the Acquisition of Healthcare Resource Group, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;1, 2022 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;HRG is a great strategic fit for CPSI, and this transaction supports our goal to complete accretive
acquisitions that complement our growth strategy with a stable client base and high mix of recurring revenues,&#148; stated Matt Chambless, chief financial officer of CPSI. &#147;The scalability of our combined RCM solutions and added efficiencies
will help drive margin expansion. We also expect to benefit from additional operating synergies as we integrate HRG into the CPSI family.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven
McCoy, chief executive officer of HRG, added, &#147;We look forward to joining CPSI in capitalizing on the expected continued growth opportunity in the healthcare RCM outsourcing market. CPSI and TruBridge have a long-standing and favorable
reputation in the healthcare marketplace, and we share a common culture of working closely with our clients to deliver measurable results and exceeding expectations. We believe our combined companies will provide unique opportunities to leverage our
collective expertise with proven solutions and exceptional service that will benefit more healthcare organizations.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CPSI will hold a conference
call and live webcast to discuss the details of this acquisition on Wednesday, March&nbsp;2, 2022, at 9:00 a.m. Eastern Time. The number to call for the interactive teleconference is
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">877-407-0890.</FONT></FONT> To listen to the live webcast or access the <FONT STYLE="white-space:nowrap">30-day</FONT> online replay, visit the Company&#146;s website,
<U>www.cpsi.com</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CPSI&#146;s legal advisor in this transaction was&nbsp;Maynard, Cooper&nbsp;&amp; Gale, P.C. and Brentwood Capital Advisors LLC
served as exclusive financial advisor to HRG. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>About CPSI </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CPSI is a leading provider of healthcare solutions and services for community hospitals, their clinics and post-acute care facilities. Founded in 1979, CPSI is
the parent of five companies &#150; Evident, LLC, American HealthTech, Inc., TruBridge, LLC, iNetXperts, Corp. d/b/a Get Real Health and TruCode LLC. Our combined companies are focused on helping improve the health of the communities we serve,
connecting communities for a better patient care experience, and improving the financial operations of our customers. Evident provides comprehensive EHR solutions for community hospitals and their affiliated clinics. American HealthTech is one of
the nation&#146;s largest providers of EHR solutions and services for post-acute care facilities. TruBridge focuses on providing business, consulting and managed IT services, along with its complete RCM solution, for all care settings. Get Real
Health focuses on solutions aimed at improving patient engagement for individuals and healthcare providers. TruCode provides medical coding software that enables complete and accurate code assignment for optimal reimbursement. For more information,
visit <U>www.cpsi.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains forward-looking statements within the meaning of the &#147;safe harbor&#148; provisions of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as &#147;expects,&#148; &#147;anticipates,&#148; &#147;estimates,&#148; &#147;believes,&#148;
&#147;predicts,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;potential,&#148; &#147;may,&#148; &#147;continue,&#148; &#147;should,&#148; &#147;will&#148; and words of comparable meaning. Without limiting the generality of the preceding
statement, all statements in this press release concerning the business outlook, anticipated profitability, revenues, expenses, leverage or other items of future financial performance, and potential product or services growth, of HRG or CPSI,
together with other statements regarding HRG and CPSI that are not historical facts, are forward-looking statements. We caution investors that any such forward-looking statements are only predictions reflecting the best judgment of CPSI based upon
currently available information and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause CPSI&#146;s actual results, performance or plans with respect to HRG to differ materially from any future results,
performance or plans expressed or implied by such forward-looking statements. Such factors may include: risks associated with business acquisition transactions, such as the risk </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-MORE- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CPSI Announces the Acquisition of Healthcare Resource Group, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March&nbsp;1, 2022 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
that HRG will not be integrated successfully, that such integration may be more difficult, time-consuming or costly than expected or that the expected benefits of the acquisition will not occur;
unexpected costs, liabilities, charges or expenses resulting from the acquisition of HRG; risks related to future opportunities and plans for CPSI and HRG following the acquisition, including uncertainty of the expected financial performance and
results of CPSI following the closing of the acquisition; any disruptions from the acquisition, making it more difficult to conduct business as usual or maintain relationships with customers, employees or suppliers; the inability to retain key
personnel; and the possibility that if CPSI does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of CPSI&#146;s common stock could decline; and other
risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> We also
caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date
of this press release. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-END- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cpsi-20220301.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/2/2022 4:10:02 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:cpsi="http://cpsi.com/20220301"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://cpsi.com/20220301"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpsi-20220301_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cpsi-20220301_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cpsi-20220301_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/2/2022 4:10:02 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cpsi-20220301_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/2/2022 4:10:02 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cpsi-20220301.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g301274g0302061905604.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g301274g0302061905604.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Y ,T# 2(  A$! Q$!_\0
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MB#>2D$1G^^:]\^#\;Q> (%D1D;SY.&&#VJ\1_#0H[G>T445PF@4444 %%%%
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64 +1244 +1244 +1244 +1244 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140221432713912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMPUTER PROGRAMS & SYSTEMS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001169445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-49796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-3032373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">54 St. Emanuel Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Mobile<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">36602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(251)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">639-8100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CPSI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d301274d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cpsi-20220301.xsd" xlink:type="simple"/>
    <context id="duration_2022-03-01_to_2022-03-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001169445</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-03-01_to_2022-03-01"
      id="Hidden_dei_EntityRegistrantName">COMPUTER PROGRAMS &amp; SYSTEMS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-03-01_to_2022-03-01">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-03-01_to_2022-03-01"
      id="Hidden_dei_EntityCentralIndexKey">0001169445</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-03-01_to_2022-03-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-03-01_to_2022-03-01">2022-03-01</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-03-01_to_2022-03-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-03-01_to_2022-03-01">000-49796</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-03-01_to_2022-03-01">74-3032373</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-03-01_to_2022-03-01">54 St. Emanuel Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-03-01_to_2022-03-01">Mobile</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-03-01_to_2022-03-01">AL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-03-01_to_2022-03-01">36602</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-03-01_to_2022-03-01">(251)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-03-01_to_2022-03-01">639-8100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-03-01_to_2022-03-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-03-01_to_2022-03-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-03-01_to_2022-03-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-03-01_to_2022-03-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-03-01_to_2022-03-01">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-03-01_to_2022-03-01">CPSI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-03-01_to_2022-03-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-03-01_to_2022-03-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MX/U&2O-6L;?0\I\(DW\ 4$L#!!0    (   R8E2?H!OPL0(  .(,   -
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MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^
MKSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE
M?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @
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M6@L5!K!O<B )+LF5&U)=Z7FFMW>3>TFH=>Y!L/?P&HT=S8\?M_P!4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (   R8E0'04UB@0   +$    0
M          "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @  #)B
M5&>_8-+M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @  #)B5)E<G",0!@  G"<  !,              ( !
MRP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "   ,F)4'CA;PT@$
M  !0$   &               @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @  #)B5)^@&_"Q @  X@P   T              ( !
MB@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "   ,F)4EXJ[',     3 @
M"P              @ %F#P  7W)E;',O+G)E;'-02P$"% ,4    "   ,F)4
M'#AEZC\!   \ @  #P              @ %/$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @  #)B5"0>FZ*M    ^ $  !H              ( !NQ$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @  #)B5&60
M>9(9 0  SP,  !,              ( !H!(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  ZA,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d301274d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d301274d8k.htm">d301274d8k.htm</File>
    <File>cpsi-20220301.xsd</File>
    <File>cpsi-20220301_lab.xml</File>
    <File>cpsi-20220301_pre.xml</File>
    <File>d301274dex21.htm</File>
    <File>d301274dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d301274d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d301274d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cpsi-20220301_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cpsi-20220301_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cpsi-20220301.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cpsi",
   "nsuri": "http://cpsi.com/20220301",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d301274d8k.htm",
      "contextRef": "duration_2022-03-01_to_2022-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d301274d8k.htm",
      "contextRef": "duration_2022-03-01_to_2022-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://cpsi.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-22-062200-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-062200-xbrl.zip
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M%X*T$F2EB%[C:]&&Y46^NEZ*)Z[TD?F[$]DIGO[U!7WF/U!+ P04    "
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MYA(7)C>*FAHO0 L: J(QO*]]_U]1(%>]/NF.?5?,6/#F(LG;%W(CJJEDE"6
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M[34^D,ZG'FD>U*O0\.F@_QVU&Z*V#T;9!H9[PVNP8&#&W+\P9%-F0->:&T7
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MQ,7'*51%SO==\%%H$='G%EFJ!W X[AJ.LP(AV=R#B>: 4B1*)$<B<O528("
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MKG?274EQVK%R3U?U;^!>Z%)!_U5 A:G':R/IY,1 Z4YE>SV3[2V#3_5=4'C
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M.= HP"Z-] Y5+N.?7C+KCC![N&%P:K$1=0?Q J@JH9D&J"01[A%3W8&P1B*
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M!<>RO7D7K];OL,',EW&51S"%/*BSK?_\MX.7^V^"R^LX'S\["Q'=Y3@)XVV
M;7FQO8'$5VMWW:QT2NQ(V)X#VEZ_YZNU^W7.PKD!*5T@^I\.9>&AK-VI\V64
M5 6Z.\^C:33>BO2EE]OK[7RU?L<.QB ]!-_ZY9![\ZT?S)._YVOX>]CA\^O)
MQY/SHP_!V?FGOY]>;$^'E2V^V3^LW>=S\F46I<430UVR[>OV^5Q4HU%4%"98
M=%04\57*<&6DHP>LHS/XPXC!D)^.:.$1K;^NL8RW(H#Q<GMQ?WY8NW/G)"W!
M^@F.KO*(D@[>!+]G8ZMF;,%A;&\\[X>UNWK^#$'GW@+WYE9O^KH=.1<1['DX
MC+<CZ6FKMW[=WAG&ZQ/$MS?!WZ.TBMX$? O0Z/FO*I^#&11O0XALJP]FW5Z9
M$\2;YBPT D=QTF&+' +;&[/\X1$0=BM,!9^!E@I:Z\F7:%29-"A[.$]'LMB2
M6[>/YKQ*HH*[*Z5%F5>C+=&8MOH0UIY#L:CW]Q8<QO9&*G]8/_ZN"56R!&=3
M^SQ*HG ['![;&Y[\8?T O!=1B3FQ6[#M=XLW]K_M.KG_Z85RC[:3O_S\QR]'
M:1H1".4?O_P4U Y.C?4_OV&]F<B/J];I';07^CU_X.]__.$__+OY%6O[MB&2
M HM__^GCI;T9UW$9/2MFX2CZ*<UN\Q"F233+M';T#+0;?/Z7^P96ZL\]>\@@
M6[2+%]CM"',ISS8A8+=C#XA0@N7T].SPB8A:-Y";U]JTW"=26DY*SY](J8,?
MU7*\_[<3$Y_:VR<Z\??F732)4\0AB?+I$Y4(E1P_48F_-^?1/ZLX!S*1$/8@
M>!\G"(DW,&#5!:=J/=$/GN:[)_KQ]\9K.3)P !C!69;$HSBR=,1M06VWO:#,
M@F%$S"E.L8W $X7Q>9\\49B_-R=?PNDLB8+C,!E5B:V@_QB5P9]9_ADCL-(6
M_HF$@O=/U.-O2SWWV#;H^5]/*K]N#ZD8D!)00]HJ6/]'^-:?G.MKVLJ?W_YR
M<?GI^+^#LS_.CW\[NCAQ0*,!QZ'.< _:ID/>][;YZ#OUXC_N>)TNK^,BN"BS
MT>?@K,I'UV&A<A*#G1*__L]_.WCQPQL,$[B,AS]^P4]_?+,[",;42"FDB/SO
M(8S!-'HP" [W#P]QC,@-<9QD!4J]=_ C;Q1XSW#>[Z&^%4XSE(N@=56P:=B-
M_2H/IQS5E";LJ*R-]D ]"]Y%27@;YE$PRO)9EC.CW+'OD[IE]2+X&F>4I5%P
M#2.RBA>%HVN</WXC+:&")"YP8?"\B9#@./!O\S_+W$!-Y_0?OP0[^"IX:;]G
MY\A.6C?)@*8URJA1?7P3)?-!4'NX\)9T448W$8B'T7$&C\))X#)R+R+?4F!?
M.YDE 7WU.MRPWZ(P*:]'N/'  #,@G2CX-<^JF3N9/\/B&HZZA U49]/OU0B"
ME>O6(Z+"6SRDO7I02MV+PQ>/<T_/3XY/+X\^7&SF7A[M!7+2'B$$V6T*W"LQ
MM!H71867#TXDJ\I"&B($Q34<#%W($6N7P$GQBLNOC$'3>A+!!?U8'<@><OVN
M[7^<Y;]URQ]'!29*@\E5P"?XOW2GF0SIG_((F64SP\0F>38U8PSTEOG+I/)4
M_'B4D;J4NQX32*OX38D^*'AYB<^6UT&,U GLRG+#35#GQL5&1)4;9"/',"NF
M.[:+D^@*]GL>#+,*&1E<XF@X#T+<+F1.$Z#G[+;@0'/'K!]MVTSC%[MM7U7V
MOSMY?_KQE)K,X)U:-(/'.;<+2\6=8LUZI$%8(7O'*S!&=VQLP4!&DFXDS 7>
M/99;4A7PS\8%(9ETB[<W+/J]49X5Q;,\F@!=('(64@V^))S-$K!TAF N@["P
M+_.'"FZ1G.P,6$0TYX$3'[,/>2.WTY#9Z;+K^5A*YA&\'7'LK9[YZ7UP^=M)
M</SI][.CC_\(+GX[.C_9D&S[^2CX>/0[O"GZ<OC_#D P/=\_./SAQ?^C0M,C
MG/XAE_\%\$_43$(@">3(1D,E2H7O]T#7",(1:!=CU_#<L>P&\0RL4!&>A!(%
MF'R+2)$'C#@I:O*D*4@&\$3$TQPE44AI]"AU3M)1-1TR1ERPP_1:@DZ#W8O*
MJLPHT3Y,BPGI7()W":2_N[>(/S[2P>#.'ZJ=MR;!&4Q+;?M#9_;ZKC/;"7<#
ME#GA%9SE%=@.P0QG9*6W%?OM0IY.!8\@<3XX_1A'N.L:<7/UHA#U>T!583 &
M008'#>9*!8PI^F<5LGJ"/SD&Y9=_1\PO'/]5D34!$RVJ$!XGIN<39YR.DHKD
M**OCG-;<Y,V'6/^$W!E6A3P<>"607-N3?S_%/S=Q7L/=X*CD/6:+;R 7"U33
M)%DH^U^M,*&#YW>>4;P;S,(Y[CL9>WR56?#P 3H-+YO-8,Y 9$5EG\2C?_6F
M"-)P&FGA>;=L &, ]GLT]$Q .'@&:#35[#RS>P9V $<8."NQ9B36[+FV ;1>
M#P8WL$P4\88!P;6(IUAG C<,%+CP)HP3$L@$RFX$M;\A_BWQNOB^>3#AW>><
MW4'C9#]$U)N)C,IA!,0WJ5W^@:(!.-X(RY7#G'Z/PV03?OJD*.,I>3K,CJ)W
M=@@?I/ #L,M0]_!>2?Z,^^QO*#V0R:ZYH@ 3'I4>.F8+^1U, $\6)_DA(N>P
MW?/_]7ZZ!].13TC&+<10[9/8*+H1$,)-QN'GE6BLW[L#D9%N$)(H" R$@24V
MXB%F7O>\S&W$5EL7LYI-7.6;79@6\6*GVYT48$#<@MQ$QJD_8"X.QF@&?!2]
M6-BO)HCX6UFF6*A75/_HKE6'ODCKAN_[/?M2*ZR!T\/FDS0#722[ ;) O8ZG
MQ*(N+JQ7(1JS1^LVY8/!/VHSH\.T(_B+XM>D68F35V/.$E DPP(D5V%&)5QH
M^$V<R(@((AA*)%O.'$Z%-R]$F0/ZC]A;=@QZ>;]GMA2((T;-=%B5CLO1B^(V
M_;MM"X/F#I*7TY\1KG 6QKZ:M$P9.@1E@VXK"4=]9;M(Y7T4H;;%BL (9-?
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MC-HV1FTMG)3"W?S;IBT#N5<^/US%%/ NG'<LY]%-7-SMVM",6JY&+931=CG
M[FR]'6862^Y&L-+5J"_I@1>C/MS]KH6C\"7#MUVE[DMA?]UR)=ZY++]/!*:
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M7X;QU &S0HN'W+Z/4B7P#?JP7S[YL._9+KZA6AL>&$Y@X6.#=.A;)?*#5=@
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ME'K*2EL:EWI7QXC(*U<N[#]Q-L6WZ+A^]>2X7M<EN]KU['"60R7Z4UEI,<H
M&;#.9P6+6JT]7T%9UDZ^FT92OJ&"NM-E^,5ZQQ#1C-RPUB8+1=?EC"7OHDK9
MYTXH\'SX%?7K$30R'-RZW>J%H ?/#YY[J&3H7\MR] %E$LYTEYK2U_J]!G<L
M=ALQ?^J!H+4I"J85_F?B4,<.$.3!'M]WOW#6SK3#1&GD7;?HIM<N4+64YAJV
M*$WYE4I3?J72E"]QETPLH-:WTF4JUWLNXM&@O"5ME_TT%I\[-V+8UJ)Q,RA1
M<)JO&9@.-"QH&;51"L)T]_%L9J2R;<MI@5B$IU]0#XB=V^N(AKIA)'P8ODKY
MWX*7KU'ZL%0@'Y&L\])W_-XI'4W-U4[9)IY\X;&C%A=YBFQSB#1[P1\F[<SK
M'JJ?XD)V2N.2K5BP?Z(\W5YC021HJ4G,Z[Y;.\G#1CM)/#BW9EUOZA9," =8
M)-%9@Z9_YV<\VIW2?DJI=G=>OU2;KEW=-/5+UMM3T^<OMJ5FJH NI*A7-=.T
MO7]0$OA?%V[9C9YDI7U:MHN7HIM/+2P@+AH]=,K&^P<MU<,+#V+GBS!!AGUO
MV^D.YYP3-<@G' >6LQQ7)A6"-@+^6;=4[M*OS1F67+S7[#]7,[4D";=F'[M)
M&3QNV<:&U;F@Z:[5HCM\("Z*V3)-D$=3K!Y<:*ETSW/A)MYEFOW>SER=?.L5
M.Z*P%$H_ F0G))Z6C0?BQ;#[?5?T8(MWY2WH]Y03\KTDOW7E,=;;/%LD8V8,
MRB"=9FDT%WYI[UI8@<@/L;  VY0IP+)Z:S(E>CW)ZV.%#"-JZ$8W"04'<,D]
M3.S#7U@9ZMGS@R#E$'N_Q\9K6H,XM5,5[!(^$708N&4;MF(T-(^OB,J)>ZQZ
M1\J7*(3] L)&59&>S#+P!.ZS9GP'/E^QOY57&WH@O\)*;JM7)!!\SIU&I2%X
MAF9R6)DRBQI&]Q@#;Z*1X+%01Q&V !;JD1P[-^IOZRC69T(S#),B\QO&#6NJ
MF7I?[1P%W9+7:93H1JR]T3H-:?4ZI/I+TJK,UC=8QZ)D_\,7CV#:@J)[='YY
M>OSA)#@]/47[%C3?KVI<PPS.3\[.3R[ A#VZ//WT\2(X^O@N^//H_/SHX^7I
MR45@YM1A*SS:I'X].G]W^O'7X.+DPX>3<Y[6Y6\GP?&GW\^./OYCV;P>QX8Y
M^8)E@4A0M?102LP= 2?$UI3<0 .4?:K>HV@ 8N%6KGJY^3 C+,\-)_2L4F!$
M:34=1L87Q<V0,*->&(-V<1\A%E 2M?$*H#&7[V*MFON-X>?FQ.2]UP7;,W2=
MF5PP?'+LEHRM?RJ]*_1;7"TETYBKV3H]\D4LG]_NX+[BF;.?!)'*=L[CY)LP
MST,5*VD1@DW*\'8TD.D-R'L/E+28N3_?.WQATR?Z/8*1JL^LT%,K%LU-6K_5
MI[C:%#@)OKM[G,.X0NM54Q=NZ"ZK+ T>O=)9#KC$!_0&6#HWLLE$D3&XBV+O
MY5JN&$GC_TYJ&L?494J:PBVEDJ4/J!&!MSPS$%W68F/B,FT?M\G[\H/UOCS?
M.U#>ET_Y%4SU7\[\_Q7K;2Y$6WMC_!KRQ!MLG@P:7QSF<:2\,QNI([]4JEDL
MBER<FAX&&*^\@8F/2;V+B]+F\YFB(JN2&@]HJ^+3#2A.@Q&V*$$;4-]/YKD&
MCIS:L]RFPLQ#:9':WNB)L^#G1-Q ;M11?>Q^:3H19\$(6,#<.+L,0+_D]6%#
MA]##JV@;7CI%8]C!JSD0UY/PD;W6#78= L@^ PT.+=AZOP#>YZ*YU1CG@+W2
M^55%<(N\CL4AF'#AJ(QL/TNS5[09WVIDXX>GR,:]4_(I=9LL\1KTJ!B*TB6\
MAL\KO@%T#-]0U]R!NBF#^E69AI^-$U_(6[P#MD<A_X14/"\UT%%N:Q.-A5>D
M);1G%*5V 7T 3$_K9 WE<B-0!1PT6C+QX>*)!W3)>2=4S:&#:QD(P)4<G7+)
M%^QG\7I/B,M?E]0UVO8I$'+K/5D()7QA7^27S">9;DW/#E_!2^?:=.4V5[XQ
MHDGZ!6G\$L(R2S&-/IWWUQN+MJ'9;TXOTWKF\<,K4F?'!/I@8@W([P6*!P,3
MM)=&3Z=R:WIM?8N,KTKL 7@I)V>[B39^ :<L41#./*?7H]GO"Q@_@.(@KHMV
MBN#V%W3H(_DEM]_VJ6 O.&D]";77"#8N74BPJG$-U S2JO"ROJA6()=>NZ $
MA[D!#/?Z-MZYE215:F>9T73X=L =_QP)I UZTE56J9D,>N5<E(LL%-"][\Z/
MEFS$@"9(S!KD=PYZTPQO)5(#NW@M'.Z &R#99BJ2ZI+E%@67GI#X&WJ=G(D6
MCDA;<]XI^K'^K3'=+4T<68JR+G4\(@6 Y>B,+HCHD9H)$?9OE5#Z4CQ>S;Y(
MP0H-400Q_1M[X2/63#38 T\GXT*% 9IDC+<E4'^P)H:*;H87\,='#, U;_9?
M(AT7:]V4DJNKT7 @>BN\,T2\&7FG<3\7BH%)V/1,;*\27>SGN/T-Y1&M1?$S
MIAJ)>D!8R_!J"@#G+L8MJ5I7&$B4'S46Z11W?^5^.%>W#6J+D%^2$&>]NR7<
M"\LT5C>E%R7P/TR?-/<;Q"<CN)(<KQ+<W:N(\PK4/C%K0GPX#$-P7:P,,8-?
M@##F1ZCK-';7L%#/WK/6NVL_<(C> ^Z^9=J!B%?8*M2(_22A%'W8[?OJ;5_'
M+1KXZ0GL9S9(Y!*KQ/:J!)/'S0ZPJ$K^0F@N M'FSVF]($V'I.F90#X)*/B>
MB_2:TZRCJWH'*5L$&F37'BT@O9KQI +^6$F$OH>!]PN/"34F6IO93<:[CQCJ
MQ4#W<7*-XKG_^!=SR?@DU.GF3/N&5,G2$D2]UH;@\DY4FE7^:,=L-P&%0V+:
MUQW@VA6LNC2U?[]?#5N5V _65M?2ZKFZ406!,3"Q*,RABVXM$G9M5F9&7JI&
M]&46YSXOIBMO(AO4+$<I,HN0Z&M&S.'^_HOF:,&.U4Q9C-4?: ([Q1[23=<,
M.*QH"$V'+5G3:U'RZ*!$+.W(]V8 K^4C9VSS3/#V=29L>*MQN07U-0GF<OO3
M*'4XN/B3HP!0/Q%!QI;]Y357CY=&]F+_]9%.(WOCL[R.GDG6L!2D(]O>/I_?
M[7461T0+,)"(F#**BB%B6M"K%7B(M%(&+E5QRV1!NT!W+"LIG'$GP[ J2<%:
MXB=[2^\APW2E=3,".S<0=$S64KA-+1)8+?5Y.;TSH6!(NQD@DF!,&7H(?XRS
M:)\DJ9K*T@E,=;K4W;QX&>B:9GJ$+'A36]J.[.KYT$8(_9Y(G6(T;KL+ON*#
MD^*^..BGL944MF=S2_HVB 6_[2)F-IG>BD@-'7>CY:JVV(.L5,IA#@3Y5G6:
M\=N\K+ E'N0M[8L5+"8G87FV7*NE;O)\3,LS!S$B#:)$H($ZP[;;ZK/V:F?7
M1J&!(5!;1B!;L"$X,$V(E@&.LXB5<83V50V#L6H%_C5FHT%[^;5,M+\&@Z[^
M8_+1\L\]I\R G'A.G[2VH-8L^7?&)&4VVWRI5;=0<<NSI#&%^@,)SJA=!=76
M$;_WVTV=__')P?S(X;,?5?CL4(7/;.?9-^A2 ;5G I)ZTP#+EWY:#-X/2HAA
MUX;R9W3TJ1BX_L KHBOP8_JM8&^&H!%.D7-B6IWQJ(C1K\#15<K5W-:F[7H>
M0)P!->?Q'%T&FLP9> T7\-W6$40IX9.30 ZO0JQQ=4/XF6#MH%'+L=>P,Q2I
MWC8U $['OE<:^!5!$D]C.9AAF'[.JUDYFF-=%]J#Q+,*>"()<_H,$8I0DX3-
M&(%Y&J/,,WF[XBG &8.ABZ6)J+*!] 3E@EM[4I&8&H(D.2LF/!\49Y@_.8E'
M'O*\A?\"/1P'H7VSI6DUC&9_B9Q@4TM<5UGIEB!VQ&ELJ 4+7*TZO$M-:"25
MPYR)#1")%]X:N/A8LQ')8*6G H^:^[W5R9E, CJQF<$BFDE=3FE:)M86185I
MJLGC7<A?BI)Q%0/_+JQV!8S6',ITS1SAB%LNQR.]K:L.E&W6TA8EK':!*&NE
MB_SV6B^XG7\#MZ"!E2H@I'3/!IP$,' 9 ((@%,["D>0#",_5=-+(8[1[UT&,
M6L/GD+[90,D1D%N*W\>YSMUOM@!L?S>N^ZXO5P!/IJ4$;8^2/<ZMCH5+V/'0
M1%@E:6;NO%T<#B"/(@=;W5V_#ZTQ>J>]99L0S<-=^#.6&$]'@Q!D#_7F'MX!
M99XSG+>JO6G%D).D6_>,=/+E]].D8WL-2)I3])I/JC:*BV:P.JYKMQ.9&(/D
M(&?<7%=<QDDX*WCWL'**FO"6U]P!P?05(1?53828R"/1VV@@T]2D2AA70H=9
M8)S<B(M&@TZU"\>&>>,:5!N1//C5!;G4YQ.U3V#Z3"2YCA8+QFX5)KMFO^S^
M.:MLE:5@K]#%:VEX0]U-=Y.[SQEBH@-#GWGH>:L?@'7K>K.WG]IE#/S.R.8!
M1!R:A#@:<3R.-5)M RR+SX/\<TEPY!*W#$L7;,3L<\3Q]G&.M?5%52 FU4"J
MYP:N=H)&I_XX\\[Q)=O.!/G5T:^TG\(!C)[3_08B]YLUT7M+Q_@:H*5T_:%:
MVY9C"!:< AO@_JZ/HU'"TJ4Q H7:Q/_('8= YYS+P-S4)4$G+(OF*:8(Q:)Z
M^8R+E#$N.G"S6GJF=C[&S=UV4U:^&Z%3#!'CXU[#,$F0B[0%0&J5(6PY%2?<
MQ;K:>)A5Z=B0W>]N\>(/DTU@M\V-C0<:@B+Y@2YAH:AX2E63BFFJ) ANAZ X
M:7NRI,J4Z/?.\)P(BUEG4^S6)&4M_^<NN1:;B8B9K  M/9>HHX.:D*!CS"V"
MHZX%LE?/8H,.* ^./GL?)Z;2B\./0X0[$:Z34IX\-S1V5[>C%_3J3="6*3G]
M7JN68Y=\UQYIWZZW[_63M^^1O7VOE;?ON?+VO;?MNT\=POGZG'T'/]XW#?[^
M]2]HH'6%HH1Y-UL>NX"4[A"#7I$Q&=VNS;GM#=66D$[L?^Q:3LL3\RC,T:3'
M0-D[L \Q/U)RS@X&P>'^P8_TWZ^9D1SN'^ZW9&XZS]/[N!C!3/Z!67?N "V8
MD'9 F3BY"I-7Z0J+LC@3M541!TRH1_+.P8&,.H4#O4;N%&=C6>5'4.'4*O=Q
M?8<'"U=UBG<JGBY9$>>)EMD5HU%8MKQL3QI;*(^H#B>^X^[R.FH=2.5>Y 1&
M5I%:IN.;IB:@F;S!2%<3W )NR\$!6$YAL:TN5<9&&.?</*$0V(;V<2GB9R=K
MM)&!*,%T@BX[7!(-.+&+\FR:/Q4G3W$=3)+LMH/439BP\,B#Z: P#E:37:CL
M).=#L4!5OGN,@*(R1K)-"\R7(\PQ^!>\(<^J*[*-]<L(_\PYQ]H/CKUK S(<
M2<"&A8(PZZ8^[KR3(GO$/4<0-%0FEK(HO/;/X#X8%N70&L27+/E-!#."2C*I
M-:"^#)29;'P$[,2^ H7BBA3X863I8-?ZBP@+G+6#29:5,!2[K4,"4L3^[41(
M>":W696,I5$0YD;:T>"%DDR"75LXD.VZ""V[9YM0+8>[C10%4':!\U,G$*9V
MQ)U$E0__#HIY@;#XB#>(QX[I(Q)>+722_2Q+$-"QWF!EP$[>'3]1T%AF.&)J
M5#33RXV]PJGN!3=&P+W$,A")8\F%-SQ"C#V^[9I)L+,U+LQ]+5JM"X46Y'B*
M:6"GYH*1 #96N.C5>U$>R3(8]\GY-]DKBPV)^!I;CWVK7.EP@(.6#'9*/#*P
MCK3OW!NRI0""Z1RF*&V7%/8[B#35*E?)KSP2& =2"HCKMLR%TCYF>4R\7+L<
M%O5)YN3T%-1-W5["FZUB>PLW'J]USE274Q-,L2T%4!*3.VPU,4IPE\T]XC;/
MQ.^K(F)'J"*-Q78G[>:(> &Q9>6;,-PI%:=[V[%NQI#$;'=B=TPSTCB1N1TC
M['"[Q5N5 &X-;4\/.#(CG-N?>=I3CCR0V.$0C@RV8!SYU\,T5\.SPTMQG%4Y
M^7!<!Z+_!GF01&.&[[FO7CO@()')N*6.'H5$S_H]BJ6A,XEZ(*#<GU345("A
M11IYUJ003"98'6$"7]I#T=P4'9IB.LECD"36%J<_%VP&25#Q!(TQM8[;DD<Y
MMBYR^H!FVQ;PGP7S6X$<O;B.HE+RC_L]#W0LU#(L'(-&4% !)K:@,"(_FS;N
M17.UM!R*T]@^LZW3D*ZS.#;%\5!1ON*JW,+P<+<2Q>&,7.A4JU15/H61''9+
MO]<Z8?V^;-G.F:VG4QF&&+8;EK[07#0&G'I;J19>E?5L9NMFD2^PK,EYCL29
MS+=6U-&[2AG!O%&L)6#.8J";F:W4TK<[V,H9_Z;)4Q9<E=05SZC#EI$8,3*)
MTW]68A%@_L7,PI#Q+>7#0)V&Z]1J72<?YSYZ!U,K/&FC"YA!8W686(/LEH28
MP\JN=SO!MYQ'##3KI;IM,"'1RT/D^%/,T7E*.923F5 FH&@$Z@%W?6GI<A9C
MRYX7W<=!S<)OZXH\T":& 5M"TZ]BT.$:W[D+2-PA*."DYC ^2$WK,9#1>JV@
M8N.GX_HM0*V-K@',810M915"OR012Z>W( ]@]+,=B4TOLZ9VO7O'PQK3&:EQ
MP/+-H/H/N+J,8#D& @J X]G*[0$7]!6,IFI#8BXZ:<,L6)8JM5A4WSM!RU+@
MXK!P*J(F5:B,85<G$N/2N&H0\.^E93K'(Y#+!@7AM9,%HHK2;O,LO8+3)CB;
M:VP\QDH$S=6D7IE#0M],EL,<O(*\UI@J_?X,C2-J[[BA#C!GNG3%[PFON32>
M"3#/*RIOFZ 8H_P)!N.24NRA-1.9G0-K&EU'H\^X2*.$PS^O\G J+JDD"U..
MMO5[!R^9[/_8N]@[WN-_OWK^:B?<W7G^:I?0?\/Q6 $+8M^VP';-P%(_R@K1
MV+\'^X?V?AZ=GUS@4[M64H)<NZ(*"$F""QU@&_SHWU\,7K_X87#PZL>]_?U
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M+S^M!B-/7T8JO=\\9HJ2:Y:FG7B_=Y>99UY?$(,DHQ ,PP9T(;^5,0M] X<
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ML=^+#?QIQI281]3QC#LU8P$OI2'X^AJ6LT]0B=]YZ>MK,#EA+*80I_,:[(A
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M.RW,$T4>!)6)9QL+'M31? 6-)9'CXBL7=KX<$=.0%:,LULR(WFC%<EV7M^'
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M2\:2;)J6SCM$L3#(2DH8BLY<W8E^YT/Y#0=<W$:7IR.S9TS?A'//6 \8!\T
M%X!=5Z)T5-FI54!G@(B^=+TF+R4&T>XS4JC+=(>A>NKB.2#%AX6="HLX!)DY
M\I22=8HZT9#>8$T\&D+T:LC@8>-"T!, S*V,D40RRM,J&L1-PTSY75:?PE:H
M3\W9>@W$'0069U@_Q,<F=7'%I/W$))XF-^@C+]FUO6)(6B5"IY'TC:T0,F,
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MFXR3;655UED'3U\%;';%N7>37UFNFDUF<@A'HY$G )><@5!2D++J[1205H'
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M'^I 9X4+1?(V0N8'%881$](]3Q'2VVEY6!>W093>56-P8 NK#GW*%P#)YUZ
M%5?R^ZRN;\?9Y&]5>-"K"&"Y$>7-(3#YS;TC8*GYP1Q=O[M'3WUK&II %C2Q
M'D#<#\]B42,4_["-5?0WY7#P.+M2V?1^BR8R+<K+-_[CLB[&R"WC"M/CR'^I
M0OO?L["?JX7]O%4Z@V$9MX*/D#84/DPZ;E *3(:57C+2%"T !.1FW$VRDR4V
MGW'?\:8>J)1':KUT.:XDV!2KCHB>D/WR5?$&05P9AR\>.Z6RE$UQ4RQ:K O
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M$0W(]X2#?:EPL*\5#O;$O&A1%C/&Q$,//@CS" 'GF7-$@^6%$;!%JF%^48)
M+-I%MJI(LVL(D2S6P+.S844R$$XQ-SX&>((6(0*Q2$'(J82Z9F9A>F/U+$Q4
M4M>([2&;7F,>7^MD2UZ;:< 7MGY5.B^$*R$)@>;<!18@XZXMZ2KC[);I.04X
M^$NZU,ZN&GZ5?I-MM,Q':-1@708Q:T&.PX/I_ZMY%I7[84_=W\**+,^-I:PA
M';T9?E<7SD097CP-!5W%CY2KB);O53&XOC#("P.V*GY*WM-M;((=5TP;\[ V
MQ,P^SRW%G6.L)/Y*OFNP7ZOY%1L[P7RDU ( SW$ME_'):65).KC.BP4**P@Q
MH%UQF,GM65RD2L%CY44=BZ!C :3]SN77%*?P0 D1IKOAX/RRJ*?/B#/S/?#M
MP&_HV.!_SS!7CHSIP8*&1!,X=4NZ &@X["E$)WA# "J*%CH]VS[<Z0];5/TN
M_==BM8W9@L'X*A'IKNJ\$0P</Y[H_B6&(XYL*EZFU[:>4\2^ F:_%TB@CPMS
M!D<5-\:FTM%,I6)B7)VPMQU.D (]P\&-L6B;"L*-O/+HG"*'M_?-_IJFH/\-
MT3I66KR;R+'Y. >?5W=M^@LD,<;K '87')M\7A 8H_$&;=9:P["ZN\^=M5>'
M!6M8/9N[>ZT\RMLA37NCC <PE;Z;ZAGB*(.UD37!RO+0][RV:%VANVJ%-K!<
MRO3))_W(K*Z]XWM5@:#&K(EFAI"36X3<,#N/@VOC,!W);QFJC?P;'#MB:2[.
MA>+7G2%$T11ZDH6]4.%6=2-B)%?SK&22.97Z7>19R63&O*"2%V]>';HE.<W?
M(HX#!:#,J?@_- 9F(UP@IQ$VQ0>VM@:7MBUF=;VN=-"K$7N7O4*5)##R9_"N
M@!>_)70:CA%535K@NM3+VJ:YS6[N26RUT)ZR9E'C$1Z@PS8&T34,7R2 W!GG
M\^H&WGE-PX$Y1X!8(Z#+UIG;N#VW$3N^<RTY?%6@20Z;BQ,20/H.5:8_<-3\
MX&?4_!&!VQ\K8!:UI !RJ E6&9Q1\F=B;A!%^)"),9EEUQ4K0OO190LR/#D]
MB]8&!T1YO&[)>B[Q5U#FFAP^W]^#K<5@RP@6&Y^F7\VG"6Y:GWL1GOI!-]/C
M7SQ"#GX;L[=6-M'(VL]9U+QIJ@D8UF:S;FI%6&Q,*BB.BY*KAB4[W6JE.]&0
M*YJ]O7.H80LHT?!8<_1QTJ;&;XW[=5"]&SLQSEL7G3V4S=5T3H5T5$9,UHXY
MF*S68[P[>JZ)C C$#!DRL5@\1N7_O:"67[1KJHB#N1?#@=<--8ZY*.79^P0@
M\KY($@<>2*D.W!XZS?][94X"=%.@UIFYM^#R%1B_&6KS%?W7S*KY-0Y8;V8;
M0V;^!5LN1PG!V!N,KMW""H$SE<[PG5=[_V+Y2[RTK%7?M;>=WE7>+>DT5$_*
M M$2'_2MZF\Q<&7HSF=E4]*R\XZC><8L$#N:YJ4]'\&J\FBY$%V!V2^A[ZF<
M_."S#OE!,_\+1'>$,2Q/@##=^)P^,H9.%FS=DXZF?ZVH)"O6AG.I8F4[CQ9#
M> 3B8LJFZ)<L4?XLC:[6X>"AR_7D]*COHB2]DP4S<T7MJUU,[Y9@WU%DF(7(
MU'EDV4\<#A2)R/)93AS;.F)GZ=(D]D^.%A<N6SXQXT=_R!90N8R!"\4F&B?I
M_WXC%TAYW\&)#-.M64\C54A<W4W5U6ZI 89(U4)@B1RPPH)R98;.$EZ7CC.+
M4D6"I<:Y:7(U.9"-X8:Z$)5CS5)5F2O2[L XF^,%I\7#F^F?.>3X <X&,?QJ
M90X[R9R?E)/=X>!8')XS='@^6X>'+D0;RE&4&8K$2M6Z<$BFO2;T8F1.CCLD
MO-^P^M[WIWK7,B9PQ%)E5VRT)K3I(39-5G/(K%DRE-<:7AU<WNHL$POJQL;-
MO*-O1OPX*/X3]QZU:<9K7-;_#(N4@Y?1A[3D4#>+OV7:0.A.^/?WE*9YI=(T
M^WLJU,)<DL#W18SN*MS2X1YHU(Q(5MFHA6419'M82:31#-'LK26UZI(H,]-R
MU1)T7AJWF"R)K%XFL9CV)J96=P=+KXCM:R=SSO=L54,\CX*@+-0F)X]3>C*_
M9?2%\' I@&B:&)?+/C#_:JP#BF^ L%#!%ZP:+KI,\&DL2N;"[HCOG[BG32O]
M12Q^HC[1398Y )[7V(CZ7!KC3$5I% SX,)R_(+JT6(U0A-4IJ+ 0*FH\P&5U
M<?$H(W;1;G-5=QX;(_7>)VBT#NKZ=06%\#[-I23]LMA8*&*BM&--#@>KJZF6
M$:?M#T%?(!TARF%[N1ASH +VHY@%83IKSY<&W0;E'S7L(+FOA'R#R<F7Y-12
M>];Y;"Z0!W5O11QNDHK.;<[481DPS)XMUI/[';SX!E$><S(=G9Z?O/_U./GC
M)(&S:$T+OD68R33@Y-.'X]\^G7P\>7]T?O+YDVW%D]+0=9WFKS$^1>?YR]U]
M=9R?K8RU9EPX)3V%Y[/;!U@JQ_2KF"Z:2)P]U2=EZE"35DFPZ]BT5AVY[9-<
M> ^*1;#4P4*$38B AP;;Z@M8R2/7"7581A./.8XK+<R!LLIM70""?<A8I42T
M'&X($Q";P$-S;])%?N',LA\R@OK\9P3U\=)6+SU-PS!>\%D9'F;)RI[DG>J+
M*2FKJZX65,'7ME4)<^?E^;1 9KM(M)\L>']A)^=);U3D2MOWL4?$U=@#!,3=
M6C(D#OEU-^JBMN.L8T\,6\2^-!F[J= >_;X%EM\A$24'"?3/KK+;E%"<YO 1
M87<+SO"?0U).YC#D6$)B 9X$>.ST]:%FENF5&L .-LRP"EH6C5H":SC5P%^W
MV@8Q^R6U_$AH3/]C.^E5& RE&)"!A%,VP9PZ]-@B ,E&TO>8XA&_I22?K]M
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MH^K,EHCEWO?THRY'BW+J&]*[PX**)9UC"VHXN.^*BKQ!G(W?&07OK;).?MJ
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M9YP=^^RKO_/W#KD_<4/N3[QBT"W@.";T+I2A?W#HO4L/ZV0,9DJ\F%5*YFZ
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MC;M5RSE[;K@T%^;Q&[Q+R^02U_OH^"2QZ)C'P?@&1ZW<NK4O</"<^3>+;+
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MYB>2Q]0F^,+?%+3DXV-4J5*0IU<SN%_K"7X':,D'H)OZ]?Y=%=6*&''4D9\
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MIR@8NE\:DO%3Y]"GHP7K:Z\0J+OS@)/,N?T##=N%'38-;)DKWJ0)%3N\+0@
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M&OQ*>6(O*Y@LN.[':(U.O7<1K-+@?3TKJP)^/2D2&.W@77F=(I?Q/\I%,9W
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MP$E@S=!J]$B7NE?[I$OOXZ:<P0'+;I+C,#A^?/RDQ[S4B2A+!LJ8.U*3Q#:
M1<BOH9>NJ$ LC>;0*=%R:&B6,0<1SI:4<V\Y,9#(?J<32VYL U\K,1DH((18
MM1'N/_V5=YB;6&Y_,^=66]"?]A?0"F#F.%FW+?23\_NL+G/B=G9+W9S?)0>3
M;^</]M<E=51^E0_VUSS[=RL%ABBBVL)^X72+(V!TLE):*7S!:HA>H9FM]!+Y
M</CY!Z2>//X:D;K_C=PIP1\N^MY8L6^S:]^W#5TSG?0O&E-2E76M<>;AO*7,
MI*\(/;:%ODZ7A9/;)I5OUU3:TT'SMG507A;P:RI_014 6]C)8-Y,R:JIY[ZV
M.TM1B6 F[812#IH*S)\D5!)H:*[-0')K0+5CH70D='NRB*ZXK'R&1XTF*V&R
M<U9Q&'V51QB*Q"=QR\8\?2E3IH\CQ_D&3#V).5>%_2+D_)8EI=B 6GA9RC]8
M(T I*$@CC8[%@A-N.!W&^Y!0UHBD]DPG4KT1R#.'%$BV_DF%+$WNCSI,===4
M*'=X-N9M)<D<^JS+LDRNLSQW$AGP#EPD;G9%+57^!2:MU0X4"DZQD^-&7@/W
M1M. <:=3>&!UE9LBQEM'6A\"2YWMEJ0!W;X[WSVD[EQ((M-=NC,^5(M)KAO,
MZ,/,T> ZG068W\^[RWR=P).@DR(;G/H0W::I<S'2NI=QB=R!)#^DN 9SOK[*
MBSM,W2X0:SHTI9R%#RQ%MW=_41LF&Q?%?C,4<J]??WH6/GGZ9&R$H#OZDGN]
M(I]XQ\'=R>?&IWUF749GZJ:N4G#@@77Q/3DRJ7 NC9(<I'FO]<__^O@Q2_'5
MH^6CX. L0J+0F%3;PX#E T@R!!^*3-:H?>X9G"!E\C#Z^'.)&,H#Q1W7L A!
M;T9]6*!W4"=!R8JT-0W67^HS1,\^3Z^R>HCI3YA4UYQ-BBYDXV!.TB;*<KJ=
M/1_L[5'X1"GTE!>%+L0*.9V9H34.7F4UYDXGB E)2$UJBTG]EK0>DU5+;**3
MP/,PIH&71'<:;,'8 +P5^OGA'@0&31-$+Z'(6IZ7U[8&FLJMS0KL3-!T8F<(
M;#>.8@]F3@S6X(QBQ+XG'Q@<#V"EYE**N8WS'18NWQ$[=V %E])&<5C&0PGI
MH.90X0R**WXWCPA5_$:4$S]4RS3Z"/5.F(S*B_=.;WPQ<J!#YEG0GVZ=I?G"
M+:+YG!U^3[XZ_.Y]B55#.AB#0]$.)Z\0D7T)3'E6_-86<A+]UB:7''/BD%:(
MVRNND+T</>5US3\RE$!(IRDAYZ[*M(C(3P62.<GB1F4//+ZNR4/.>,-D<KB,
M?YOB6%2*02? N/9(!ZEB6!CK-3&C\L'!-%-TKXZ/CX@#:_+<D6>0RE*XE$AP
M&93^P48M^QF@_\;*VXQ+T8(YQ@H1D^FP\S)"ZR"17I0$:-%#Y369R)QL@O>K
M>X9!D!%_#\,\)I75+YLQ:8J@@LQ3 J%#5/VJ*LFS6!I0?HM+R$^FUDCU$[9%
MTF@HF=!&E*#C55E<SML\2+*:%QU[.)FF00 #W]EPE"5#(\8[N,B455UEI04Y
MZ$6<QSP4JNR2B7HN+ =&;YV=@@Z$_ML?09Z-V5B) NR/[;L[ \$']QVE6V<1
M>M>S>'![K^1'+ETS6#$E# 6>-38;9VO*U^G[7]Z^.GKR%S4AHUH(%^T3?\7"
MLN#'-,IAN[]WB"C0^/H)ZQ=YR)X\H3CRJ%X"S 7-!AQLI"B&FFT4[E:[30*P
MBJUQ>]4,QLALW:83G*9K24&F0*SSV0W6PF\8?(%I;F,.O:B,/T3Z T2/D4@;
M8@2[!:(K+0?F/SH%[?2.LC+P=X[[L"DO^=UT;G B%1[#FIBB!"4<WFXE?'_W
M,ESW>52-"VND7XFK;Z< EG*VH/F<?HH,8J"8MAS=XNZ7U<! A.*^_1S]K80(
M[3A<QY%\Q/>!3@8'(&M0?S3*PC)%" -F4WCQ?6W9&Y:,[$G?.>=SGB%)L.0)
MJW^<L8TWH&4?>)3%29G6LH<HLBHD'JRS$.AP!%^S]FD.>172F&9LRH_05^R6
M0)@EADT,NU3)#/'=R4!F@+G&!4JW Z!^!M7^#'V5[E@FG.2:0\.]K,V[45L'
M$N<MNA&5AN?DF7++0A1?7 '$G1H UI54RZ,9PT=RJ1'>LTZ[MU!V=\J;#I3]
MFD,CKB]MMA;N&*JE3IUR<#P8,F+4R!2QF..Z"2ARF&]#N,<%RC6T'2+,(?+!
MR&R'P:X ?1CKVC$9![<@[3/"&)'H-T6^H86(I%<O,'-&B+3-9!BZXYKYQ;LU
M-T:EWEC0>NA-HTEWWSZ/FZ##QQ4(FX""[$;PV-,</K:A;VVZV.!-08_#S4;L
M2<"W!8@+#>%C7AW#);.]2D3B8#W%'^W=_"6>HRUCK[28>FPL,OEL\BY3(0&3
MA.2'QPUTIB#3#E)/;WX(<H?$%H<I&0[3Y%H2) ?#\+%P)@1]<5BO*6]ZQAFF
MO*5UE&' <5$R;4I,Z=_.;3.L("L^ILEFG%=10=RL3[Q"/DDZMEU6C!M"+5R4
MH&VCRNA:K1B8#37>BD@F>;I:E 7(M1;II4(7-F>)/GAS*2PC,),=5K@C]DS8
MEE7F(L*)P!@)'%7.KTJ."R<X/)[P4LH9+5[ZPEZ*PEYPY[1= D%,68^*-6Q^
M?'NF[726I>V(X" 18,85(_<YF"*SK%RFF#G,.?%D//@ +E79<+8^D23T?C26
M>^ABN1]IN!O-=1#$@HKEWWV9EIB&3:<8 Z6@ I96)%/=R@(G!UOAFCVV XNG
M8S&6.>NI;C7G'_2XC"]M"(@+JXQ0AR[F*6)28XE;%5T7K!\89':OOD%!FD!]
MP(YG<O 1ZAN_W^ZC940+7!.F9';7K#83*C&M /2CX4%&XY *<)JL9]EH!J^8
MW3_L_=(&XAGH[P9W=@9ZX7S+0UZC&DU):/S9SO?0:L!19YR^Z01;?"FC.O<?
MZY%ON&/(L#,]!TK]!>2?'G]U1]_[V576S9%A88\^;0@)TLF+/Z^1RM@( _Q&
MXH%=./H9&%(%U>DP[UQC,5D)E<1X%92G2"S*"\SW2V"?<4-V/F=$36P/I])9
ME>KHJH%]]T$VSNJ4P6L9^)*7\*W'63&E&H:,-J_J#?4#S0#9,-+G*6*/WS*2
M]_S1T[$SY:!;='HV>& 3"M[@JC$HZ!QW#A$T6,#%0F%N@@F=9Q6R2\"0U*C+
M=;XOYW/4=?98U7%Y! \P]!WR&C0>J-*+EIE^B=[G%1=A\3?(=*A5)>:JMM$_
MRR[=$'T_[A1T40)NP"GW+'PV/J><]N">T(B'H1-&[N!5%*^)_/(.S(SCY_E:
M#\PPO2S'UI@ZK=)/$NQ%^SI'HDR$2LQ3K?JRF53&^8:6TI)\-E&LXJ(5)CC]
M)D65,N9L%?T.F>#;C)C;&U-5MG(P!$&?K1A,4,BO,V863M0?$ N:"3OM8F'G
M1E1XAFDPD>JH);X[YH5P*]@T0<RI$<:1D32N@PXBOOCX8]#W<[3Q,G1@(T^R
M5Q\:NC3IWDN915WUZ]PO\P(;A,H]F6B%J-,.V;X"8R<)70<9#@S7B:SDT&;0
M6CFT'WZ8_<RP\C@+\\ B^U?L@T<F5UBMZ$'$F>G>[MR+MW9_=L-5ATZ CVI]
M5DV(M'4$]TJ+H5[(8@/SCG(A* C-*H @^B(A&7VB$Y3_ $L\):YLLEUS78\1
MK(MUG3$BZDS"'.0FX&Z'BI<<!H1$64O,S+XI]"N$J3RHC<W"-7"TRFZ$WQGO
M,QO;=!H[7QI2$K!^BV#(SQ1VXUB8M-'"Y)-K@(9P3%]E52ZR&7D1=^14[8Y"
M/WGZ ,+03!,8X52@=0K+H5\)U75/#^17AVPK46(H:^4'@N[$A<D1SKR\X-"C
M:%75GU(1''(4\EAWXKBXQ3K7=^"E]%?.>ZM!3.6;GA8&9H<C(<$ #VFO34/8
M3THPX[#8;FTE/J/;RFY\YU'PNC_$"IDR,&6P\AY9"*URQ4020YW6AZ!7$\TL
M!.TB9\1.<^3DZ*D)K(ZN4@Q26]X-@_)3=C6^LN3!(]ZZ/\</0>_SD1Y?(FW>
M9O(4!]W Q]LDNCWU;",WE5/OP C93)Z['DC[F$[\O ].->[DXUO6A(8 ]^$M
M!6A=3T0:&,[,5]%ZD(YG;)>-A\DRG1!2R^TMA@XTR^?L6GWZU;5Z_VO-)1[?
MC#)+!>?*!<MJ;:IG+L?IF H/0]:#*$Q.[$;2NIAWPQS2WAO8HL"XEB$'TU*.
M@/ND-E47=WY, 7G.N/J#5C&#83$(%D6/</L*$#^,YRH3\P"^^$A_K-KEBO\H
M6[8/4LRQD;]6S=I8$POJ#Z999P45S= E-5*5RQ/C!5^LCXQF!&3&ABT\8B7V
M"(,]2I5,R<_@N<@N*R8IAZ^Y#XXC]BJK^&$>&1H8*&279Q5^G922SMLV^"<B
M)[5$LA)<1P3E<EEA2JA\R!EFE"] JZ.=Z2>RAR,#BT  @=,)I_.@2[_-\D1,
M(;1L*'KO9,@AK<(G_E8O%7*9+@V,A/+18P'G1]%H4M;AJ$<#,\A,)[T->Y-3
MX=M'3X['1^SBS@SR2MW(['HHO2$!E0<GL'P2V@V]",I-K<D7!\GXW7+UK=V&
M)'&!*8<9_&T/!Z*0)F)#.2)"PR$>>LQ8L50/E)7U?^"&S"E<C'ICG>8F.2+B
M/:TY6%%RE=5"RRJD3,KX6_FJH]90<FO'/3?8)0/+X@3.AJ'SP^,.\?5IZ <L
M.;@_>B!]4 5[F+/"J6EATDL4  J]?[I&K.F?:*7P@7)^^A.<%6<P9?C1(5O0
MI(^#LS<7AYP6*4GO+A>9^Z@?W_XDND9<2O5*PCY<E\<;%S&G/,28Z@AGCE?_
M/](F-(/;E2G3"8\MIC+^3X4Y1$44O,J:_^240>_ :%)W'<Q3SEV$C7#P7(:%
M0KH[2V==*TFRGA6TEC?<'6O_N66>R>8T#)2<O5KV,&9K(ZK!C4Z"YYVPSTB]
MD@KIJ%Y@@1>E( VG$>Y'$?H2%)GIA!Y'#H4A,E!]Z1#^Q45;X0TADF-3RB:C
M=YARLEWWOX+QCRE^(_?SZY.!VW5A86/->](M%[H4O.:&N;T!_1C^'2XKL7 4
MC"MQ^CV_M?/JN3K%1X05W39#=^_8J ?O!FB)+ZI70]OCB^C@=JBB+ZI?*G$'
M]<)("!A4&,_63BG*9O@C8G= -$9'"D\G&XG'1Q4]6PZQFP_)P$/Q,.6GNH.R
M>>R^ (_PLZ\>X?M>K1>O3P=7HV]TBF*;"?3=:R$D1G>OU.N/*81LZVX=-GGR
M &2I,\@G\;#8]"]!H_K)7YX^?0"-WLQM?]LY>3%^HNL.+K&-L= 47>EXB88]
MR8]NA?D^'&4"4\1Y  DFTV(MMLF2T&L526'$\VZ?WNQM,TXG?SI^3LFIH99J
M\@7U M,N9D@A%F6Y0DSM1 H@9P4,'H*=,8X:?%TS )M3,;P/0=HPI1Z7MNPR
MZ(5(SR>RXW #<C]/)ZDHN>BX=$ H U/U/!@?[\$BP*Y"HA.E-%%TN.U#Q%UH
M\$9G/;UGY^-.[\Z3[XZ6L$X6!J.B*!!JK8XLVIKO0I)@O3*X;6\;3SL6_%:"
M5V"7?LK;816M]UL*![@6M&0_P4S+;-9JC=<0XN0FYJ2]LWH.J57P7Q'$@C"J
M)+Z8U[J_+.@WY,$)@0ZX)7EH.S][N995RF/N' @4^"T:KO5# (955$5$$L\K
MR5^@(_?5KNHR;CO92\2'=,/TI9']?=JILIAS:6%$Y=5WANIYWC%3Q^S<Z_.W
M%R<VZV P<,]*2Z!@#D[Q913@=,.Y(V&L2C"V*$F07\"25$:#^_\,C!:3&Y&,
MZ:?60?B$(7OB@O)8\S;HFW3/N<E$]S.R%,C$N?0-C$$D&>.=2\?O^Y;&#72_
M1(=U-=!=P3C#\_D&=+I/60L(#CR4)HK2(/P%6%J4A?^]FNURQ??!13N#-9A%
M%=<N[WJ+!L># Y.Q_WWP<TE;.\]BY$>-<ZJM, H0'D:['SO;_MCO)<2$=5LX
M8*G0O.YZ\#-Y*H%RPU-V-N28;WA9E1\Q?1<.]3<9T40=<@K_S@=0MBCSE4\G
M!T22V%W5WP0;>TE$(+T!W/>MF0SBKK=Z+QW7"+H)]^8V*;)E]^V7'\%*]+[K
M?Y\K9[H.P@Y%BH PB9EAD,ENLK1VSS&N+*Q._E^^M.SILI]0#KHR^49"^(5L
M>P3DH<*=UDF__=[+)KB@1+%]9.Z3%R*3T@(THR8X R5_K_N^=:9,$+L/P[VD
MV)/O^%8R0T>>QGVP_ W[;0]!^N&T/=B8_N3K\[<P5#YGM_OSKV[W>U]WY;P!
M-;)O@V#^:8N@$K5<@6E3L+2$:<Q\RTFL+M_,=(*N$L1AF44U<U@M5UFN2')-
M6>8!\Y[P#W2@+6$)YWAQGLTJTC QNRX7P"=.\#$IL?#E(KLD4L+T*LUM-27#
MM:5-5*VE,R#_+ENDD ^AR6T5ITJ8RE54_($Q$#DCG6%HJA2]' @\)4:U%!0J
MO8%V!@834=NH[A'L,&10%2(=@ZLWJKG!8#GW5=S^IQ?AB_$K]B\,+N8'J2X-
MSFUQZ0#]VE"NJ%.B2D>Y%JJZ=:JU@>#$Q/]LR405B'U)WC=]A/%;]L(B#HHF
M*G"$TZ>WX34;@8C&&58/]&3(*3&=W 2!Q:+3[ 9AD<+O!P=CHX-"B>_81\9-
M:=KJMCGPSQ\]&3^[VECR/8[<WFX!:=Y)K?8 #K< (7J B1[RH5D\)BLW94AX
M6$$<;#$9>YB$X+\Q@F'Y3>K_><$U)5IR5R7ETZ[*:Z[>J:7B=BX0B_2*')I*
M&)DEHJK ]JL2E0B&+Q?!Z+'?\$"3^IQ*9;VE72_9XB= QC0UT+FX%B*.#R!(
MJ!3\"AUOA17Z6_ &*;82->K[(R0_KH/!C:,0G31RKB^&?_'NB]Q*?0OKZ^*D
MTLCVI@]A!&X_?P<.<90W;8?=>7,>WH>U*8V-3W1U()%__^&=3FXSI!S+(45;
M@GO84;WI&DO9X'<)0.,7A]XX]/L)ZXT.E^@&8XN9.DY)0>"\T48K<\;X2SKS
M@/=-)YUW:23I,LH8?0&$,6ARAPH):(:;7=5484'TK[(SB$P>+- *MJ5,M"E[
MV+];CX(/.,UIM13MSDHME;ND<J9,E=N=/HZ0F5O&U%@^()CG60EZP.U30YZS
M?W+<;GP:#%7,4TS)SD-6< 2"!Q.CVX(PK_*0 "9S CY.P>1Q)$@3?<("0;Q\
MC@4YZ2>$I"1LK&76+D-6NZ@*YVH=PF'D,+F FI_-YZZ!P"P;#GM[X#"SBP*G
M;#"&FYB<+X+*L %IQD5Q]6I3+ZN20$F1ZSQ$K%/S-_\BZ"QUZ,!J5^4ZRO&9
M,?O7S1^\WT)"H18K2XI#H.-74=ZFB+2*[=;-);^'^H?"KP@?"<W($J3W'#\N
M:&#+.&Y7%IXH4106;0,=EG!CE$N.%3VRPMKPE3BG.A^UV50\:0%?# "GO2U*
M N@&K(&ECPQC8>51H2!N#JH?K1%]B+!.&U),BF2..]U\XY2 PGN<(M"!^-?S
MOYRX\:]#/-_6>&)H.1BOJ;9P/R59;>A9--HF53K806( "%;0<;0N&8O;V!6%
M!9U5#F^2FA+KKZE6%IY%+R6X*DROT;%"M:O)CDSIK,!:8<Z)W22PNJ(5%Y5>
M2Z-2V8-9 1L")I17@98LP!\-NNE"H>VIN0+.E@S 0V#Y2Z':'B4UL!Z/4%YQ
MR@7B1BUQTR)$%*'L*,XL[F7>ZU[A-6IBZ/%B(P'Z3 8GG*511GH96@UK@3D"
M 1 5C=%$3;T%22#86C0AO+'T-!4>@T2@ZM&S#NH[:04P3'E.]5D@>8VV*X=Z
MG_J<VE"4Q8H!0JQ&I0A#B=(=,M20O)E21NS)KL_3TXF:#2M<V^VVUN4=@AYB
MPW<), ?>WDO3@EL%#RHP+'L.:K$AM7:X(KC#>A<_F#J.6XA7$,P'>6FL1*Y5
M)-<DT@6X&W.O&>^8F@M27ND$3"D+=M 0(5&FU%")/8/_J-Q(:5T3 A6675ZV
M$89"I0)SMO:XH!!/3(&C\+%Y=#WR.1J(@[YWGN)O=71%(&%1P])"HS]4UYH:
MB2VI6B%I9RY(=T6XGDQ)(*C?3!L0\;(N)6, ;2#B]?P"7,,OOKJ&?X]EVG-U
M6*VOHI]"(8*2T[M*5T1>1N=9,#>+D4 B;$"+[R6$!2T;<M0X];FZ)_K;\XO@
M#=POA_GSQX\/@XH=9XDPAJ*[.!G.CNQRQ^'!B_YFLNN:)HH75JHC]8#/RT,X
M&J:ZWHA^DM;.0&#W!GJ!J1M>.RLDV!6=GW I,YM-YW@+<?AY.+5FV#TM'Y3K
M\,,BJY(C9-5:3R>G./6WSK5^,7X&FM.;0, 7RUO7T':A4\?ID5/%-I E:&+:
M;KC0*# =)0%9-?41O <0;HM#"VG-=#J(M6JPM-R'NOO02<CH93":9"[.T>W]
M/NKIO;TDL M@E.=&D2'-AVW4VAS?,H@:X:JE\T.YUR'IQ<HXYLD44I@[+,DD
M7N!\Y*::9-T"M*DF,[I0=X((#IVA-24_V'VH>H;<?'0;_AA<9Q9D':29'!2B
MXR7"D;&T*6@#KW:>6M,Y8BSQ[ Z#C&K@)F"/6G%NF8@[*CY2C'+&B5X#L!_>
M\_W8?6W[27@B/5;5M+@$92/9,%W3B=M]]DE:*JPLL<Y.<E_PANH!G[*UL6EH
MG  KCHQEG5([@W3H#)VK@\!U+OG8[JGH+W>?KL>G2K!8';QV41I31G\5N.Q<
M#,%' =F/.R]^D^5,XX4=G^%AO/,6!!Z@Q;QA4Z6?P.Y7;%NF> _W6,_]78+^
M]QMNB2Z=VJU$3F<._&$1O#!RK,'#';*]6MG(.&NRN[8[[)B"8>HZ ?(<B;?6
M<IS,$(53V^>XL<#RNX:5318@.H#8<^/TPCIMI!QF*.;;-2A#WDZS%#UV2A"'
MF\MRWG3$+/) ]\CHT2H5=C_V'>Q<(UA0=9=%<F.Q21WSVTDA+RZ>A$_BS^_-
MWZX#O1^[,78W[=S:DUK3"1BTEY>I4T=T;QOGYD>)PP ]Y ET(]RI _>QX>1E
M367 ;>1ZM0:<,YWCUSA]YMD<2>>XA"<X>/[XSX=>+^:V9;3_75@0RN+ST3Q&
MUY7Z.I(CIQIWK;+(3QG?A^*O/;W4QD$'UX27C$2.K"BG?2OYLP:JU?+W&I(0
M,Y4$[6<2;CL;@P79V"J]60-#8TN><]Z!$8M*5%MR]NP+4+OKA,?Z?<Y0<;^-
MB1_^TDF$P@TJ807?<^]'*#KA#]^:4&'!LMKE5R-7J)9WJ^]TU*Q2&.G52@"(
MAO$2+%SW4L&%L:LQ0@R1\H=_H-2 $4H'-$"M\7%0B*/:)"*1^H7+V+"ZPM),
M$84*II#D2?] \NL=1UVFH#BTE%!-N=4;4_/],G^]#:M\S'TH&)9M?DD#9(V.
M4Y/"Q\X8(=330Y^9=UI<;;7-X6 QVF\;3P-"*A)M'L>7 PDQ"(XJ'!)EA3JB
MTD'+L6^\T7BK9HB)NPL337*!GUN4U_[/.*M$IBA334R'5+K^!3AFO_WJF+W_
M3=76P^7^? G]KN6MO7QQ5 [&E:>4,378?LFFTAV*3=7R>ZR!Y-)ED'P_()3Q
M2]#L GJ:BKY'Z")FF7Q59HEJ?DG9SAJAE:#!,,S5SGBEJ;1&*[UEZ\/?FDQ#
M(IBL8^)G)BD]T&(LSXQ3^_&-<7L[RLJ8,P"R=A ]KRWH'$>ZUIK<(C$&F_-H
M1AD]ME;0(TAW?QBU4SF'G+=1D1FOW%!TEQ>;_K6EF%[G6FB^II.MV=6A#S<^
M2(!R9^1*.D[N^)0]>HS0B8%%3OQ>5$Q2^.!40WO]-B.X/3U=-B3Q]Z22!X&G
M\S7E;I)RCT@:D7>V#ZR&3BF=XQ"XZ<!UL2+&M -^R2HJ''N%(WQ>ELL!N>I0
M8CC$S%YE0T L+R[+/'-PP2^S%,9_WN,P15'8-*OZK]]\,T.I?%V6B>00/9IG
MU3+]]"@NE]_  L%"B_J;XV?'WR2^__ZSUFN^VZ[7_.V;E^]?_0N^_/'#3^_^
M_O\!4$L#!!0    (   R8E1PS-+: 1(   $_   1    9#,P,3(W-&1E>#DY
M,2YH=&WM6VMSVSBR_>XJ_P>4=S*5U)44V<[#KZBN+"NVZ_JUDC+9O=\@$I(P
MH0@.0-K1_/H]W0 I2G'LV=UX:F]=3Z42B0*!?O?I;LS1V>CRHG-TUN^>=#8W
MCD;GHXM^I_^WYOY^:_OHM?^*YZ_# G%T?'WR=W%\VKN^N!Y\V/I\=C[J;W7$
MY@86]52:*]LY.CG_10Q'?[_H?]BZTW$^.]AKO=7IEI")GJ8?MA(UR;=XKYMR
MV5S:J4Z;N<D.VEE^*,+WL<ES,_>/)B;-FT[_K@ZVE]\G<JZ3Q<%(SY435^I.
M#,Q<XJ3NQ?GIU8<MJZ<S''5TW.E_G>FQS@6Q)8Y>'W>.7M]T:@34=M_![FOT
M?$/.5N?G=.RR0]H%C'^/CWO>(T'AC?/+4S$<]#YL37?;VSOOWTS;N^V=]KOM
M_?;;=^TWK5^S*3$Q^K!U<7UZ[86U2G#M)*;XWQ59IW=]->KV1@^<\R,TTQE9
M&:F%&$8S:U2L+-G6DQ[8FVDU$9?2?E&Y3J?B>C+1D;)/S>?1I\!JRY6L_G>4
M.=V*S/SH]:?.D_/]<N?M]BMQ]!%JK9QQIG/5=!G(.DC-G9795N?=[GYS;[O=
M/GI-*SOB 8M^]T/D<MSIW0S/1??JZOK35:\_%*.SONCV_OKI?'@^.K^^$M<?
M!8+-Q>BLUQWTQ: _O/XTZ/7%Z>#ZTTU#G%_U6I4#/S&A1^>=X\+I5#DG>F8^
MUJG,M4G%A;I55DZQ?IA;E4[SF3 3/)4Q&=B--;<:ZG;T<("E::%$;Q$E"E:8
MXK4YPJ08*GL+.W3@Y;SS"#\_QL'/E$SR622M E7.%#92XM2:(H-0TZ@E8*ZI
MDQ%S>(; F5#P= ?KCK(\\]T_&2@%Y9?N\46_W.KX>G#2'S212BZZ-\/^0?GA
M04;6N=X2?IL/6^TMT>M?7-QT3T[.KTZK[\.;;J_\_OG\9'3V80OV_F++TS,0
M+E] -1_$5@;=-,=6R2]-G3JH\$#>&AV'A2?ERV]?+)D:G:S]N/MB2_P2L@^$
M4F4BG_-^_LOVF_W[7MM>>^V> ^H;K:XEY:S\&L0K5I4COF]"?U#2G9WVSK:P
MWJ2=D&DL9/QKX7(5B_[Q^>BD2R;_T^YN:\_3CUT3,B=:^=-NZ]W*TP9V<IF"
MP=VJ9.'C(3.,OP;T%YG*L^4]6UZPO!VAOI*YP-@>-<$W[=;V/2;XMK7S@ F&
M9+FY\4"Z?)E9/%JD"NPH]ZJ>-9]M]]EV[[7=86DN(C<B\^@ ]@C#C35E6YD(
MY7(]EV3$/^VLA<EPO-!S>M6#!^P3' (EC<5[(C(NW]QPN2VBO$"&GQ@K\AD]
M)]B"??$AD^GBV5*?+?7[EKJ__8+"YS*\PI*LB@IK"=C>;SIUS/IL._]_;>?]
M>Q$A#YLY53Y6(4\ZA"JRF[F.*6(E.$")F7&9SF4"XXJL06&ULP<I(X2Y/V!?
M/[PFNKP^/K_H-R"B;DN\O)0VFHGM!@?75P(:>=L^%%RNOKSJ#D^Z?SW@;Z\:
M0HK9LIQR)BDHD+LRRC; ;RP7"/*I*=((X3>?R5P@6,\D,?Y;H2T>/E*1;6Z\
M)*-X?W@V.*4/>X>O6N)8.KR)?##,S!>9JH;X+-T,8LX)SF"ET#A!)*$8#>G&
MDEM[]4 R%8 2$9>E\V59&DX<]"[#B37F"$)%^% DK%975K#,FTKE.%E1+ZU.
M=*HCSGLA?0E%[1>MT@A"PI,)%H]UHG-\I3<R5-B@ ZD,']S$EZ,M\1%BC#W?
MV_O[;SRC+,L,FWSEW D ]Z;=%FJ>)6:AE&MX"D$I3+.F+1"%$QP=C_<L[$(D
M)N+DB^TI:=[(2(-*<65L/KM#;F;2AJ;PWQI8%R4%RU=&,E9SK)VK6$?(Y!'W
M0+%[;O48WXV=RE3_SHT#YWG48"53^ ORWFFW_TN,5;RY44FN]>2MOA%X9"-T
MC#_$G71>L7./0;+"ND)ZG"%%K";0(D%D^B&"U/'VU"IO,$Y/"5Y@%_8>'YN"
M"WEV:?>)5]\8+A$@B>^DF,GF1@3[I?=G#.89T%>X:&RL-7<DZ$@"A\-,!.UD
MV0W)0M\=4K"Y-0DK.H)7P<E@-FQ2?XXD5_EARR0N1K8XMCJ>*@H6KA@C:6AI
M%[2$B&]L;MP!X(FYL>P451$"[BTUG,@0IX%YF!AM.;%F7K?D%=LB9<%"0QA9
M=7"3*>M7M>I!)ZLZ59 8E"KF"ZMES+%B)I-$I=3CTJD/$$3(F# IF3V[ZH(M
M@&)>0DA4D\]!V7<*?$G22V0+G9?KK<HE#"F=;F[\5L@$'@:+0*"A\#^9M,1G
MG<] 0Z[DG"B@X  Y>#N@]ZGZLQ0Y5!6&)/LQ2?Q7HU,OLTKN?J<[OZN;2>M1
M\%SG)8:>*X5_9PB8D06=Y+Y!TNRF(6+1IO  F48:"T #L#4606"@\KO:P&^0
MH"!#"A[]I(GLV"QB<6**:2(YLBG"**D/7!%WP-57 #GV8A,ZX*4E^OP;-X2/
M_9\5XS[HE%,-Q8"0QFH5167N>(1XD-^9;U*.[W_V+A'+0Z9H"?B+MN)&X?2!
MNM7JS@>%LX^7W:/AIWMPY-[;%X?B5EG63I,'2 <>!%DU!0;"2QUO1%6: GO8
MOG <FBB.4R0S689@7J1LI8Q&0@\7/F.759+#*2I86XX0S;_.>78 ^Y71K(7,
M7 4HVF?5Y(@2\!^C"@/;,'YX_YV7I_J*\(4CY!A>RJ^%Q$>[,!1J.G(<@Y]L
MC1W\2@9>9:UE[L&Q/8-2LI]&^,<V/+%E'C*\1OG?JOW@9C@X<49P]%F1PE22
M#\'=)<1-61K;:&0SN/R4W([E NFZF>%Z@.E65'TN(_;F1I7@2=!4AH+ZE@<3
M(B!]<93]T8&9J/O!WEK-\.3S0Y_,MSK-R^M!OUF23ZW*D_-?@%##P!,<\1^P
MQ07#JG^K^3?TT*-:13%6D!,JBN1.+AP-^X[.!F)X_K]@;'>KW)('K@=_V>?_
M5JN5DMQ>_VK4'_R+T]BGG,>&D4\((SY.=VL A-+F(].)1R:M_S:%-^0%.T\]
M%?P6(Y6,_1"/>%(=5K6(KS"FY/HP3FH_30& )P2\C TIA4(%9]:\-E5R!4=A
MYZ.-07BA$,+P@8)(A&A""6ISHP9.0WGA5W'BYI<!C)#7P^F+*LOG7(3X6"G&
MC%1!R$Q/9ZA"O_K>1MG.*+L<C1"<?!8$C,UST9O).79RB+<^>RX!P%KV;(6L
M24B0LD<9U/'S2F99S5$!YN)Y/5P&2#A3229B2ZDZ]/X ?2#%E?#M>^$DP+%*
M%0N?T&$-.P?01Y5:U8!D=,9!?<IM0]9F&M(8.ZG7_DK ?D+8,LQ)"9L;EU'/
M+!H/(150VO BJ^&4Q)@O9'1WTC)0(11(##,GD!N*!BJI]._TT/CBKAHB $-"
M.@4^!6M:8H1%60G6X!TIL,37W-5@5-#R9ZT ?E0RMX2F$Y-.F["J-"XA\$3>
M&DLFNKEA55;D'D5]>Y;?.TN RD,-I3R"]>73'"]%@+_4Z(5H[HS]PM5/8AQ5
M$.P,;'P>,Y!D8I5 H 0/I"N8!!I]8 \7T$ZDE <,+)ZR6(",QWA3W:[A)-_G
M((MBBRV;VI#=;X5Z&&RAX#,H+;C<\9@>A;[R1#/@3M?\A&C+@DT').EC A]=
M6C_74=]#XW^6.;,M>!\V2<S*2@%&"3Q1G9OX0H8T 8V.4?BR \?:146H^&(J
MDA+GD;5V*V4Z_GQ6<:I<+.$KM52R4Y7;N=@_:+>%;,U;HH_ME4T%4<G(6Z3%
M? P;H*!+M)0S @H'5GJ% .VI)=&(]$A-CUTA>73!WOOWS3?M]\WVWGZ[%49F
MY>1L!.O0(+0"TRO2 85("V4Y_.A!N^TF9%-N;5+4JF3G<"0([);DZ .=[]*5
M_0,<Y@BI@]5/G;N[NU;]GL[3]Q#JK8Q$3:G:C4$K6.? L)9#[Z3S2K^4BQ1A
MKP%N*-+[AS_+>78H3E'$-,1-J]=B>SN&+E&@F5CT?#P477^ $Q<7/5^>46'B
MR-62PI$"EOFN),;7(0^*8^]'W;OYU.ERE<3^1%KX,R[\^*3QO>;IO>U>DF[5
M!B5WHN#L$TC5SFN0R6E;]4*Y=6)<WI1(<L JM&-H6&DJD5=:G>_W&R&9P1')
M=#-I&0,1(KE5M3@<FM7]6Z[[&Z39ANC.E:7Z-Z#KD8IF'DXWZNTI7JJO5/XW
M"L:.+,IF+1&_'K^6XA25[P!OARW*3,>%)UYLB>O[\P*S91#7?'.0, V)M-Y4
M\2(-381*=)Q4%(N57!+!**5D0?FMMH*$+1'\<X2NLFGL9;EL$S5J;1RN5U<:
M.<N>6(75RO%%JQ1C:0&^L6_53*7L'7W49TLK^([B P8FW4O@F$0SO QFT+I/
M-V1])E7<%25B?9>EB@TT/W'Y:G]EE9)O[/$A0UOB%:\G.CMLSJV^</.M4>_Y
MTP%^6A"+\U%U%B1-8,<G<9V[):BOP]Z&UQHRCW<C* ][@I+2QC8W@I'5"*HQ
M!X>-*<4M-5HJ7J73<H QX;@9:W!1E$J8W=/R;%567.EXK77BS"2_HW=J\XT:
M9PSA(Q03?OQ.(WU'':>*"I/13#]!_M'S<6$=TT?^;3U8T2DW$EDRFQL^._VS
M">A'1=R/'D,W+P"HB?<AU4)S!H]_REW+\\Z($EW&G6^KN/7( )U;4@'A-Y-
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M,3(W-&0X:RYH=&U02P$"% ,4    "   ,F)4+U-@I=]1 0"C2P< $
M        @ %N)0  9#,P,3(W-&1E>#(Q+FAT;5!+ 0(4 Q0    (   R8E1P
MS-+: 1(   $_   1              "  7MW 0!D,S Q,C<T9&5X.3DQ+FAT
7;5!+!08     !@ & 'X!  "KB0$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
